apiLogger::2021-10-11 07:23:24,445::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 07:23:24,458::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 07:23:24,459::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3l6xxz40 
apiLogger::2021-10-11 07:23:24,460::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 07:23:24,460::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 07:23:24,572::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 07:23:24,572::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3l6xxz40
apiLogger::2021-10-11 07:23:26,191::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 07:23:26,191::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 07:23:26,191::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 07:23:26,191::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 07:23:26,196::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 07:23:26,196::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 07:23:26,196::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 07:23:26,196::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 07:23:26,200::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 07:23:26,200::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 07:23:26,200::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-11 07:23:26,200::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-11 07:23:26,203::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-11 07:23:26,203::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-11 07:23:26,203::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 07:23:26,203::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-11 07:23:26,203::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-11 07:23:26,204::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 07:23:26,204::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-11 07:23:26,204::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 07:23:26,204::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 07:23:26,204::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 07:23:40,591::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 07:23:40,591::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 07:37:34,587::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 07:37:34,592::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 07:37:34,593::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpo50mck28 
apiLogger::2021-10-11 07:37:34,593::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 07:37:34,593::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 07:37:34,685::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 07:37:34,685::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpo50mck28
apiLogger::2021-10-11 07:37:36,544::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 07:37:36,545::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 07:37:36,545::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 07:37:36,545::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 07:37:36,548::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 07:37:36,549::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 07:37:36,549::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 07:37:36,549::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 07:37:36,552::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-11 07:37:36,552::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 07:37:36,552::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 07:37:36,552::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-11 07:37:36,552::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-11 07:37:36,552::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 07:37:36,552::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-11 07:37:36,552::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 07:37:36,552::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 07:37:36,553::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 07:37:50,940::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 07:37:50,940::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 08:11:41,779::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 08:11:41,821::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 08:11:41,821::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi99sk7fg 
apiLogger::2021-10-11 08:11:41,823::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 08:11:41,823::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 08:11:43,021::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 08:11:43,021::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi99sk7fg
apiLogger::2021-10-11 08:11:47,768::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 08:11:47,768::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 08:11:47,768::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 08:11:47,768::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 08:11:47,772::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-11 08:11:47,772::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 08:11:47,772::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 08:11:47,772::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 08:11:47,772::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-11 08:11:47,773::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 08:11:47,773::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-11 08:11:47,773::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 08:11:47,773::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 08:11:47,773::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fad648bdcc0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 08:12:12,322::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 08:12:12,322::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 08:50:35,049::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 08:50:35,050::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 08:50:35,050::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpielhm0x4 
apiLogger::2021-10-11 08:50:37,207::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 08:50:37,207::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 08:50:37,232::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 08:50:37,232::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpielhm0x4
apiLogger::2021-10-11 08:50:37,654::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 08:50:37,654::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 08:50:37,654::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 08:50:37,654::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 08:50:37,659::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-11 08:50:37,659::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 08:50:37,659::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 08:50:37,659::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 08:50:37,659::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-11 08:50:37,660::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 08:50:37,660::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-11 08:50:37,660::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 08:50:37,660::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 08:50:37,660::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7bc744278>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 08:51:07,768::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 08:51:07,768::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 08:51:18,734::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 08:51:18,735::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 08:51:18,736::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfm75m5jz 
apiLogger::2021-10-11 08:51:18,736::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 08:51:18,736::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 08:51:18,760::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 08:51:18,760::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfm75m5jz
apiLogger::2021-10-11 08:51:19,151::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 08:51:19,151::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 08:51:19,152::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 08:51:19,152::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 08:51:19,154::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-11 08:51:19,154::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 08:51:19,155::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 08:51:19,155::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 08:51:19,155::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-11 08:51:19,155::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 08:51:19,155::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-11 08:51:19,155::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 08:51:19,155::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 08:51:19,155::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 08:51:29,279::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 08:51:29,279::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 09:29:20,617::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 09:29:20,718::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 09:29:20,718::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnjohjc2h 
apiLogger::2021-10-11 09:29:20,722::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 09:29:20,722::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 09:29:21,436::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 09:29:21,436::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnjohjc2h
apiLogger::2021-10-11 09:29:25,428::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 09:29:25,428::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 09:29:25,428::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 09:29:25,428::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 09:29:25,433::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-11 09:29:25,433::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 09:29:25,433::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 09:29:25,433::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 09:29:25,433::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-11 09:29:25,433::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 09:29:25,433::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-11 09:29:25,433::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 09:29:25,433::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 09:29:25,433::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 09:29:58,671::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 09:29:58,671::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 11:21:26,478::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 11:21:26,522::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 11:21:26,523::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgkcgw_m7 
apiLogger::2021-10-11 11:21:26,524::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 11:21:26,524::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 11:21:27,730::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 11:21:27,730::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgkcgw_m7
apiLogger::2021-10-11 11:21:32,548::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 11:21:32,549::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 11:21:32,549::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 11:21:32,549::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 11:21:32,553::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-11 11:21:32,553::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 11:21:32,553::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 11:21:32,553::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 11:21:32,553::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-11 11:21:32,553::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 11:21:32,553::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-11 11:21:32,553::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 11:21:32,553::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 11:21:32,553::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 11:21:57,706::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 11:21:57,706::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 11:35:34,078::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 11:35:34,078::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 11:35:34,079::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmcnqi_f2 
apiLogger::2021-10-11 11:35:34,079::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 11:35:34,079::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 11:35:34,084::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 11:35:34,084::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmcnqi_f2
apiLogger::2021-10-11 11:35:34,097::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 11:35:34,097::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 11:35:34,097::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 11:35:34,097::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 11:35:34,100::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 11:35:34,100::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 11:35:34,101::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 11:35:34,101::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 11-Oct-2021 11:34:11 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : test\n ']
apiLogger::2021-10-11 11:35:34,101::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-11 11:35:34,101::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 11:39:36,066::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 11:39:36,072::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 11:39:36,072::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_o3zr2vn 
apiLogger::2021-10-11 11:39:36,073::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 11:39:36,073::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 11:39:36,171::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 11:39:36,171::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_o3zr2vn
apiLogger::2021-10-11 11:39:38,766::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 11:39:38,766::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 11:39:38,766::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 11:39:38,766::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 11:39:38,770::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 11:39:38,770::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 11:39:38,770::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 11:39:38,770::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 11:39:38,772::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-11 11:39:38,773::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 11:39:38,773::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 11:39:38,773::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-11 11:39:38,773::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,001\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nMETOPROLO Medical 1_HYPERTENSION_UN\n1 L History /UNK/2005 UN/UNK/2005 Yes 0.5 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 21/JAN/\n9 TARGIN Event 2020 4/JAN/2021 No 2021 10/5 mg BID Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/\n10 ENDONE Event 2020 4/JAN/2021 Yes 5 mg PRN Oral\n2_LEFT AXILLA\nAdverse DISCOMFORT_16/\n11 TARGIN Event NOV/2020 21/JAN/2021 Yes 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_05-MAR-2021']
apiLogger::2021-10-11 11:39:38,773::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 11:39:38,773::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-11 11:39:38,773::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 11:39:38,773::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 11:39:38,773::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 11:39:55,741::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 11:39:55,742::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 11:52:26,093::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 11:52:26,138::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 11:52:26,138::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdkyi6_js 
apiLogger::2021-10-11 11:52:26,140::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 11:52:26,140::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 11:52:27,343::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 11:52:27,343::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdkyi6_js
apiLogger::2021-10-11 11:52:32,138::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 11:52:32,139::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 11:52:32,139::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 11:52:32,139::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 11:52:32,142::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-11 11:52:32,142::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 11:52:32,142::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 11:52:32,142::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 11:52:32,142::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-11 11:52:32,143::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 11:52:32,143::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-11 11:52:32,143::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 11:52:32,143::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 11:52:32,143::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 11:52:57,309::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 11:52:57,309::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 12:09:18,679::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 12:09:18,681::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 12:09:18,681::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpcsj5bupz 
apiLogger::2021-10-11 12:09:18,681::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 12:09:18,681::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 12:09:18,712::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 12:09:18,712::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpcsj5bupz
apiLogger::2021-10-11 12:09:19,021::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 12:09:19,021::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 12:09:19,021::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 12:09:19,021::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 12:09:19,024::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-11 12:09:19,024::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 12:09:19,024::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 12:09:19,024::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 12:09:19,024::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-11 12:09:19,025::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 12:09:19,025::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-11 12:09:19,025::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 12:09:19,025::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 12:09:19,025::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 12:09:27,430::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 12:09:27,430::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 12:17:18,792::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 12:17:18,836::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 12:17:18,837::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmtfndbuu 
apiLogger::2021-10-11 12:17:18,838::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 12:17:18,839::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 12:17:20,043::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 12:17:20,043::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmtfndbuu
apiLogger::2021-10-11 12:17:24,841::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 12:17:24,841::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 12:17:24,841::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 12:17:24,842::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 12:17:24,845::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-11 12:17:24,845::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 12:17:24,845::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 12:17:24,845::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 12:17:24,845::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-11 12:17:24,846::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 12:17:24,846::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-11 12:17:24,846::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 12:17:24,846::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 12:17:24,846::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 12:17:50,212::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 12:17:50,212::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 13:23:18,700::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 13:23:18,707::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 13:23:18,707::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpai0n2n8a 
apiLogger::2021-10-11 13:23:18,707::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 13:23:18,708::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 13:23:18,821::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 13:23:18,821::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpai0n2n8a
apiLogger::2021-10-11 13:23:20,449::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 13:23:20,449::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 13:23:20,449::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 13:23:20,449::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 13:23:20,452::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 13:23:20,452::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 13:23:20,452::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 13:23:20,452::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 13:23:20,455::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 13:23:20,456::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 13:23:20,456::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-11 13:23:20,456::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-11 13:23:20,458::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-11 13:23:20,458::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-11 13:23:20,458::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 13:23:20,458::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-11 13:23:20,459::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-11 13:23:20,459::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 13:23:20,459::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-11 13:23:20,459::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 13:23:20,459::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 13:23:20,459::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 13:23:35,118::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 13:23:35,118::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 13:37:18,897::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 13:37:18,940::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 13:37:18,940::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1a_7t2iy 
apiLogger::2021-10-11 13:37:18,942::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 13:37:18,942::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 13:37:20,151::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 13:37:20,151::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1a_7t2iy
apiLogger::2021-10-11 13:37:24,951::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 13:37:24,951::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 13:37:24,951::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 13:37:24,951::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 13:37:24,955::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-11 13:37:24,955::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 13:37:24,955::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 13:37:24,955::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 13:37:24,955::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-11 13:37:24,955::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 13:37:24,955::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-11 13:37:24,956::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 13:37:24,956::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 13:37:24,956::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 13:37:50,112::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 13:37:50,112::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 13:57:22,329::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 13:57:22,371::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 13:57:22,372::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi89wkokg 
apiLogger::2021-10-11 13:57:22,373::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 13:57:22,374::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 13:57:23,584::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 13:57:23,584::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi89wkokg
apiLogger::2021-10-11 13:57:28,394::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 13:57:28,395::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 13:57:28,395::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 13:57:28,395::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 13:57:28,398::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-11 13:57:28,398::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 13:57:28,398::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 13:57:28,398::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 13:57:28,399::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-11 13:57:28,399::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 13:57:28,399::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-11 13:57:28,399::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 13:57:28,399::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 13:57:28,399::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 13:57:53,680::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 13:57:53,680::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 18:27:32,173::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 18:27:32,178::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 18:27:32,179::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqa4drdud 
apiLogger::2021-10-11 18:27:32,179::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 18:27:32,180::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 18:27:32,272::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 18:27:32,272::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqa4drdud
apiLogger::2021-10-11 18:27:34,146::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 18:27:34,146::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 18:27:34,146::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 18:27:34,146::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 18:27:34,149::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 18:27:34,149::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 18:27:34,150::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 18:27:34,150::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 18:27:34,153::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-11 18:27:34,153::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 18:27:34,153::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 18:27:34,153::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-11 18:27:34,153::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-11 18:27:34,153::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 18:27:34,153::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-11 18:27:34,153::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 18:27:34,153::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 18:27:34,154::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 18:27:48,941::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 18:27:48,941::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 18:43:42,191::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 18:43:42,197::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 18:43:42,197::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9iyyuwte 
apiLogger::2021-10-11 18:43:42,197::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 18:43:42,197::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 18:43:42,290::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 18:43:42,290::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9iyyuwte
apiLogger::2021-10-11 18:43:44,159::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 18:43:44,159::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 18:43:44,159::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 18:43:44,159::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 18:43:44,162::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 18:43:44,162::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 18:43:44,163::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 18:43:44,163::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 18:43:44,165::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-11 18:43:44,165::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 18:43:44,166::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 18:43:44,166::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-11 18:43:44,166::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-11 18:43:44,166::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 18:43:44,166::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-11 18:43:44,166::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 18:43:44,166::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 18:43:44,166::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 18:43:58,847::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 18:43:58,847::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 20:11:18,761::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 20:11:18,762::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 20:11:18,763::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp341blkh9 
apiLogger::2021-10-11 20:11:18,763::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 20:11:18,763::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 20:11:18,794::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 20:11:18,794::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp341blkh9
apiLogger::2021-10-11 20:11:19,188::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 20:11:19,188::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 20:11:19,188::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 20:11:19,188::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 20:11:19,191::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-11 20:11:19,192::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 20:11:19,192::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 20:11:19,192::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 20:11:19,192::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-11 20:11:19,192::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 20:11:19,192::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-11 20:11:19,192::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 20:11:19,192::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 20:11:19,192::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 20:11:29,408::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 20:11:29,408::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 21:05:18,617::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 21:05:18,619::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 21:05:18,619::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp69cn23m5 
apiLogger::2021-10-11 21:05:18,620::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 21:05:18,620::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 21:05:18,624::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 21:05:18,624::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp69cn23m5
apiLogger::2021-10-11 21:05:19,538::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 21:05:19,538::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 21:05:19,538::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 21:05:19,538::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 21:05:19,542::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-11 21:05:19,542::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 21:05:19,542::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-11 21:05:19,542::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-11 21:05:19,542::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(0)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-11 21:05:19,542::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-11 21:05:19,542::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-11 21:05:19,542::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-11 21:05:19,542::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-11 21:05:19,543::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-11 21:05:29,521::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-11 21:05:29,521::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-11 21:59:24,547::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-11 21:59:24,549::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-11 21:59:24,549::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3tiu5irs 
apiLogger::2021-10-11 21:59:24,549::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-11 21:59:24,549::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-11 21:59:24,582::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-11 21:59:24,583::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3tiu5irs
apiLogger::2021-10-11 21:59:24,771::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-11 21:59:24,772::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-11 21:59:24,772::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-11 21:59:24,772::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-11 21:59:24,776::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 21:59:24,776::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-11 21:59:24,776::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-11 21:59:24,776::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-11 21:59:24,779::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-11 21:59:24,779::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-11 21:59:24,779::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-11 21:59:24,779::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 11-Oct-2021 21:58:47 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : FW: EPIC68 (Brainstorm for Data Subteam )\n-----Original Appointment----- From: Dennis Lumbao <dennis.lumbao@regeneron.com> Sent: Monday,\nOctober 11, 2021 5:22 PM To: Dennis Lumbao; Marc Lamberti-External Subject: EPIC68 (Brainstorm for\nData Subteam ) When: Tuesday, October 12, 2021 3:05 PM-3:30 PM (UTC-05:00) Eastern Time (US\n&Canada). Where: Microsoft Teams Meeting \n________________________________________________________________________________ \nMicrosoft Teams meeting\n \nJoin on your computer or mobile app \nClick here to join the meeting\nJoin with a video conferencing device \nteams@video.regeneron.com\nVideo Conference ID: 112 497 152 9 \nAlternate VTC instructions\nOr call in (audio only) \n+1 914-487-4281,,274190928#United States, Yonkers \nPhone Conference ID: 274 190 928# \nFind a local number| Reset PIN\nLearn More| Help| Meeting options\n________________________________________________________________________________ \n------------\nFrom: Dennis Lumbao \nSent: Monday, October 11, 2021 4:28 PM \nTo: Marc Lamberti-External \nSubject: RE: EPIC #68 Project Team Weekly Check In (Build Phase) <<>>\nHi Marc,\nThanks for sharing. Can we chat soon. Would like to see if there is a way you can help the Data\nsubteam/Elaine put together a mini project plan. \nAppears from the past 2 weeks, she tied up and want to brainstorm with you. \nD\nDennis Lumbao\n(914) 847-7825|wk.mobile (914) 374-2981 \ndennis.lumbao@regeneron.com\nFrom: Marc Lamberti-External <marc.lamberti@regeneron.com> Sent: Monday, October 11,\n2021 2:04 PM To: Dennis Lumbao <dennis.lumbao@regeneron.com>; Elaine Job <\nelaine.job@regeneron.com>; Rita Oommen <rita.oommen@regeneron.com>; Nagwa Khilla <\nnagwa.khilla@regeneron.com>; Rhonda Morgan <rhonda.morgan@regeneron.com>; Gemma\nSayers <gemma.sayers@regeneron.com>; Selena Smith <selena.smith@regeneron.com>;\nGerald Stanley <gerald.stanley@regeneron.com>; Ben Ogunsulire <\nolugbenga.ogunsulire@regeneron.com>; Anu Verma <anu.verma@regeneron.com>; Jonathan\nVan Tol <jonathan.vantol@regeneron.com>; Anne Smith <anne.smith@regeneron.com>; Emmanuel Okoye <emmanuel.okoye@regeneron.com>; Shazia Ali <shazia.ali@regeneron.com\n>; Elizabeth Stankevich <elizabeth.stankevich@regeneron.com>; Maureen Heu <\nmaureen.heu@regeneron.com>; Quasheeda Fields <quasheeda.fields@regeneron.com>; Lauren\nEarp <lauren.earp@regeneron.com>; Magaly Woolard <magaly.woolard@regeneron.com>\nSubject: RE: EPIC #68 Project Team Weekly Check In (Build Phase) <<>>\nHi All,\nBelow is the link to the Medidata Safety Gateway demo mentioned during today’s call:\nhttps://app.goconsensus.com/play/64b62b16?autoplay\nI felt the Medidata team did a great job providing an overview of the product and how it could help\naddress current challenges.\nFeel free to start at 3:55 to skip over introductions.\nBest Regards,\nMarc\nMarc Lamberti\n617.515.6030\nUpcoming PTO: 22-Oct']
apiLogger::2021-10-11 21:59:24,779::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-11 21:59:24,779::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 00:45:18,768::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 00:45:18,789::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 00:45:18,789::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprgp80q3f 
apiLogger::2021-10-12 00:45:18,790::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 00:45:18,790::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 00:45:18,999::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 00:45:18,999::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprgp80q3f
apiLogger::2021-10-12 00:45:21,824::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 00:45:21,824::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 00:45:21,824::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 00:45:21,824::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 00:45:21,828::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 00:45:21,828::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 00:45:21,828::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 00:45:21,828::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 00:45:21,828::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-12 00:45:21,828::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 00:45:21,828::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 00:45:21,828::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 00:45:21,828::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 00:45:21,829::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 00:45:41,355::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 00:45:41,355::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 01:01:18,946::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 01:01:19,047::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 01:01:19,047::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppl3h7lwr 
apiLogger::2021-10-12 01:01:19,052::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 01:01:19,052::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 01:01:19,769::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 01:01:19,769::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppl3h7lwr
apiLogger::2021-10-12 01:01:23,665::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 01:01:23,665::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 01:01:23,665::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 01:01:23,665::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 01:01:23,668::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 01:01:23,669::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 01:01:23,669::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 01:01:23,669::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 01:01:23,669::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-12 01:01:23,669::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 01:01:23,669::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 01:01:23,669::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 01:01:23,669::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 01:01:23,669::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 01:01:57,073::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 01:01:57,073::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 04:01:25,091::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 04:01:25,118::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 04:01:25,119::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpc2nce_lo 
apiLogger::2021-10-12 04:01:25,120::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 04:01:25,120::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 04:01:25,500::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 04:01:25,501::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpc2nce_lo
apiLogger::2021-10-12 04:01:28,839::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 04:01:28,839::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 04:01:28,839::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 04:01:28,840::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 04:01:28,843::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 04:01:28,843::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 04:01:28,843::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 04:01:28,843::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 04:01:28,844::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-12 04:01:28,844::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 04:01:28,844::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 04:01:28,844::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 04:01:28,844::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 04:01:28,844::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 04:01:49,085::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 04:01:49,085::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 04:15:33,331::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 04:15:33,374::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 04:15:33,375::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphwurbqi4 
apiLogger::2021-10-12 04:15:33,376::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 04:15:33,376::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 04:15:34,585::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 04:15:34,585::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphwurbqi4
apiLogger::2021-10-12 04:15:39,391::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 04:15:39,391::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 04:15:39,391::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 04:15:39,392::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 04:15:39,395::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 04:15:39,396::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 04:15:39,396::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 04:15:39,396::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 04:15:39,396::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-12 04:15:39,396::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 04:15:39,396::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 04:15:39,396::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 04:15:39,396::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 04:15:39,396::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 04:16:04,589::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 04:16:04,589::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 04:16:04,694::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 04:16:04,757::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 04:16:04,757::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpt2c6htl3 
apiLogger::2021-10-12 04:16:04,759::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 04:16:04,760::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 04:16:05,716::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 04:16:05,717::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpt2c6htl3
apiLogger::2021-10-12 04:16:09,110::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 04:16:09,110::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 04:16:09,110::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 04:16:09,110::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 04:16:09,114::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 04:16:09,114::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 04:16:09,114::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 04:16:09,114::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 04:16:09,114::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-12 04:16:09,114::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 04:16:09,114::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 04:16:09,114::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 04:16:09,114::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 04:16:09,114::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 04:16:32,997::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 04:16:32,997::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 05:13:18,871::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 05:13:18,880::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 05:13:18,881::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp64wen9l3 
apiLogger::2021-10-12 05:13:18,882::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 05:13:18,882::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 05:13:18,964::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 05:13:18,964::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp64wen9l3
apiLogger::2021-10-12 05:13:21,240::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 05:13:21,240::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 05:13:21,240::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 05:13:21,240::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 05:13:21,244::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 05:13:21,244::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 05:13:21,244::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 05:13:21,244::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 05:13:21,244::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-12 05:13:21,245::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 05:13:21,245::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 05:13:21,245::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 05:13:21,245::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 05:13:21,245::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 05:13:32,616::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 05:13:32,616::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 05:35:29,589::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 05:35:29,617::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 05:35:29,617::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpo8qe3guv 
apiLogger::2021-10-12 05:35:29,619::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 05:35:29,619::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 05:35:29,999::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 05:35:30,000::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpo8qe3guv
apiLogger::2021-10-12 05:35:33,343::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 05:35:33,343::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 05:35:33,343::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 05:35:33,343::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 05:35:33,347::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 05:35:33,347::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 05:35:33,347::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 05:35:33,347::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 05:35:33,347::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-12 05:35:33,347::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 05:35:33,347::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 05:35:33,347::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 05:35:33,347::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 05:35:33,348::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 05:35:53,909::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 05:35:53,910::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 05:37:30,729::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 05:37:30,757::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 05:37:30,757::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3y_ia9n0 
apiLogger::2021-10-12 05:37:30,759::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 05:37:30,759::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 05:37:31,139::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 05:37:31,139::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3y_ia9n0
apiLogger::2021-10-12 05:37:34,468::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 05:37:34,468::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 05:37:34,468::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 05:37:34,469::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 05:37:34,472::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 05:37:34,472::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 05:37:34,472::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 05:37:34,472::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 05:37:34,473::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-12 05:37:34,473::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 05:37:34,473::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 05:37:34,473::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 05:37:34,473::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 05:37:34,473::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 05:37:54,919::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 05:37:54,919::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 05:53:18,701::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 05:53:18,712::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 05:53:18,712::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmptcs1y4ix 
apiLogger::2021-10-12 05:53:18,713::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 05:53:18,713::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 05:53:19,217::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 05:53:19,217::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmptcs1y4ix
apiLogger::2021-10-12 05:53:22,304::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 05:53:22,304::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 05:53:22,304::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 05:53:22,304::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 05:53:22,308::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 05:53:22,308::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 05:53:22,308::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 05:53:22,308::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 05:53:22,311::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 05:53:22,311::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 05:53:22,311::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 05:53:22,311::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-12 05:53:22,311::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,008\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2? Yes\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\n1\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n8_PAROXY\nSMAL\nATRIAL\nFIBRILLATI\nMETOPROLO Medical 1_HYPERTENSION_UN ON_UN/ 3/MAR/\n1 L History /UNK/2005 UNK/2017 UN/UNK/2005 No 2021 25 mg QD Oral\nMedical 1_HYPERTENSION_UN\n2 FRUSEMIDE History /UNK/2005 UN/UNK/2005 Yes 40 mg QD Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_UN/UNK/2005 UN/UNK/2005 Yes 10 mg QD Oral\nMedical 3_DIABETES_UN/UNK/\n4 METFORMIN History 2005 UN/UNK/2005 Yes 500 mg QD Oral\n1_LEFT AXILLA\nAdverse CELLULITIS_16/NOV/ 26/NOV/\n5 CEPHALEXIN Event 2020 16/NOV/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 14/DEC/ Intraven\n6 LLIN Event 2020 9/DEC/2020 No 2020 1 g QID ous\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 19/DEC/\n7 LLIN Event 2020 14/DEC/2020 No 2020 500 mg QID Oral\n1_LEFT AXILLA\nFLUCLOXACI Adverse CELLULITIS_16/NOV/ 26/DEC/\n8 LLIN Event 2020 21/DEC/2020 No 2020 500 mg QID Oral\nAdverse 2_LEFT AXILLA 21/JAN/\n9 TARGIN Event PAIN_16/NOV/2020 4/JAN/2021 No 2021 10/5 mg BID Oral\nAdverse 2_LEFT AXILLA\n10 ENDONE Event PAIN_16/NOV/2020 4/JAN/2021 Yes 5 mg PRN Oral\nAdverse 2_LEFT AXILLA 22/FEB/\n11 TARGIN Event PAIN_16/NOV/2020 21/JAN/2021 No 2021 15/7.5 mg BID Oral\n3_ATRIAL\nAdverse FIBRILLATION_4/MAR/ 4/MAR/\n12 DIGOXIN Event 2021 4/MAR/2021 No 2021 250 mcg Other STAT Oral\n8_PAROXYSMAL\nATRIAL\nMedical FIBRILLATION_UN/\n13 WARFARIN History UNK/2017 UN/DEC/2017 Yes mg QD Oral\n3_ATRIAL\nMETOPROLO Adverse FIBRILLATION_4/MAR/\n14 L Event 2021 4/MAR/2021 Yes 25 mg BID Oral\nAdverse 4_HYPOMAGNESEMIA\n15 MAGMIN Event _4/MAR/2021 4/MAR/2021 Yes 2 Tablet BID Oral\nPARACETAM Adverse 2_LEFT AXILLA\n16 OL Event PAIN_16/NOV/2020 23/FEB/2021 Yes 1330 mg TID Oral\nAdverse 2_LEFT AXILLA Sublingu\n17 FENTANYL Event PAIN_16/NOV/2020 12/MAR/2021 Yes 300 mcg PRN al\nAdverse 2_LEFT AXILLA\n18 TARGIN Event PAIN_16/NOV/2020 23/FEB/2021 Yes 20/10 mg BID Oral\nAdverse 8_SKIN ULCERATION Intraven\n19 CEFAZOLIN Event - SACRAL_7/APR/2021 7/APR/2021 Yes 1 g QID ous\n6_LEFT AXILLA\nMETRONIDA Adverse CELLULITIS_9/DEC/\n20 ZOLE GEL Event 2020 16/MAR/2021 No 8/APR/2021 1 Other APPLICATION BID Topical\nAdverse 8_SKIN ULCERATION\n21 CEFAZOLIN Event - SACRAL_7/APR/2021 9/APR/2021 Yes 500 mg QID Oral\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nSKIN PUNCH\n1 BIOPSY Diagnostic 11/DEC/2020\nLATERAL LEFT\nCHEST WALL CORE\n2 BIOPSY Diagnostic 24/DEC/2020\nLEFT AXILLA\n3 ULTRASOUND Diagnostic 16/NOV/2020\nSKIN PUNCH\n4 BIOPSY Diagnostic 14/DEC/2020\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 HYPERTENSION UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\n3 DIABETES UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nRADIATION\n4 DERMATITIS 01/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\n5 FATIGUE 16/AUG/2020 UNCHECKED Yes Grade 1 UNCHECKED\nLEFT ARM\n6 LYMPHOEDEMA UN/JUL/2020 UNCHECKED Yes Grade 1 UNCHECKED\nISCHAEMIC HEART\n7 DISEASE UN/UNK/2005 UNCHECKED Yes Grade 1 UNCHECKED\nPAROXYSMAL\n8 ATRIAL FIBRILLATION UN/UNK/2017 UNCHECKED Yes Grade 1 UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: non-HN CSCC\nDate of Initial Diagnosis 4 SEP 2019\nStage Based on Surgical Pathology Stage I\nT T1\nN N2a\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion CHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve: AXILLA\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_22-APR-2021']
apiLogger::2021-10-12 05:53:22,312::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 05:53:22,312::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 05:53:22,312::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 05:53:22,312::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 05:53:22,312::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 05:53:41,611::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 05:53:41,611::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 05:55:18,885::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 05:55:18,928::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 05:55:18,928::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8mr01vge 
apiLogger::2021-10-12 05:55:18,930::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 05:55:18,930::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 05:55:20,136::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 05:55:20,136::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8mr01vge
apiLogger::2021-10-12 05:55:24,941::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 05:55:24,941::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 05:55:24,941::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 05:55:24,941::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 05:55:24,945::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 05:55:24,945::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 05:55:24,945::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 05:55:24,945::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 05:55:24,945::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-12 05:55:24,946::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 05:55:24,946::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 05:55:24,946::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 05:55:24,946::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 05:55:24,946::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 05:55:50,583::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 05:55:50,583::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 06:11:18,826::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 06:11:18,830::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 06:11:18,831::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx5vxe0z4 
apiLogger::2021-10-12 06:11:18,831::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 06:11:18,831::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 06:11:18,906::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 06:11:18,906::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx5vxe0z4
apiLogger::2021-10-12 06:11:20,954::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 06:11:20,954::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 06:11:20,954::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 06:11:20,954::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 06:11:20,958::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 06:11:20,958::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 06:11:20,958::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 06:11:20,958::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 06:11:20,958::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-12 06:11:20,958::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 06:11:20,958::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 06:11:20,958::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 06:11:20,958::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 06:11:20,958::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 06:11:36,247::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 06:11:36,247::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 06:21:22,426::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 06:21:22,441::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 06:21:22,441::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpunwhx09l 
apiLogger::2021-10-12 06:21:22,442::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 06:21:22,443::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 06:21:23,769::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 06:21:23,769::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpunwhx09l
apiLogger::2021-10-12 06:21:25,112::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 06:21:25,112::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 06:21:25,112::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 06:21:25,112::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 06:21:25,116::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 06:21:25,116::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 06:21:25,116::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 06:21:25,116::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 06:21:25,120::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 06:21:25,120::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 06:21:25,120::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-12 06:21:25,120::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-12 06:21:25,120::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-12 06:21:25,120::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 06:21:25,440::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 06:21:25,454::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 06:21:25,454::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyca4qayq 
apiLogger::2021-10-12 06:21:25,455::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 06:21:25,455::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 06:21:25,601::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 06:21:25,601::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyca4qayq
apiLogger::2021-10-12 06:21:26,109::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 06:21:26,109::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 06:21:26,109::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 06:21:26,109::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 06:21:26,114::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 06:21:26,114::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 06:21:26,114::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 06:21:26,114::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-12 06:21:26,115::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-12 06:21:26,115::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 06:21:26,528::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 06:21:26,528::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 06:21:26,529::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6wbo9_b0 
apiLogger::2021-10-12 06:21:26,529::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 06:21:26,529::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 06:21:26,534::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 06:21:26,534::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6wbo9_b0
apiLogger::2021-10-12 06:21:26,547::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 06:21:26,547::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 06:21:26,547::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 06:21:26,548::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 06:21:26,551::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 06:21:26,551::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 06:21:26,551::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 06:21:26,551::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Prashant Kapoor-External <prashant.kapoor@regeneron.com>\nReceived Date : 12-Oct-2021 06:20:46 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial - Prashant Kapoor\nScenario 1 12-Oct-2021 ']
apiLogger::2021-10-12 06:21:26,551::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-12 06:21:26,551::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 06:27:26,699::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 06:27:26,726::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 06:27:26,726::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvn0cbrl7 
apiLogger::2021-10-12 06:27:26,728::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 06:27:26,728::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 06:27:27,106::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 06:27:27,106::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvn0cbrl7
apiLogger::2021-10-12 06:27:30,433::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 06:27:30,433::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 06:27:30,433::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 06:27:30,433::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 06:27:30,437::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 06:27:30,437::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 06:27:30,437::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 06:27:30,437::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 06:27:30,437::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-12 06:27:30,438::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 06:27:30,438::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 06:27:30,438::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 06:27:30,438::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 06:27:30,438::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 06:27:51,005::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 06:27:51,005::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 06:33:31,808::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 06:33:31,837::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 06:33:31,838::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwa8apwks 
apiLogger::2021-10-12 06:33:31,839::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 06:33:31,839::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 06:33:32,221::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 06:33:32,222::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwa8apwks
apiLogger::2021-10-12 06:33:35,561::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 06:33:35,561::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 06:33:35,561::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 06:33:35,561::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 06:33:35,565::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 06:33:35,565::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 06:33:35,565::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 06:33:35,565::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 06:33:35,566::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-12 06:33:35,566::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 06:33:35,566::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 06:33:35,566::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 06:33:35,566::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 06:33:35,566::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 06:33:55,913::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 06:33:55,914::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 06:41:41,208::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 06:41:41,229::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 06:41:41,229::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpd7y0hzcx 
apiLogger::2021-10-12 06:41:41,230::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 06:41:41,230::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 06:41:41,438::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 06:41:41,438::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpd7y0hzcx
apiLogger::2021-10-12 06:41:44,248::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 06:41:44,248::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 06:41:44,248::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 06:41:44,248::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 06:41:44,252::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 06:41:44,252::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 06:41:44,252::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 06:41:44,252::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 06:41:44,253::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-12 06:41:44,253::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 06:41:44,253::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 06:41:44,253::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 06:41:44,253::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 06:41:44,253::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 06:42:03,657::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 06:42:03,657::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 07:23:30,648::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 07:23:30,654::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 07:23:30,654::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpe5etin8f 
apiLogger::2021-10-12 07:23:30,655::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 07:23:30,655::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 07:23:30,752::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 07:23:30,752::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpe5etin8f
apiLogger::2021-10-12 07:23:32,743::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 07:23:32,743::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 07:23:32,743::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 07:23:32,744::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 07:23:32,747::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 07:23:32,747::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 07:23:32,747::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 07:23:32,747::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 07:23:32,750::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 07:23:32,751::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 07:23:32,751::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 07:23:32,751::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-12 07:23:32,751::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-12 07:23:32,751::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 07:23:32,751::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 07:23:32,751::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 07:23:32,751::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 07:23:32,751::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 07:23:47,751::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 07:23:47,751::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 07:37:45,827::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 07:37:45,834::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 07:37:45,834::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppo1vx_wf 
apiLogger::2021-10-12 07:37:45,835::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 07:37:45,835::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 07:37:45,948::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 07:37:45,948::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppo1vx_wf
apiLogger::2021-10-12 07:37:47,570::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 07:37:47,570::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 07:37:47,570::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 07:37:47,570::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 07:37:47,574::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 07:37:47,574::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 07:37:47,574::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 07:37:47,574::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 07:37:47,577::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 07:37:47,577::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 07:37:47,577::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-12 07:37:47,577::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-12 07:37:47,580::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 07:37:47,580::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-12 07:37:47,580::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 07:37:47,580::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-12 07:37:47,580::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-12 07:37:47,580::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 07:37:47,580::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 07:37:47,581::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 07:37:47,581::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 07:37:47,581::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 07:38:02,334::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 07:38:02,334::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 09:02:02,630::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 09:02:02,694::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 09:02:02,694::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv5hzfux_ 
apiLogger::2021-10-12 09:02:02,697::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 09:02:02,697::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 09:02:03,650::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 09:02:03,650::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv5hzfux_
apiLogger::2021-10-12 09:02:06,947::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 09:02:06,948::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 09:02:06,948::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 09:02:06,948::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 09:02:06,952::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 09:02:06,952::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 09:02:06,952::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 09:02:06,952::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 09:02:06,952::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-12 09:02:06,952::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 09:02:06,952::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 09:02:06,952::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 09:02:06,952::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 09:02:06,952::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 09:02:30,730::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 09:02:30,730::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 09:16:00,396::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 09:16:00,491::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 09:16:00,491::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp914ua3bl 
apiLogger::2021-10-12 09:16:00,495::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 09:16:00,496::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 09:16:01,210::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 09:16:01,210::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp914ua3bl
apiLogger::2021-10-12 09:16:05,091::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 09:16:05,091::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 09:16:05,091::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 09:16:05,092::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 09:16:05,095::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 09:16:05,095::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 09:16:05,095::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 09:16:05,096::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 09:16:05,096::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-12 09:16:05,096::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 09:16:05,096::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 09:16:05,096::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 09:16:05,096::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 09:16:05,096::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 09:16:38,435::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 09:16:38,435::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 10:26:00,418::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 10:26:00,483::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 10:26:00,484::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn20s32z_ 
apiLogger::2021-10-12 10:26:00,486::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 10:26:00,486::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 10:26:01,440::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 10:26:01,440::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn20s32z_
apiLogger::2021-10-12 10:26:04,736::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 10:26:04,736::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 10:26:04,737::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 10:26:04,737::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 10:26:04,740::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 10:26:04,741::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 10:26:04,741::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 10:26:04,741::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 10:26:04,741::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-12 10:26:04,741::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 10:26:04,741::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 10:26:04,741::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 10:26:04,741::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 10:26:04,741::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 10:26:28,400::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 10:26:28,400::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 11:06:00,261::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 11:06:00,268::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 11:06:00,268::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphhw3r8bw 
apiLogger::2021-10-12 11:06:00,269::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 11:06:00,269::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 11:06:00,382::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 11:06:00,382::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphhw3r8bw
apiLogger::2021-10-12 11:06:02,000::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 11:06:02,001::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 11:06:02,001::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 11:06:02,001::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 11:06:02,004::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 11:06:02,005::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 11:06:02,005::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 11:06:02,005::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 11:06:02,008::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 11:06:02,008::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 11:06:02,008::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-12 11:06:02,008::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-12 11:06:02,011::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 11:06:02,011::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-12 11:06:02,011::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 11:06:02,011::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-12 11:06:02,011::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-12 11:06:02,012::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 11:06:02,012::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 11:06:02,012::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 11:06:02,012::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 11:06:02,012::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 11:06:16,665::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 11:06:16,665::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 11:24:00,424::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 11:24:00,430::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 11:24:00,430::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx4i751vd 
apiLogger::2021-10-12 11:24:00,431::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 11:24:00,431::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 11:24:00,579::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 11:24:00,579::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx4i751vd
apiLogger::2021-10-12 11:24:02,167::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 11:24:02,168::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 11:24:02,168::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 11:24:02,168::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 11:24:02,172::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 11:24:02,172::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 11:24:02,172::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 11:24:02,172::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 11:24:02,175::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 11:24:02,175::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 11:24:02,176::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-12 11:24:02,176::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-12 11:24:02,179::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 11:24:02,179::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-12 11:24:02,179::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 11:24:02,179::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-12 11:24:02,179::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,0033\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-12 11:24:02,179::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 11:24:02,179::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 11:24:02,180::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 11:24:02,180::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 11:24:02,180::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 11:24:16,817::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 11:24:16,817::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 11:24:16,887::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 11:24:16,893::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 11:24:16,894::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsf_lr210 
apiLogger::2021-10-12 11:24:16,894::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 11:24:16,894::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 11:24:16,975::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 11:24:16,975::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsf_lr210
apiLogger::2021-10-12 11:24:19,235::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 11:24:19,235::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 11:24:19,235::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 11:24:19,236::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 11:24:19,240::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 11:24:19,240::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 11:24:19,240::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 11:24:19,240::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 11:24:19,240::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-12 11:24:19,240::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 11:24:19,240::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 11:24:19,240::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 11:24:19,240::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 11:24:19,240::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 11:24:30,475::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 11:24:30,475::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 11:42:00,252::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 11:42:00,273::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 11:42:00,274::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfov587zf 
apiLogger::2021-10-12 11:42:00,275::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 11:42:00,275::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 11:42:00,483::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 11:42:00,483::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfov587zf
apiLogger::2021-10-12 11:42:03,292::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 11:42:03,292::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 11:42:03,292::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 11:42:03,292::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 11:42:03,296::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 11:42:03,296::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 11:42:03,296::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 11:42:03,296::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 11:42:03,296::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-12 11:42:03,297::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 11:42:03,297::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 11:42:03,297::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 11:42:03,297::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 11:42:03,297::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 11:42:22,556::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 11:42:22,556::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 11:48:00,358::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 11:48:00,378::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 11:48:00,379::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpeid5d7p3 
apiLogger::2021-10-12 11:48:00,380::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 11:48:00,380::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 11:48:00,589::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 11:48:00,589::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpeid5d7p3
apiLogger::2021-10-12 11:48:03,398::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 11:48:03,398::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 11:48:03,398::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 11:48:03,398::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 11:48:03,402::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-12 11:48:03,403::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 11:48:03,403::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 11:48:03,403::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 11:48:03,403::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-12 11:48:03,403::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 11:48:03,403::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-12 11:48:03,403::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 11:48:03,403::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 11:48:03,403::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 11:48:22,885::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 11:48:22,885::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 11:56:00,167::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 11:56:00,172::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 11:56:00,173::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphxeejpyk 
apiLogger::2021-10-12 11:56:00,173::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 11:56:00,173::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 11:56:00,265::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 11:56:00,266::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphxeejpyk
apiLogger::2021-10-12 11:56:02,125::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 11:56:02,126::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 11:56:02,126::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 11:56:02,126::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 11:56:02,129::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 11:56:02,130::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 11:56:02,130::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 11:56:02,130::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 11:56:02,133::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 11:56:02,133::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 11:56:02,133::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 11:56:02,133::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-12 11:56:02,133::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-12 11:56:02,133::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 11:56:02,133::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 11:56:02,133::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 11:56:02,133::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 11:56:02,134::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 11:56:16,702::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 11:56:16,702::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 13:20:00,576::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 13:20:00,670::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 13:20:00,671::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnyowh5xs 
apiLogger::2021-10-12 13:20:00,675::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 13:20:00,675::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 13:20:01,388::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 13:20:01,388::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnyowh5xs
apiLogger::2021-10-12 13:20:05,274::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 13:20:05,274::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 13:20:05,274::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 13:20:05,274::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 13:20:05,278::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 13:20:05,278::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 13:20:05,278::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 13:20:05,278::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 13:20:05,278::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-12 13:20:05,279::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 13:20:05,279::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 13:20:05,279::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 13:20:05,279::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 13:20:05,279::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 13:20:38,358::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 13:20:38,358::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 13:58:00,560::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 13:58:00,658::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 13:58:00,658::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv1rmgnqc 
apiLogger::2021-10-12 13:58:00,663::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 13:58:00,663::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 13:58:01,378::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 13:58:01,378::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv1rmgnqc
apiLogger::2021-10-12 13:58:05,269::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 13:58:05,269::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 13:58:05,269::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 13:58:05,269::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 13:58:05,273::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-12 13:58:05,273::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 13:58:05,273::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 13:58:05,273::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-12 13:58:05,273::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-12 13:58:05,274::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 13:58:05,274::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-12 13:58:05,274::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 13:58:05,274::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 13:58:05,274::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 13:58:38,663::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 13:58:38,663::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-12 21:10:00,332::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-12 21:10:00,338::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-12 21:10:00,338::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm0u67q5r 
apiLogger::2021-10-12 21:10:00,339::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-12 21:10:00,339::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-12 21:10:00,470::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-12 21:10:00,470::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm0u67q5r
apiLogger::2021-10-12 21:10:02,300::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-12 21:10:02,300::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-12 21:10:02,300::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-12 21:10:02,300::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-12 21:10:02,304::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-12 21:10:02,304::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-12 21:10:02,304::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-12 21:10:02,304::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-12 21:10:02,307::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-12 21:10:02,307::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-12 21:10:02,307::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-12 21:10:02,307::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-12 21:10:02,308::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n36,018,0033\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-12 21:10:02,308::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-12 21:10:02,308::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-12 21:10:02,308::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-12 21:10:02,308::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-12 21:10:02,308::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fb7f12a8320>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-12 21:10:17,093::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-12 21:10:17,093::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 06:10:26,040::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 06:10:26,041::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 06:10:26,043::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpilzgkpy8 
apiLogger::2021-10-13 06:10:28,070::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 06:10:28,070::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 06:10:28,095::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 06:10:28,096::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpilzgkpy8
apiLogger::2021-10-13 06:10:28,523::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 06:10:28,524::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 06:10:28,524::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 06:10:28,524::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 06:10:28,529::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-13 06:10:28,529::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 06:10:28,529::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-13 06:10:28,529::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-13 06:10:28,529::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-13 06:10:28,530::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-13 06:10:28,530::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-13 06:10:28,530::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-13 06:10:28,530::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-13 06:10:28,530::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde9d9828>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-13 06:10:55,726::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-13 06:10:55,726::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 06:22:00,494::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 06:22:00,586::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 06:22:00,586::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmhwphym4 
apiLogger::2021-10-13 06:22:00,590::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 06:22:00,590::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 06:22:01,304::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 06:22:01,304::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmhwphym4
apiLogger::2021-10-13 06:22:05,347::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 06:22:05,347::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 06:22:05,347::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 06:22:05,347::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 06:22:05,353::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-13 06:22:05,353::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 06:22:05,353::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-13 06:22:05,353::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-13 06:22:05,353::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-13 06:22:05,353::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-13 06:22:05,353::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-13 06:22:05,353::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-13 06:22:05,354::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-13 06:22:05,354::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-13 06:22:38,645::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-13 06:22:38,645::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 08:10:00,181::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 08:10:00,188::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 08:10:00,188::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5bl8fo_z 
apiLogger::2021-10-13 08:10:00,188::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 08:10:00,188::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 08:10:00,302::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 08:10:00,302::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5bl8fo_z
apiLogger::2021-10-13 08:10:01,969::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 08:10:01,969::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 08:10:01,970::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 08:10:01,970::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 08:10:01,973::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 08:10:01,973::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 08:10:01,973::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 08:10:01,973::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 08:10:01,980::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 08:10:01,980::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 08:10:01,980::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 08:10:01,980::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-13 08:10:01,982::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-13 08:10:01,983::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-13 08:10:01,983::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-13 08:10:01,983::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-13 08:10:01,983::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-13 08:10:01,983::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-13 08:10:01,983::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-13 08:10:01,983::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-13 08:10:01,983::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-13 08:10:01,983::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-13 08:10:16,530::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-13 08:10:16,530::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 08:40:00,250::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 08:40:00,265::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 08:40:00,265::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpoxacur7d 
apiLogger::2021-10-13 08:40:00,266::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 08:40:00,267::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 08:40:01,579::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 08:40:01,579::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpoxacur7d
apiLogger::2021-10-13 08:40:02,911::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 08:40:02,911::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 08:40:02,911::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 08:40:02,911::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 08:40:02,915::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 08:40:02,915::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 08:40:02,915::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 08:40:02,915::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 08:40:02,918::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 08:40:02,918::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 08:40:02,918::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 08:40:02,918::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-13 08:40:02,918::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 08:40:02,918::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 08:40:03,213::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 08:40:03,227::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 08:40:03,227::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7tvcdzgr 
apiLogger::2021-10-13 08:40:03,228::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 08:40:03,228::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 08:40:03,373::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 08:40:03,373::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7tvcdzgr
apiLogger::2021-10-13 08:40:03,882::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 08:40:03,882::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 08:40:03,882::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 08:40:03,882::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 08:40:03,886::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 08:40:03,886::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 08:40:03,886::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 08:40:03,886::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-13 08:40:03,886::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 08:40:03,887::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 08:40:04,300::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 08:40:04,301::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 08:40:04,301::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi0gnwas4 
apiLogger::2021-10-13 08:40:04,301::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 08:40:04,301::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 08:40:04,306::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 08:40:04,306::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi0gnwas4
apiLogger::2021-10-13 08:40:04,319::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 08:40:04,319::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 08:40:04,319::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 08:40:04,319::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 08:40:04,322::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 08:40:04,322::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 08:40:04,322::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 08:40:04,322::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 13-Oct-2021 08:39:13 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : sc -1 -e2e\n ']
apiLogger::2021-10-13 08:40:04,322::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 08:40:04,322::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 10:32:00,305::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 10:32:00,310::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 10:32:00,310::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn64a8ycx 
apiLogger::2021-10-13 10:32:00,311::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 10:32:00,311::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 10:32:00,403::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 10:32:00,403::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn64a8ycx
apiLogger::2021-10-13 10:32:02,281::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 10:32:02,281::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 10:32:02,281::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 10:32:02,281::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 10:32:02,284::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 10:32:02,284::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 10:32:02,284::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 10:32:02,284::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 10:32:02,287::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-13 10:32:02,287::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 10:32:02,287::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-13 10:32:02,287::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-13 10:32:02,287::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-13 10:32:02,287::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-13 10:32:02,287::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-13 10:32:02,287::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-13 10:32:02,287::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-13 10:32:02,287::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-13 10:32:16,730::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-13 10:32:16,730::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 13:50:00,213::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 13:50:00,217::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 13:50:00,218::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmph3f6oh1y 
apiLogger::2021-10-13 13:50:00,218::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 13:50:00,218::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 13:50:00,385::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 13:50:00,385::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmph3f6oh1y
apiLogger::2021-10-13 13:50:01,114::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 13:50:01,114::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 13:50:01,114::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 13:50:01,114::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 13:50:01,118::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:01,118::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 13:50:01,119::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 13:50:01,119::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 13:50:01,122::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:01,122::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 13:50:01,122::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 13:50:01,122::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-13 13:50:01,125::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:01,125::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-13 13:50:01,125::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-13 13:50:01,125::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-13 13:50:01,125::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 13:50:01,125::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 13:50:01,354::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 13:50:01,372::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 13:50:01,372::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqtkq23p4 
apiLogger::2021-10-13 13:50:01,373::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 13:50:01,373::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 13:50:01,618::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 13:50:01,618::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqtkq23p4
apiLogger::2021-10-13 13:50:02,395::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 13:50:02,395::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 13:50:02,395::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 13:50:02,395::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 13:50:02,399::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:02,399::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 13:50:02,399::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 13:50:02,399::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 13:50:02,402::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:02,403::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 13:50:02,403::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 13:50:02,403::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-13 13:50:02,405::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:02,405::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-13 13:50:02,405::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-13 13:50:02,405::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-13 13:50:02,406::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:02,407::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-13 13:50:02,407::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-13 13:50:02,407::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-13 13:50:02,408::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:02,409::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-13 13:50:02,409::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-13 13:50:02,409::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-13 13:50:02,409::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-13 13:50:02,409::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 13:50:02,710::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 13:50:02,725::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 13:50:02,725::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphuxajhnz 
apiLogger::2021-10-13 13:50:02,726::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 13:50:02,726::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 13:50:02,872::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 13:50:02,872::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphuxajhnz
apiLogger::2021-10-13 13:50:03,362::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 13:50:03,363::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 13:50:03,363::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 13:50:03,363::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 13:50:03,366::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:03,367::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 13:50:03,367::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 13:50:03,367::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-13 13:50:03,367::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 13:50:03,367::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 13:50:03,794::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 13:50:03,795::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 13:50:03,795::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplyericre 
apiLogger::2021-10-13 13:50:03,795::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 13:50:03,796::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 13:50:03,801::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 13:50:03,801::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplyericre
apiLogger::2021-10-13 13:50:03,812::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 13:50:03,812::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 13:50:03,812::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 13:50:03,812::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 13:50:03,815::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:50:03,815::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 13:50:03,815::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 13:50:03,815::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 13-Oct-2021 13:48:58 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : sc-1-fup\n ']
apiLogger::2021-10-13 13:50:03,815::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 13:50:03,815::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 13:58:00,276::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 13:58:00,290::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 13:58:00,291::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpg1n7dugv 
apiLogger::2021-10-13 13:58:00,292::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 13:58:00,292::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 13:58:01,602::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 13:58:01,603::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpg1n7dugv
apiLogger::2021-10-13 13:58:02,917::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 13:58:02,917::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 13:58:02,917::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 13:58:02,917::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 13:58:02,921::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:58:02,921::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 13:58:02,921::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 13:58:02,922::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 13:58:02,924::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:58:02,925::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 13:58:02,925::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 13:58:02,925::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-13 13:58:02,925::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 13:58:02,925::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 13:58:03,243::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 13:58:03,258::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 13:58:03,258::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpl_b1kt18 
apiLogger::2021-10-13 13:58:03,259::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 13:58:03,259::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 13:58:03,405::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 13:58:03,405::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpl_b1kt18
apiLogger::2021-10-13 13:58:03,896::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 13:58:03,896::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 13:58:03,896::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 13:58:03,896::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 13:58:03,900::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:58:03,900::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 13:58:03,900::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 13:58:03,900::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-13 13:58:03,901::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 13:58:03,901::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 13:58:04,314::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 13:58:04,315::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 13:58:04,315::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplotl6dqh 
apiLogger::2021-10-13 13:58:04,316::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 13:58:04,316::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 13:58:04,321::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 13:58:04,321::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplotl6dqh
apiLogger::2021-10-13 13:58:04,347::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 13:58:04,347::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 13:58:04,347::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 13:58:04,347::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 13:58:04,350::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 13:58:04,350::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 13:58:04,350::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 13:58:04,351::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Justin Staley <justin.staley@regeneron.com>\nReceived Date : 13-Oct-2021 13:56:14 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial Justin Staley\n13Oct2021 \n \nBest Regards \n \nJustin Staley, MBS \nAssociate Specialist, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \njustin.staley@regeneron.com \n ']
apiLogger::2021-10-13 13:58:04,351::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 13:58:04,351::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 15:16:00,222::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 15:16:00,226::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 15:16:00,226::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp75v4y9no 
apiLogger::2021-10-13 15:16:00,227::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 15:16:00,227::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 15:16:00,395::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 15:16:00,395::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp75v4y9no
apiLogger::2021-10-13 15:16:01,122::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 15:16:01,122::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 15:16:01,122::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 15:16:01,122::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 15:16:01,126::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 15:16:01,126::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 15:16:01,126::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 15:16:01,126::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 15:16:01,129::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 15:16:01,130::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 15:16:01,130::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 15:16:01,130::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-13 15:16:01,132::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 15:16:01,133::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-13 15:16:01,133::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-13 15:16:01,133::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-13 15:16:01,133::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 15:16:01,133::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 15:16:01,445::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 15:16:01,445::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 15:16:01,446::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpivu9qtr_ 
apiLogger::2021-10-13 15:16:01,446::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 15:16:01,446::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 15:16:01,451::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 15:16:01,451::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpivu9qtr_
apiLogger::2021-10-13 15:16:01,465::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 15:16:01,466::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 15:16:01,466::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 15:16:01,466::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 15:16:01,469::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 15:16:01,469::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 15:16:01,469::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 15:16:01,469::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Prashant Kapoor-External <prashant.kapoor@regeneron.com>\nReceived Date : 13-Oct-2021 15:15:05 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 - Prashant Kapoor\nScenario 1 Follow Up 13-Oct-2021 ']
apiLogger::2021-10-13 15:16:01,469::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 15:16:01,469::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 17:12:00,992::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 17:12:01,010::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 17:12:01,010::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpngnrlyoy 
apiLogger::2021-10-13 17:12:01,011::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 17:12:01,011::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 17:12:01,257::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 17:12:01,257::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpngnrlyoy
apiLogger::2021-10-13 17:12:02,006::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 17:12:02,006::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 17:12:02,006::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 17:12:02,006::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 17:12:02,010::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:02,010::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 17:12:02,010::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 17:12:02,010::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 17:12:02,013::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:02,013::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 17:12:02,013::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 17:12:02,013::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-13 17:12:02,015::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:02,015::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-13 17:12:02,015::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-13 17:12:02,015::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-13 17:12:02,017::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:02,017::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-13 17:12:02,017::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-13 17:12:02,017::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-13 17:12:02,019::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:02,019::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-13 17:12:02,019::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-13 17:12:02,019::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-13 17:12:02,019::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-13 17:12:02,019::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 17:12:02,307::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 17:12:02,309::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 17:12:02,309::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpb81p3vob 
apiLogger::2021-10-13 17:12:02,309::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 17:12:02,309::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 17:12:02,317::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 17:12:02,317::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpb81p3vob
apiLogger::2021-10-13 17:12:02,322::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 17:12:02,323::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 17:12:02,323::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 17:12:02,323::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 17:12:02,325::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:02,325::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 17:12:02,325::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 17:12:02,325::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-13 17:12:02,325::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-13 17:12:02,325::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 17:12:02,515::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 17:12:02,519::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 17:12:02,519::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwosh54nc 
apiLogger::2021-10-13 17:12:02,519::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 17:12:02,519::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 17:12:02,687::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 17:12:02,687::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwosh54nc
apiLogger::2021-10-13 17:12:03,414::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 17:12:03,414::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 17:12:03,414::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 17:12:03,414::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 17:12:03,418::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:03,418::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 17:12:03,418::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 17:12:03,418::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 17:12:03,421::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:03,421::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 17:12:03,421::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 17:12:03,421::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-13 17:12:03,424::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:03,424::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-13 17:12:03,424::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-13 17:12:03,424::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-13 17:12:03,424::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 17:12:03,424::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 17:12:04,162::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 17:12:04,163::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 17:12:04,163::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu2ntlnp8 
apiLogger::2021-10-13 17:12:04,163::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 17:12:04,163::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 17:12:04,170::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 17:12:04,170::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu2ntlnp8
apiLogger::2021-10-13 17:12:04,201::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 17:12:04,201::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 17:12:04,201::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 17:12:04,201::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 17:12:04,204::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 17:12:04,205::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 17:12:04,205::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 17:12:04,205::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 13-Oct-2021 17:11:03 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88291 Version 2\n \nFrom: Marc Lamberti-External Sent: Sunday, October 10, 2021 10:49 PM To: Medsaf.dev3\n<Medsaf.dev3@regeneron.com> Subject: <External> Regeneron Adverse Event Report for Eylea\nVial: REGEMC-88291 Version 2 \n \nScenario 1 Follow Up \n \nMarc Lamberti \n617.515.6030 \n ']
apiLogger::2021-10-13 17:12:04,205::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 17:12:04,205::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 18:49:03,436::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 18:49:03,450::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 18:49:03,450::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphmk0r656 
apiLogger::2021-10-13 18:49:03,451::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 18:49:03,451::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 18:49:03,596::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 18:49:03,596::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphmk0r656
apiLogger::2021-10-13 18:49:04,087::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 18:49:04,087::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 18:49:04,087::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 18:49:04,087::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 18:49:04,091::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 18:49:04,091::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 18:49:04,091::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 18:49:04,091::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-13 18:49:04,091::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 18:49:04,092::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 18:49:04,349::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 18:49:04,364::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 18:49:04,364::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx950glcc 
apiLogger::2021-10-13 18:49:04,365::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 18:49:04,365::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 18:49:05,678::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 18:49:05,678::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx950glcc
apiLogger::2021-10-13 18:49:06,994::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 18:49:06,995::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 18:49:06,995::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 18:49:06,995::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 18:49:06,998::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 18:49:06,999::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 18:49:06,999::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 18:49:06,999::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-13 18:49:07,001::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 18:49:07,002::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-13 18:49:07,002::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-13 18:49:07,002::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-13 18:49:07,002::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 18:49:07,002::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-13 18:49:07,458::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-13 18:49:07,458::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-13 18:49:07,459::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpc1u8yso8 
apiLogger::2021-10-13 18:49:07,459::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-13 18:49:07,459::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-13 18:49:07,464::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-13 18:49:07,464::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpc1u8yso8
apiLogger::2021-10-13 18:49:07,488::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-13 18:49:07,488::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-13 18:49:07,488::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-13 18:49:07,488::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-13 18:49:07,492::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-13 18:49:07,492::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-13 18:49:07,492::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-13 18:49:07,492::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Justin Staley <justin.staley@regeneron.com>\nReceived Date : 13-Oct-2021 18:48:35 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Justin Staley\n13Oct2021 \n \nBest Regards \n \nJustin Staley, MBS \nAssociate Specialist, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \njustin.staley@regeneron.com \n ']
apiLogger::2021-10-13 18:49:07,492::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-13 18:49:07,492::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 00:30:31,462::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 00:30:31,559::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 00:30:31,560::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpq8pdsjtd 
apiLogger::2021-10-14 00:30:31,564::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 00:30:31,564::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 00:30:32,279::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 00:30:32,279::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpq8pdsjtd
apiLogger::2021-10-14 00:30:36,198::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 00:30:36,198::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 00:30:36,198::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 00:30:36,198::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 00:30:36,202::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 00:30:36,202::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 00:30:36,202::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 00:30:36,202::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 00:30:36,202::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 00:30:36,202::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 00:30:36,202::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 00:30:36,202::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 00:30:36,202::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 00:30:36,202::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 00:31:09,393::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 00:31:09,394::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 01:10:00,535::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 01:10:00,639::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 01:10:00,639::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppfor3wsy 
apiLogger::2021-10-14 01:10:00,644::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 01:10:00,645::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 01:10:01,365::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 01:10:01,365::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppfor3wsy
apiLogger::2021-10-14 01:10:05,601::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 01:10:05,601::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 01:10:05,601::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 01:10:05,601::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 01:10:05,605::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 01:10:05,605::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 01:10:05,605::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 01:10:05,605::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 01:10:05,605::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\n892012005\nAn AESI of TROMBOITOPENIA has been reported for Subject Number   with Start Date (dd-mon-yyyy) : 27 \nJUL 2021  with AE suspected to be caused by blinded study drug? : NO \nWWRD (GMT): 27 Jul 2021 20:56:17 \n1 R2810-ONC-16113:  920 -Baskent Universitesi Tip Fakultesi Adana Hastanesi:   \n8 05 892012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi:   \n892012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 892012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 01:10:05,605::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 01:10:05,605::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 01:10:05,605::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 01:10:05,605::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 01:10:05,605::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 01:10:42,170::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 01:10:42,170::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 02:42:00,478::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 02:42:00,570::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 02:42:00,571::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwz4nitep 
apiLogger::2021-10-14 02:42:00,575::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 02:42:00,575::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 02:42:01,291::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 02:42:01,291::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwz4nitep
apiLogger::2021-10-14 02:42:05,218::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 02:42:05,219::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 02:42:05,219::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 02:42:05,219::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 02:42:05,222::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 02:42:05,222::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 02:42:05,222::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 02:42:05,222::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 02:42:05,222::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 02:42:05,223::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 02:42:05,223::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 02:42:05,223::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 02:42:05,223::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 02:42:05,223::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 02:42:38,228::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 02:42:38,228::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 03:08:00,380::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 03:08:00,472::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 03:08:00,472::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_h4_u8ix 
apiLogger::2021-10-14 03:08:00,477::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 03:08:00,477::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 03:08:01,192::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 03:08:01,193::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_h4_u8ix
apiLogger::2021-10-14 03:08:05,128::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 03:08:05,128::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 03:08:05,128::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 03:08:05,128::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 03:08:05,132::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 03:08:05,132::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 03:08:05,132::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 03:08:05,132::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 03:08:05,132::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 03:08:05,132::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 03:08:05,132::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 03:08:05,132::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 03:08:05,132::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 03:08:05,132::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 03:08:38,352::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 03:08:38,352::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 03:20:00,450::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 03:20:00,542::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 03:20:00,542::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi3urrg9w 
apiLogger::2021-10-14 03:20:00,546::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 03:20:00,547::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 03:20:01,261::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 03:20:01,261::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi3urrg9w
apiLogger::2021-10-14 03:20:05,184::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 03:20:05,184::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 03:20:05,184::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 03:20:05,185::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 03:20:05,188::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 03:20:05,188::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 03:20:05,188::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 03:20:05,188::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 03:20:05,188::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 03:20:05,189::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 03:20:05,189::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 03:20:05,189::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 03:20:05,189::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 03:20:05,189::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 03:20:38,014::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 03:20:38,014::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 04:20:07,357::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 04:20:07,447::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 04:20:07,447::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphtbnm2mq 
apiLogger::2021-10-14 04:20:07,451::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 04:20:07,451::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 04:20:08,204::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 04:20:08,204::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphtbnm2mq
apiLogger::2021-10-14 04:20:12,291::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 04:20:12,291::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 04:20:12,291::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 04:20:12,291::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 04:20:12,295::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 04:20:12,295::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 04:20:12,295::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 04:20:12,295::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 04:20:12,295::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 04:20:12,295::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 04:20:12,295::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 04:20:12,295::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 04:20:12,295::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 04:20:12,295::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 04:20:45,724::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 04:20:45,724::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 05:52:00,229::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 05:52:00,238::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 05:52:00,239::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpe_7qj9c5 
apiLogger::2021-10-14 05:52:00,240::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 05:52:00,240::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 05:52:00,390::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 05:52:00,390::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpe_7qj9c5
apiLogger::2021-10-14 05:52:02,006::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 05:52:02,006::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 05:52:02,006::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 05:52:02,006::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 05:52:02,010::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 05:52:02,011::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 05:52:02,011::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 05:52:02,011::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 05:52:02,013::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 05:52:02,014::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 05:52:02,014::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 05:52:02,014::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-14 05:52:02,016::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-14 05:52:02,016::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-14 05:52:02,016::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 05:52:02,016::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-14 05:52:02,016::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-14 05:52:02,017::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 05:52:02,017::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-14 05:52:02,017::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 05:52:02,017::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 05:52:02,017::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 05:52:16,785::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 05:52:16,785::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 06:14:00,202::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 06:14:00,208::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 06:14:00,209::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbhv8mxdc 
apiLogger::2021-10-14 06:14:00,209::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 06:14:00,209::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 06:14:00,342::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 06:14:00,342::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbhv8mxdc
apiLogger::2021-10-14 06:14:02,190::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 06:14:02,191::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 06:14:02,191::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 06:14:02,191::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 06:14:02,194::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 06:14:02,194::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 06:14:02,194::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 06:14:02,194::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 06:14:02,197::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-14 06:14:02,197::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 06:14:02,197::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 06:14:02,197::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-14 06:14:02,197::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-14 06:14:02,197::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 06:14:02,198::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-14 06:14:02,198::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 06:14:02,198::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 06:14:02,198::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 06:14:16,983::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 06:14:16,983::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 06:30:00,402::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 06:30:00,487::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 06:30:00,487::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzksvnbov 
apiLogger::2021-10-14 06:30:00,491::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 06:30:00,491::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 06:30:01,281::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 06:30:01,282::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzksvnbov
apiLogger::2021-10-14 06:30:05,453::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 06:30:05,453::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 06:30:05,453::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 06:30:05,453::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 06:30:05,457::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 06:30:05,457::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 06:30:05,457::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 06:30:05,457::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 06:30:05,457::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 06:30:05,457::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 06:30:05,457::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 06:30:05,457::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 06:30:05,458::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 06:30:05,458::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 06:30:39,023::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 06:30:39,023::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 06:48:00,234::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 06:48:00,249::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 06:48:00,249::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpz3q68bx3 
apiLogger::2021-10-14 06:48:00,250::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 06:48:00,250::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 06:48:01,562::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 06:48:01,562::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpz3q68bx3
apiLogger::2021-10-14 06:48:02,873::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 06:48:02,873::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 06:48:02,873::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 06:48:02,873::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 06:48:02,877::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 06:48:02,878::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 06:48:02,878::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 06:48:02,878::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 06:48:02,881::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 06:48:02,881::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 06:48:02,881::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 06:48:02,881::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-14 06:48:02,881::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 06:48:02,881::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 06:48:03,162::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 06:48:03,176::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 06:48:03,176::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjm7sylhc 
apiLogger::2021-10-14 06:48:03,177::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 06:48:03,177::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 06:48:03,322::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 06:48:03,322::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjm7sylhc
apiLogger::2021-10-14 06:48:03,813::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 06:48:03,813::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 06:48:03,813::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 06:48:03,813::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 06:48:03,817::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 06:48:03,817::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 06:48:03,817::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 06:48:03,817::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-14 06:48:03,817::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 06:48:03,817::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 06:48:04,227::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 06:48:04,228::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 06:48:04,228::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_r0akv0e 
apiLogger::2021-10-14 06:48:04,229::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 06:48:04,229::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 06:48:04,234::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 06:48:04,234::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_r0akv0e
apiLogger::2021-10-14 06:48:04,247::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 06:48:04,247::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 06:48:04,247::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 06:48:04,247::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 06:48:04,250::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 06:48:04,250::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 06:48:04,250::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 06:48:04,251::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Prashant Kapoor-External <prashant.kapoor@regeneron.com>\nReceived Date : 14-Oct-2021 06:47:55 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial - Prashant Kapoor\nScenario 1 14-Oct-2021 ']
apiLogger::2021-10-14 06:48:04,251::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 06:48:04,251::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 07:12:00,264::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 07:12:00,285::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 07:12:00,285::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpojb83200 
apiLogger::2021-10-14 07:12:00,286::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 07:12:00,286::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 07:12:00,558::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 07:12:00,558::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpojb83200
apiLogger::2021-10-14 07:12:03,419::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 07:12:03,419::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 07:12:03,419::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 07:12:03,419::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 07:12:03,423::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 07:12:03,423::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 07:12:03,423::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 07:12:03,423::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 07:12:03,423::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-14 07:12:03,423::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 07:12:03,423::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 07:12:03,423::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 07:12:03,423::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 07:12:03,423::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 07:12:23,113::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 07:12:23,113::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 08:36:00,380::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 08:36:00,466::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 08:36:00,466::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkntouuic 
apiLogger::2021-10-14 08:36:00,470::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 08:36:00,470::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 08:36:01,220::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 08:36:01,221::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkntouuic
apiLogger::2021-10-14 08:36:05,281::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 08:36:05,281::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 08:36:05,282::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 08:36:05,282::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 08:36:05,285::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 08:36:05,285::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 08:36:05,285::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 08:36:05,285::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 08:36:05,285::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 08:36:05,286::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 08:36:05,286::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 08:36:05,286::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 08:36:05,286::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 08:36:05,286::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 08:36:38,484::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 08:36:38,484::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 08:40:00,400::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 08:40:00,483::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 08:40:00,483::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0tsh0ox8 
apiLogger::2021-10-14 08:40:00,487::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 08:40:00,488::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 08:40:01,239::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 08:40:01,239::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0tsh0ox8
apiLogger::2021-10-14 08:40:05,298::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 08:40:05,299::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 08:40:05,299::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 08:40:05,299::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 08:40:05,302::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 08:40:05,302::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 08:40:05,302::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 08:40:05,302::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 08:40:05,302::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 08:40:05,303::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 08:40:05,303::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 08:40:05,303::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 08:40:05,303::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 08:40:05,303::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 08:40:38,519::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 08:40:38,519::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 09:06:00,264::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 09:06:00,292::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 09:06:00,292::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpy26m4vnq 
apiLogger::2021-10-14 09:06:00,294::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 09:06:00,294::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 09:06:00,675::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 09:06:00,675::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpy26m4vnq
apiLogger::2021-10-14 09:06:04,092::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 09:06:04,092::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 09:06:04,092::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 09:06:04,092::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 09:06:04,096::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 09:06:04,096::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 09:06:04,096::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 09:06:04,096::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 09:06:04,096::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-14 09:06:04,097::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 09:06:04,097::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 09:06:04,097::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 09:06:04,097::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 09:06:04,097::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 09:06:24,417::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 09:06:24,417::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 09:14:00,253::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 09:14:00,281::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 09:14:00,281::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwau8p2yl 
apiLogger::2021-10-14 09:14:00,283::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 09:14:00,283::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 09:14:00,663::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 09:14:00,663::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwau8p2yl
apiLogger::2021-10-14 09:14:04,048::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 09:14:04,048::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 09:14:04,048::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 09:14:04,048::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 09:14:04,052::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 09:14:04,052::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 09:14:04,052::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 09:14:04,052::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 09:14:04,052::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-14 09:14:04,052::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 09:14:04,052::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 09:14:04,052::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 09:14:04,052::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 09:14:04,052::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 09:14:24,276::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 09:14:24,276::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 09:48:00,510::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 09:48:00,593::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 09:48:00,593::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpd25uegf2 
apiLogger::2021-10-14 09:48:00,597::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 09:48:00,598::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 09:48:01,348::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 09:48:01,349::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpd25uegf2
apiLogger::2021-10-14 09:48:05,413::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 09:48:05,413::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 09:48:05,413::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 09:48:05,413::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 09:48:05,417::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 09:48:05,417::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 09:48:05,417::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 09:48:05,417::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 09:48:05,417::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 09:48:05,417::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 09:48:05,417::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 09:48:05,417::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 09:48:05,417::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 09:48:05,418::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 09:48:38,712::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 09:48:38,712::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 09:58:00,185::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 09:58:00,189::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 09:58:00,190::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnnqze8o3 
apiLogger::2021-10-14 09:58:00,190::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 09:58:00,190::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 09:58:00,358::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 09:58:00,358::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnnqze8o3
apiLogger::2021-10-14 09:58:01,087::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 09:58:01,087::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 09:58:01,088::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 09:58:01,088::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 09:58:01,092::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:01,092::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 09:58:01,092::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 09:58:01,092::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 09:58:01,095::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:01,095::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 09:58:01,095::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 09:58:01,095::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-14 09:58:01,098::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:01,098::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-14 09:58:01,098::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-14 09:58:01,098::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-14 09:58:01,098::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 09:58:01,098::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 09:58:01,317::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 09:58:01,331::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 09:58:01,331::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6jatbmre 
apiLogger::2021-10-14 09:58:01,332::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 09:58:01,332::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 09:58:01,477::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 09:58:01,478::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6jatbmre
apiLogger::2021-10-14 09:58:01,970::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 09:58:01,970::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 09:58:01,970::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 09:58:01,970::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 09:58:01,975::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:01,975::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 09:58:01,975::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 09:58:01,975::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-14 09:58:01,975::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 09:58:01,975::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 09:58:02,234::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 09:58:02,252::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 09:58:02,253::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpb2dazy40 
apiLogger::2021-10-14 09:58:02,254::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 09:58:02,254::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 09:58:02,499::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 09:58:02,499::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpb2dazy40
apiLogger::2021-10-14 09:58:03,252::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 09:58:03,252::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 09:58:03,252::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 09:58:03,252::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 09:58:03,256::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:03,256::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 09:58:03,257::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 09:58:03,257::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 09:58:03,260::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:03,260::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 09:58:03,260::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 09:58:03,260::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-14 09:58:03,262::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:03,262::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-14 09:58:03,262::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-14 09:58:03,262::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-14 09:58:03,264::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:03,264::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-14 09:58:03,264::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-14 09:58:03,264::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-14 09:58:03,266::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:03,266::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-14 09:58:03,266::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-14 09:58:03,266::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-14 09:58:03,266::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-14 09:58:03,266::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 09:58:03,751::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 09:58:03,752::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 09:58:03,752::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpd9e2mq47 
apiLogger::2021-10-14 09:58:03,752::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 09:58:03,752::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 09:58:03,757::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 09:58:03,757::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpd9e2mq47
apiLogger::2021-10-14 09:58:03,771::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 09:58:03,771::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 09:58:03,771::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 09:58:03,771::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 09:58:03,774::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 09:58:03,774::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 09:58:03,774::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 09:58:03,774::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Prashant Kapoor-External <prashant.kapoor@regeneron.com>\nReceived Date : 14-Oct-2021 09:57:03 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Prashant Kapoor\nScenario 1 Follow Up 14-Oct-2021 ']
apiLogger::2021-10-14 09:58:03,774::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 09:58:03,774::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 10:49:31,253::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 10:49:31,281::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 10:49:31,282::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpriuxeb4o 
apiLogger::2021-10-14 10:49:31,283::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 10:49:31,283::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 10:49:31,663::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 10:49:31,663::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpriuxeb4o
apiLogger::2021-10-14 10:49:35,050::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 10:49:35,050::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 10:49:35,050::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 10:49:35,050::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 10:49:35,054::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 10:49:35,054::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 10:49:35,054::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 10:49:35,054::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 10:49:35,054::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-14 10:49:35,054::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 10:49:35,055::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 10:49:35,055::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 10:49:35,055::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 10:49:35,055::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 10:49:55,192::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 10:49:55,192::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 11:00:00,276::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 11:00:00,302::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 11:00:00,302::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6n62my9f 
apiLogger::2021-10-14 11:00:00,304::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 11:00:00,304::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 11:00:00,726::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 11:00:00,726::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6n62my9f
apiLogger::2021-10-14 11:00:04,135::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 11:00:04,136::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 11:00:04,136::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 11:00:04,136::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 11:00:04,139::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 11:00:04,139::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 11:00:04,140::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 11:00:04,140::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 11:00:04,140::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-14 11:00:04,140::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 11:00:04,140::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 11:00:04,140::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 11:00:04,140::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 11:00:04,140::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 11:00:24,257::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 11:00:24,257::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 11:06:15,184::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 11:06:15,211::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 11:06:15,211::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpa1qsi4la 
apiLogger::2021-10-14 11:06:15,212::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 11:06:15,213::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 11:06:15,593::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 11:06:15,593::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpa1qsi4la
apiLogger::2021-10-14 11:06:18,977::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 11:06:18,977::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 11:06:18,978::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 11:06:18,978::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 11:06:18,981::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 11:06:18,981::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 11:06:18,981::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 11:06:18,982::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 11:06:18,982::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-14 11:06:18,982::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 11:06:18,982::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 11:06:18,982::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 11:06:18,982::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 11:06:18,982::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 11:06:39,315::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 11:06:39,315::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 11:08:00,213::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 11:08:00,240::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 11:08:00,241::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppr833r48 
apiLogger::2021-10-14 11:08:00,242::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 11:08:00,242::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 11:08:00,621::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 11:08:00,622::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppr833r48
apiLogger::2021-10-14 11:08:04,011::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 11:08:04,011::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 11:08:04,011::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 11:08:04,011::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 11:08:04,015::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 11:08:04,015::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 11:08:04,015::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 11:08:04,016::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 11:08:04,016::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-14 11:08:04,016::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 11:08:04,016::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 11:08:04,016::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 11:08:04,016::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 11:08:04,016::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 11:08:24,336::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 11:08:24,336::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 11:14:00,237::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 11:14:00,264::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 11:14:00,264::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm64y327d 
apiLogger::2021-10-14 11:14:00,265::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 11:14:00,266::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 11:14:00,646::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 11:14:00,646::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm64y327d
apiLogger::2021-10-14 11:14:04,034::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 11:14:04,034::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 11:14:04,034::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 11:14:04,034::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 11:14:04,038::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-14 11:14:04,038::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 11:14:04,038::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 11:14:04,038::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 11:14:04,038::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-14 11:14:04,038::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 11:14:04,038::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-14 11:14:04,039::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 11:14:04,039::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 11:14:04,039::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 11:14:24,179::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 11:14:24,179::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 12:08:00,363::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 12:08:00,447::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 12:08:00,447::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1xaqvkwt 
apiLogger::2021-10-14 12:08:00,451::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 12:08:00,451::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 12:08:01,202::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 12:08:01,203::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1xaqvkwt
apiLogger::2021-10-14 12:08:05,270::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 12:08:05,270::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 12:08:05,270::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 12:08:05,270::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 12:08:05,274::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 12:08:05,274::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 12:08:05,274::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 12:08:05,274::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 12:08:05,274::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 12:08:05,274::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 12:08:05,274::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 12:08:05,274::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 12:08:05,274::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 12:08:05,274::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 12:08:38,294::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 12:08:38,295::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 12:56:43,139::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 12:56:43,224::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 12:56:43,224::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbfzxp7vx 
apiLogger::2021-10-14 12:56:43,228::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 12:56:43,228::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 12:56:43,980::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 12:56:43,980::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbfzxp7vx
apiLogger::2021-10-14 12:56:48,055::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 12:56:48,055::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 12:56:48,055::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 12:56:48,055::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 12:56:48,059::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 12:56:48,059::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 12:56:48,059::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 12:56:48,059::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 12:56:48,059::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID\n79201200512\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 12:56:48,060::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 12:56:48,060::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 12:56:48,060::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 12:56:48,060::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 12:56:48,060::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 12:57:21,586::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 12:57:21,586::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 13:08:42,798::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 13:08:42,812::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 13:08:42,812::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_8fwxq8g 
apiLogger::2021-10-14 13:08:42,813::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 13:08:42,813::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 13:08:42,959::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 13:08:42,959::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_8fwxq8g
apiLogger::2021-10-14 13:08:43,451::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 13:08:43,451::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 13:08:43,451::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 13:08:43,451::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 13:08:43,455::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 13:08:43,455::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 13:08:43,455::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 13:08:43,455::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-14 13:08:43,455::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 13:08:43,455::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 13:08:43,742::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 13:08:43,756::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 13:08:43,756::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfchw7ppf 
apiLogger::2021-10-14 13:08:43,757::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 13:08:43,757::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 13:08:45,071::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 13:08:45,072::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfchw7ppf
apiLogger::2021-10-14 13:08:46,391::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 13:08:46,391::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 13:08:46,391::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 13:08:46,391::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 13:08:46,395::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 13:08:46,395::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 13:08:46,395::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 13:08:46,396::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 13:08:46,399::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 13:08:46,399::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 13:08:46,399::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 13:08:46,399::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-14 13:08:46,399::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 13:08:46,399::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 13:08:46,897::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 13:08:46,898::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 13:08:46,898::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpl559roqa 
apiLogger::2021-10-14 13:08:46,898::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 13:08:46,898::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 13:08:46,904::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 13:08:46,904::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpl559roqa
apiLogger::2021-10-14 13:08:46,939::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 13:08:46,939::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 13:08:46,939::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 13:08:46,939::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 13:08:46,944::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 13:08:46,944::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 13:08:46,944::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 13:08:46,944::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : David Jennings <david.jennings@regeneron.com>\nReceived Date : 14-Oct-2021 13:07:37 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : scenario 1 initial\n14 Oct 2021 \n \n \n \nDavid Jennings, BSc \nAssociate Director, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \nUK Uxbridge \n \nEmail: David.Jennings@Regeneron.com \nMobile: (+44) 07585 550363 \n \nREGENERON\n  SCIENCE TO MEDICINE® \nRegeneron Pharmaceuticals Inc.\n777 Old Saw Mill River Road, Tarrytown, NY 10591 \n ']
apiLogger::2021-10-14 13:08:46,944::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 13:08:46,944::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 13:26:43,179::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 13:26:43,263::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 13:26:43,263::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprxsiqwvc 
apiLogger::2021-10-14 13:26:43,268::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 13:26:43,268::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 13:26:44,019::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 13:26:44,019::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprxsiqwvc
apiLogger::2021-10-14 13:26:48,092::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 13:26:48,092::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 13:26:48,092::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 13:26:48,093::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 13:26:48,096::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 13:26:48,096::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 13:26:48,096::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 13:26:48,096::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 13:26:48,097::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 13:26:48,097::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 13:26:48,097::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 13:26:48,097::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 13:26:48,097::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 13:26:48,097::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 13:27:21,527::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 13:27:21,527::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 13:27:21,607::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 13:27:21,690::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 13:27:21,690::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppu5a1tc7 
apiLogger::2021-10-14 13:27:21,695::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 13:27:21,695::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 13:27:22,442::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 13:27:22,442::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppu5a1tc7
apiLogger::2021-10-14 13:27:26,507::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 13:27:26,508::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 13:27:26,508::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 13:27:26,508::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 13:27:26,512::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 13:27:26,512::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 13:27:26,512::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 13:27:26,512::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 13:27:26,512::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 13:27:26,512::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 13:27:26,512::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 13:27:26,512::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 13:27:26,512::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 13:27:26,512::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 13:27:59,941::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 13:27:59,941::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 13:38:42,987::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 13:38:43,071::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 13:38:43,071::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqyutwlu5 
apiLogger::2021-10-14 13:38:43,075::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 13:38:43,075::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 13:38:43,829::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 13:38:43,830::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqyutwlu5
apiLogger::2021-10-14 13:38:47,901::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 13:38:47,901::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 13:38:47,901::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 13:38:47,901::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 13:38:47,905::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 13:38:47,905::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 13:38:47,905::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 13:38:47,905::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 13:38:47,905::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 13:38:47,905::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 13:38:47,905::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 13:38:47,905::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 13:38:47,905::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 13:38:47,905::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 13:39:21,239::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 13:39:21,239::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 13:42:42,940::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 13:42:43,027::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 13:42:43,028::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2w70zb1f 
apiLogger::2021-10-14 13:42:43,032::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 13:42:43,032::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 13:42:43,784::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 13:42:43,785::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2w70zb1f
apiLogger::2021-10-14 13:42:47,852::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 13:42:47,853::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 13:42:47,853::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 13:42:47,853::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 13:42:47,857::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 13:42:47,857::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 13:42:47,857::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 13:42:47,857::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 13:42:47,857::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 13:42:47,857::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 13:42:47,857::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 13:42:47,857::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 13:42:47,857::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 13:42:47,857::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 13:43:21,267::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 13:43:21,267::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:12:42,918::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:12:43,006::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:12:43,006::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpr88ot7le 
apiLogger::2021-10-14 14:12:43,011::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:12:43,011::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:12:43,761::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:12:43,762::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpr88ot7le
apiLogger::2021-10-14 14:12:47,830::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:12:47,830::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:12:47,830::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:12:47,830::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:12:47,834::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:12:47,834::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:12:47,834::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:12:47,834::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:12:47,834::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:12:47,834::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:12:47,834::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:12:47,834::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:12:47,834::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:12:47,834::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:13:21,468::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:13:21,468::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:32:42,942::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:32:43,026::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:32:43,026::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx511kwkp 
apiLogger::2021-10-14 14:32:43,030::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:32:43,030::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:32:43,782::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:32:43,782::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx511kwkp
apiLogger::2021-10-14 14:32:47,845::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:32:47,845::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:32:47,845::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:32:47,845::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:32:47,849::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:32:47,849::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:32:47,849::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:32:47,850::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:32:47,850::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:32:47,850::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:32:47,850::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:32:47,850::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:32:47,850::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:32:47,850::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:33:21,292::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:33:21,292::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:36:42,919::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:36:43,008::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:36:43,008::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpaskwddlv 
apiLogger::2021-10-14 14:36:43,012::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:36:43,012::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:36:43,762::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:36:43,762::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpaskwddlv
apiLogger::2021-10-14 14:36:47,832::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:36:47,832::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:36:47,832::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:36:47,832::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:36:47,836::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:36:47,836::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:36:47,836::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:36:47,836::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:36:47,836::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:36:47,836::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:36:47,836::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:36:47,836::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:36:47,836::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:36:47,837::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:37:21,273::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:37:21,273::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:38:43,133::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:38:43,216::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:38:43,216::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmph_hu_nly 
apiLogger::2021-10-14 14:38:43,220::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:38:43,220::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:38:43,971::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:38:43,971::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmph_hu_nly
apiLogger::2021-10-14 14:38:48,038::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:38:48,038::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:38:48,038::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:38:48,038::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:38:48,042::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:38:48,042::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:38:48,042::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:38:48,042::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:38:48,042::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:38:48,042::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:38:48,042::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:38:48,042::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:38:48,042::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:38:48,042::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:39:21,274::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:39:21,274::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:39:21,355::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:39:21,438::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:39:21,438::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbl9xbqn2 
apiLogger::2021-10-14 14:39:21,442::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:39:21,442::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:39:22,191::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:39:22,191::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbl9xbqn2
apiLogger::2021-10-14 14:39:26,260::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:39:26,261::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:39:26,261::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:39:26,261::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:39:26,264::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:39:26,265::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:39:26,265::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:39:26,265::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:39:26,265::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:39:26,265::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:39:26,265::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:39:26,265::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:39:26,265::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:39:26,265::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:39:59,787::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:39:59,787::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:42:42,974::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:42:43,057::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:42:43,058::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpy7aj57v8 
apiLogger::2021-10-14 14:42:43,062::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:42:43,062::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:42:43,812::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:42:43,813::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpy7aj57v8
apiLogger::2021-10-14 14:42:47,885::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:42:47,885::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:42:47,886::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:42:47,886::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:42:47,890::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:42:47,890::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:42:47,890::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:42:47,890::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:42:47,890::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:42:47,890::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:42:47,890::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:42:47,890::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:42:47,890::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:42:47,890::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:43:21,118::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:43:21,118::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:46:42,866::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:46:42,954::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:46:42,954::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn4srks5p 
apiLogger::2021-10-14 14:46:42,958::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:46:42,958::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:46:43,710::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:46:43,710::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn4srks5p
apiLogger::2021-10-14 14:46:47,781::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:46:47,781::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:46:47,781::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:46:47,781::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:46:47,785::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:46:47,785::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:46:47,785::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:46:47,785::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:46:47,785::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:46:47,786::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:46:47,786::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:46:47,786::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:46:47,786::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:46:47,786::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:47:20,999::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:47:20,999::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:48:42,878::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:48:42,961::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:48:42,962::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphrw7q2vz 
apiLogger::2021-10-14 14:48:42,966::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:48:42,966::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:48:43,716::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:48:43,716::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphrw7q2vz
apiLogger::2021-10-14 14:48:47,786::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:48:47,786::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:48:47,786::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:48:47,786::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:48:47,790::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:48:47,790::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:48:47,791::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:48:47,791::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:48:47,791::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:48:47,791::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:48:47,791::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:48:47,791::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:48:47,791::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:48:47,791::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:49:21,118::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:49:21,118::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:50:42,694::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:50:42,708::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:50:42,708::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwuzctpxs 
apiLogger::2021-10-14 14:50:42,709::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:50:42,709::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:50:42,855::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:50:42,855::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwuzctpxs
apiLogger::2021-10-14 14:50:43,345::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:50:43,346::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:50:43,346::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:50:43,346::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:50:43,350::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 14:50:43,350::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:50:43,350::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 14:50:43,350::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-14 14:50:43,350::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 14:50:43,351::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:50:43,604::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:50:43,619::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:50:43,619::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv0j4ziqg 
apiLogger::2021-10-14 14:50:43,620::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:50:43,620::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:50:44,931::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:50:44,931::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv0j4ziqg
apiLogger::2021-10-14 14:50:46,250::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:50:46,251::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:50:46,251::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:50:46,251::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:50:46,255::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 14:50:46,255::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:50:46,255::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 14:50:46,255::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 14:50:46,259::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 14:50:46,259::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 14:50:46,259::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 14:50:46,259::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-14 14:50:46,259::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 14:50:46,259::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:50:46,788::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:50:46,789::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:50:46,789::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxz1i7d9b 
apiLogger::2021-10-14 14:50:46,789::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:50:46,789::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:50:46,795::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:50:46,796::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxz1i7d9b
apiLogger::2021-10-14 14:50:46,814::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:50:46,815::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:50:46,815::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:50:46,815::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:50:46,818::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 14:50:46,819::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:50:46,819::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 14:50:46,819::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 14-Oct-2021 14:50:16 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario #1: Marc Lamberti\nScenario #1: 14-Oct \n \nMarc Lamberti \n617.515.6030 \nUpcoming PTO: 22-Oct \n ']
apiLogger::2021-10-14 14:50:46,819::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 14:50:46,819::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 14:52:42,935::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 14:52:43,018::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 14:52:43,019::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyyao6mdq 
apiLogger::2021-10-14 14:52:43,023::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 14:52:43,023::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 14:52:43,775::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 14:52:43,775::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyyao6mdq
apiLogger::2021-10-14 14:52:47,845::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 14:52:47,845::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 14:52:47,845::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 14:52:47,846::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 14:52:47,850::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 14:52:47,850::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 14:52:47,850::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 14:52:47,850::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 14:52:47,850::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 14:52:47,850::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 14:52:47,850::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 14:52:47,850::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 14:52:47,850::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 14:52:47,850::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 14:53:21,191::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 14:53:21,191::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 15:06:43,021::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 15:06:43,104::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 15:06:43,104::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppiej5cb5 
apiLogger::2021-10-14 15:06:43,109::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 15:06:43,109::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 15:06:43,863::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 15:06:43,864::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppiej5cb5
apiLogger::2021-10-14 15:06:47,933::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 15:06:47,934::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 15:06:47,934::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 15:06:47,934::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 15:06:47,938::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 15:06:47,938::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 15:06:47,938::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 15:06:47,938::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 15:06:47,938::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 15:06:47,938::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 15:06:47,938::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 15:06:47,938::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 15:06:47,938::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 15:06:47,938::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 15:07:21,556::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 15:07:21,557::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 15:26:42,789::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 15:26:42,800::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 15:26:42,800::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpr7fw8acu 
apiLogger::2021-10-14 15:26:42,801::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 15:26:42,801::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 15:26:43,107::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 15:26:43,107::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpr7fw8acu
apiLogger::2021-10-14 15:26:47,074::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 15:26:47,075::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 15:26:47,075::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 15:26:47,075::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 15:26:47,080::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,080::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 15:26:47,080::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 15:26:47,080::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 15:26:47,086::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,086::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 15:26:47,086::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 15:26:47,086::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-14 15:26:47,090::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,090::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-14 15:26:47,091::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-14 15:26:47,091::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-14 15:26:47,096::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,096::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-14 15:26:47,096::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-14 15:26:47,096::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-14 15:26:47,100::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,101::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-14 15:26:47,101::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-14 15:26:47,101::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-14 15:26:47,105::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,105::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-14 15:26:47,105::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-14 15:26:47,105::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-14 15:26:47,118::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,119::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-14 15:26:47,119::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-14 15:26:47,119::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-14 15:26:47,125::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,125::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-14 15:26:47,125::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-14 15:26:47,125::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-14 15:26:47,129::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,129::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-14 15:26:47,129::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-14 15:26:47,129::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-14 15:26:47,133::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,133::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-14 15:26:47,133::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-14 15:26:47,133::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '(cid:45)(cid:82)(cid:86)(cid:72)(cid:83)(cid:75)(cid:15)(cid:3)(cid:54)(cid:75)(cid:72)(cid:69)(cid:68)(cid:3)(cid:53)(cid:82)(cid:86)(cid:75)(cid:68)(cid:81)\n(cid:41)(cid:85)(cid:82)(cid:80)(cid:29) (cid:81)(cid:82)(cid:85)(cid:72)(cid:83)(cid:79)(cid:92)(cid:35)(cid:80)(cid:71)(cid:86)(cid:82)(cid:79)(cid:17)(cid:70)(cid:82)(cid:80)\n(cid:54)(cid:72)(cid:81)(cid:87)(cid:29) (cid:21)(cid:27)(cid:3)(cid:45)(cid:88)(cid:79)(cid:92)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:19)(cid:21)(cid:29)(cid:21)(cid:26)\n(cid:55)(cid:82)(cid:29) (cid:54)(cid:36)(cid:40)(cid:36)(cid:47)(cid:40)(cid:53)(cid:55)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:51)(cid:53)(cid:50)(cid:39)(cid:21)(cid:30)(cid:3)(cid:54)(cid:36)(cid:40)(cid:36)(cid:47)(cid:40)(cid:53)(cid:55)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:51)(cid:53)(cid:50)(cid:39)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:29) (cid:62)(cid:40)(cid:59)(cid:55)(cid:40)(cid:53)(cid:49)(cid:36)(cid:47)(cid:64)(cid:3)(cid:36)(cid:55)(cid:55)(cid:40)(cid:49)(cid:55)(cid:44)(cid:50)(cid:49)(cid:4)(cid:3)(cid:36)(cid:81)(cid:3)(cid:36)(cid:40)(cid:54)(cid:44)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:72)(cid:81)(cid:87)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:17)(cid:3)\n(cid:51)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:85)(cid:72)(cid:89)(cid:76)(cid:72)(cid:90)(cid:3)(cid:36)(cid:54)(cid:36)(cid:51)(cid:3)(cid:68)(cid:87)(cid:3)(cid:75)(cid:87)(cid:87)(cid:83)(cid:86)(cid:29)(cid:18)(cid:18)(cid:83)(cid:85)(cid:82)(cid:87)(cid:72)(cid:70)(cid:87)(cid:16)\n(cid:72)(cid:88)(cid:17)(cid:80)(cid:76)(cid:80)(cid:72)(cid:70)(cid:68)(cid:86)(cid:87)(cid:17)(cid:70)(cid:82)(cid:80)(cid:18)(cid:86)(cid:18)(cid:84)(cid:85)(cid:69)(cid:41)(cid:38)(cid:23)(cid:53)(cid:80)(cid:50)(cid:76)(cid:37)(cid:57)(cid:19)(cid:22)(cid:37)(cid:58)(cid:43)(cid:50)(cid:74)(cid:71)(cid:50)(cid:58)(cid:34)(cid:71)(cid:82)(cid:80)(cid:68)(cid:76)(cid:81)(cid:32)(cid:79)(cid:82)(cid:74)(cid:76)(cid:81)(cid:17)(cid:76)(cid:80)(cid:72)(cid:71)(cid:76)(cid:71)(cid:68)(cid:87)(cid:68)(cid:17)(cid:70)(cid:82)(cid:80)\n(cid:41)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:3)(cid:56)(cid:83)(cid:3)(cid:41)(cid:79)(cid:68)(cid:74)(cid:29) (cid:41)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:3)(cid:88)(cid:83)\n(cid:41)(cid:79)(cid:68)(cid:74)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:88)(cid:86)(cid:29) (cid:41)(cid:79)(cid:68)(cid:74)(cid:74)(cid:72)(cid:71)\n(cid:4)(cid:374)(cid:3)(cid:4)(cid:28)(cid:94)(cid:47)(cid:3)(cid:381)(cid:296)(cid:3)(cid:100)(cid:90)(cid:75)(cid:68)(cid:17)(cid:75)(cid:47)(cid:100)(cid:75)(cid:87)(cid:28)(cid:69)(cid:47)(cid:4)(cid:3)(cid:346)(cid:258)(cid:400)(cid:3)(cid:271)(cid:286)(cid:286)(cid:374)(cid:3)(cid:396)(cid:286)(cid:393)(cid:381)(cid:396)(cid:410)(cid:286)(cid:282)(cid:3)(cid:296)(cid:381)(cid:396)(cid:3)(cid:94)(cid:437)(cid:271)(cid:361)(cid:286)(cid:272)(cid:410)(cid:3)(cid:69)(cid:437)(cid:373)(cid:271)(cid:286)(cid:396)(cid:3)(cid:1011)(cid:1013)(cid:1006)(cid:1004)(cid:1005)(cid:1006)(cid:1004)(cid:1004)(cid:1009)(cid:3)(cid:449)(cid:349)(cid:410)(cid:346)(cid:3)(cid:94)(cid:410)(cid:258)(cid:396)(cid:410)(cid:3)(cid:24)(cid:258)(cid:410)(cid:286)(cid:3)(cid:894)(cid:282)(cid:282)(cid:882)(cid:373)(cid:381)(cid:374)(cid:882)(cid:455)(cid:455)(cid:455)(cid:455)(cid:895)(cid:3)(cid:855)(cid:3)(cid:1006)(cid:1011)(cid:3)(cid:58)(cid:104)(cid:62)(cid:3)\n(cid:1006)(cid:1004)(cid:1006)(cid:1005)(cid:3)(cid:3)(cid:449)(cid:349)(cid:410)(cid:346)(cid:3)(cid:4)(cid:28)(cid:3)(cid:400)(cid:437)(cid:400)(cid:393)(cid:286)(cid:272)(cid:410)(cid:286)(cid:282)(cid:3)(cid:410)(cid:381)(cid:3)(cid:271)(cid:286)(cid:3)(cid:272)(cid:258)(cid:437)(cid:400)(cid:286)(cid:282)(cid:3)(cid:271)(cid:455)(cid:3)(cid:271)(cid:367)(cid:349)(cid:374)(cid:282)(cid:286)(cid:282)(cid:3)(cid:400)(cid:410)(cid:437)(cid:282)(cid:455)(cid:3)(cid:282)(cid:396)(cid:437)(cid:336)(cid:845)(cid:3)(cid:855)(cid:3)(cid:69)(cid:75)(cid:3)\n(cid:3)\n(cid:116)(cid:116)(cid:90)(cid:24)(cid:3)(cid:894)(cid:39)(cid:68)(cid:100)(cid:895)(cid:855)(cid:3)(cid:1006)(cid:1011)(cid:3)(cid:58)(cid:437)(cid:367)(cid:3)(cid:1006)(cid:1004)(cid:1006)(cid:1005)(cid:3)(cid:1006)(cid:1004)(cid:855)(cid:1009)(cid:1010)(cid:855)(cid:1005)(cid:1011)(cid:3)\n(cid:3)\n(cid:20) (cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:16)(cid:37)(cid:68)(cid:86)(cid:78)(cid:72)(cid:81)(cid:87)(cid:3)(cid:56)(cid:81)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:55)(cid:76)(cid:83)(cid:3)(cid:41)(cid:68)(cid:78)(cid:88)(cid:79)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:36)(cid:71)(cid:68)(cid:81)(cid:68)(cid:3)(cid:43)(cid:68)(cid:86)(cid:87)(cid:68)(cid:81)(cid:72)(cid:86)(cid:76)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:19)(cid:19)(cid:24)\n(cid:41)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:29)(cid:3)(cid:54)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)\n(cid:41)(cid:82)(cid:85)(cid:80)(cid:29)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)\n(cid:39)(cid:68)(cid:87)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:29)(cid:3)(cid:11)(cid:36)(cid:86)(cid:72)(cid:93)(cid:72)(cid:85)(cid:20)(cid:12)(cid:3)(cid:19)(cid:27)(cid:3)(cid:41)(cid:72)(cid:69)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:19)(cid:28)(cid:29)(cid:21)(cid:26)(cid:29)(cid:23)(cid:28)\n(cid:42)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:50)(cid:81)(cid:29)(cid:3)(cid:21)(cid:27)(cid:3)(cid:45)(cid:88)(cid:79)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:20)(cid:20)(cid:29)(cid:24)(cid:26)(cid:29)(cid:22)(cid:19)\n(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:29)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:29)(cid:3)(cid:3)(cid:48)(cid:68)(cid:76)(cid:81)(cid:3)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:37)(cid:76)(cid:82)(cid:83)(cid:86)(cid:92)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:54)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:41)(cid:76)(cid:85)(cid:86)(cid:87)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81) (cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:22)\n(cid:44)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:51)(cid:68)(cid:85)(cid:87)(cid:20)(cid:3)(cid:82)(cid:85)(cid:3)(cid:51)(cid:68)(cid:85)(cid:87)(cid:3)(cid:21)(cid:3)(cid:82)(cid:73) (cid:51)(cid:68)(cid:85)(cid:87)(cid:3)(cid:21)\n(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:34)\n(cid:42)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)\n(cid:43)(cid:68)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:74)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69) (cid:60)(cid:72)(cid:86)\n(cid:86)(cid:87)(cid:88)(cid:71)(cid:92)(cid:34)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:42)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:50)(cid:81)(cid:79)(cid:92)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:72)(cid:84)(cid:88)(cid:72)(cid:81)(cid:70)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:88)(cid:80)(cid:82)(cid:85) (cid:60)(cid:72)(cid:86)\n(cid:87)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:76)(cid:85)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:88)(cid:80)(cid:82)(cid:85)(cid:3)(cid:39)(cid:49)(cid:36)(cid:3)(cid:86)(cid:68)(cid:80)(cid:83)(cid:79)(cid:72)(cid:86)(cid:34)\n(cid:38)(cid:51)(cid:51)(cid:38)(cid:20)(cid:21)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:3)(cid:19)(cid:19)(cid:21)(cid:26) (cid:20)(cid:3)(cid:82)(cid:73)(cid:3)(cid:23)\n(cid:11)(cid:28)(cid:19)(cid:26)(cid:23)(cid:12) (cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:16)(cid:37)(cid:68)(cid:86)(cid:78)(cid:72)(cid:81)(cid:87)(cid:3)(cid:56)(cid:81)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:55)(cid:76)(cid:83)(cid:3)(cid:41)(cid:68)(cid:78)(cid:88)(cid:79)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:36)(cid:71)(cid:68)(cid:81)(cid:68)(cid:3)(cid:43)(cid:68)(cid:86)(cid:87)(cid:68)(cid:81)(cid:72)(cid:86)(cid:76)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:19)(cid:19)(cid:24)\n(cid:41)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:29)(cid:3)(cid:54)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:33)(cid:33)(cid:3)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:55)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:76)(cid:72)(cid:86)(cid:3)(cid:11)(cid:20)(cid:12)\n(cid:41)(cid:82)(cid:85)(cid:80)(cid:29)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:55)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:76)(cid:72)(cid:86)(cid:3)(cid:60)(cid:72)(cid:86)(cid:18)(cid:49)(cid:82)\n(cid:39)(cid:68)(cid:87)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:29)(cid:3)(cid:11)(cid:36)(cid:86)(cid:72)(cid:93)(cid:72)(cid:85)(cid:20)(cid:12)(cid:3)(cid:19)(cid:27)(cid:3)(cid:41)(cid:72)(cid:69)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:19)(cid:28)(cid:29)(cid:21)(cid:26)(cid:29)(cid:24)(cid:21)\n(cid:42)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:50)(cid:81)(cid:29)(cid:3)(cid:21)(cid:27)(cid:3)(cid:45)(cid:88)(cid:79)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:20)(cid:20)(cid:29)(cid:24)(cid:25)(cid:29)(cid:19)(cid:25)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:54)(cid:92)(cid:86)(cid:87)(cid:72)(cid:80)(cid:76)(cid:70)(cid:3)(cid:55)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:92)(cid:34) (cid:49)(cid:82)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:68)(cid:71)(cid:76)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:92)(cid:34) (cid:60)(cid:72)(cid:86)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:34) (cid:49)(cid:82)\n(cid:38)(cid:51)(cid:51)(cid:38)(cid:20)(cid:21)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:3)(cid:19)(cid:19)(cid:21)(cid:26) (cid:20)(cid:3)(cid:82)(cid:73)(cid:3)(cid:22)\n(cid:11)(cid:28)(cid:19)(cid:26)(cid:23)(cid:12) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:51)(cid:85)(cid:82)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:83)(cid:85)(cid:82)(cid:77)(cid:72)(cid:70)(cid:87) (cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)\n(cid:44)(cid:38)(cid:50)(cid:49)(cid:3)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:70)(cid:82)(cid:71)(cid:72) (cid:19)(cid:23)(cid:24)(cid:25)(cid:18)(cid:19)(cid:20)(cid:23)(cid:25)\n(cid:72)(cid:81)(cid:89)(cid:76)(cid:85)(cid:82)(cid:81)(cid:80)(cid:72)(cid:81)(cid:87)(cid:49)(cid:68)(cid:80)(cid:72) (cid:51)(cid:85)(cid:82)(cid:71)\n(cid:54)(cid:76)(cid:87)(cid:72) (cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:16)(cid:37)(cid:68)(cid:86)(cid:78)(cid:72)(cid:81)(cid:87)(cid:3)(cid:56)(cid:81)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:55)(cid:76)(cid:83)(cid:3)(cid:41)(cid:68)(cid:78)(cid:88)(cid:79)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:36)(cid:71)(cid:68)(cid:81)(cid:68)(cid:3)(cid:43)(cid:68)(cid:86)(cid:87)(cid:68)(cid:81)(cid:72)(cid:86)(cid:76)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85) (cid:24)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:44)(cid:39) (cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:19)(cid:19)(cid:24)(cid:20)(cid:20)\n(cid:43)(cid:68)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:85)(cid:72)(cid:86)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:72)(cid:71)(cid:34) (cid:49)(cid:82)\n(cid:44)(cid:73)(cid:3)(cid:60)(cid:72)(cid:86)(cid:15)(cid:3)(cid:83)(cid:85)(cid:72)(cid:89)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:86)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:44)(cid:39)(cid:29)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:79)(cid:76)(cid:74)(cid:76)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:44)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:72)(cid:79)(cid:76)(cid:74)(cid:76)(cid:69)(cid:86)(cid:79)(cid:72)(cid:87)(cid:88)(cid:3)(cid:87)(cid:71)(cid:82)(cid:92)(cid:3)(cid:83)(cid:34)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86) (cid:60)(cid:72)(cid:86)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:54)(cid:88)(cid:38)(cid:69)(cid:77)(cid:82)(cid:72)(cid:81)(cid:70)(cid:86)(cid:87)(cid:3)(cid:72)(cid:54)(cid:81)(cid:76)(cid:74)(cid:87)(cid:3)(cid:81)(cid:11)(cid:71)(cid:72)(cid:71)(cid:71)(cid:16)(cid:3)(cid:80)(cid:87)(cid:75)(cid:82)(cid:72)(cid:81)(cid:3)(cid:41)(cid:16)(cid:92)(cid:76)(cid:85)(cid:92)(cid:86)(cid:92)(cid:87)(cid:3)(cid:92)(cid:44)(cid:81)(cid:12)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:43)(cid:76)(cid:83)(cid:68)(cid:86)(cid:68)(cid:3)(cid:87)(cid:87)(cid:72)(cid:75)(cid:3)(cid:76)(cid:72)(cid:81)(cid:3)(cid:86)(cid:3)(cid:87)(cid:88)(cid:75)(cid:69)(cid:72)(cid:77)(cid:3)(cid:72)(cid:74)(cid:70)(cid:72)(cid:87)(cid:81)(cid:3)(cid:70)(cid:82)(cid:82)(cid:80)(cid:81)(cid:76)(cid:86)(cid:70)(cid:72)(cid:86)(cid:81)(cid:3)(cid:86)(cid:87)(cid:88)(cid:72)(cid:71)(cid:69)(cid:3)(cid:3)(cid:87)(cid:86)(cid:82)(cid:87)(cid:88)(cid:71)(cid:92)(cid:34) (cid:60)(cid:72)(cid:86)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:42)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:92)(cid:86)(cid:92)(cid:3)(cid:92)(cid:38)(cid:92)(cid:82)(cid:12)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81) (cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:22)\n(cid:39)(cid:72)(cid:80)(cid:82)(cid:74)(cid:85)(cid:68)(cid:83)(cid:75)(cid:76)(cid:70)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:37)(cid:76)(cid:85)(cid:87)(cid:75)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:20)(cid:28)(cid:25)(cid:19)\n(cid:36)(cid:74)(cid:72)(cid:3)(cid:11)(cid:39)(cid:72)(cid:85)(cid:76)(cid:89)(cid:72)(cid:71)(cid:12)(cid:3)(cid:11)(cid:54)(cid:36)(cid:76)(cid:79)(cid:87)(cid:79)(cid:72)(cid:3)(cid:40)(cid:86)(cid:59)(cid:12)(cid:38)(cid:40)(cid:51)(cid:55)(cid:3)(cid:42)(cid:72)(cid:85)(cid:80)(cid:68)(cid:81) (cid:25)(cid:19)\n(cid:54)(cid:72)(cid:91) (cid:48)(cid:68)(cid:79)(cid:72)\n(cid:53)(cid:68)(cid:70)(cid:72)(cid:3)(cid:11)(cid:70)(cid:75)(cid:82)(cid:82)(cid:86)(cid:72)(cid:3)(cid:82)(cid:81)(cid:79)(cid:92)(cid:3)(cid:82)(cid:81)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:80)(cid:68)(cid:85)(cid:92)(cid:3)(cid:85)(cid:68)(cid:70)(cid:72)(cid:12) (cid:58)(cid:75)(cid:76)(cid:87)(cid:72)\n(cid:44)(cid:73)(cid:3)(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92)\n(cid:40)(cid:87)(cid:75)(cid:81)(cid:76)(cid:70)(cid:76)(cid:87)(cid:92) (cid:49)(cid:82)(cid:87)(cid:3)(cid:43)(cid:76)(cid:86)(cid:83)(cid:68)(cid:81)(cid:76)(cid:70)(cid:3)(cid:82)(cid:85)(cid:3)(cid:47)(cid:68)(cid:87)(cid:76)(cid:81)(cid:82)\n(cid:54)(cid:80)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:54)(cid:80)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:88)(cid:86) (cid:51)(cid:68)(cid:86)(cid:87)(cid:3)(cid:54)(cid:80)(cid:82)(cid:78)(cid:72)(cid:85)\n(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:60)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)(cid:54)(cid:80)(cid:82)(cid:78)(cid:72)(cid:71) (cid:22)(cid:24)\n(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:76)(cid:74)(cid:68)(cid:85)(cid:72)(cid:87)(cid:87)(cid:72)(cid:86)(cid:3)(cid:51)(cid:72)(cid:85)(cid:3)(cid:39)(cid:68)(cid:92) (cid:20)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:3)(cid:36)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:55)(cid:85)(cid:68)(cid:70)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:16)(cid:3)(cid:54)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:11)(cid:42)(cid:70)(cid:79)(cid:82)(cid:82)(cid:79)(cid:69)(cid:3)(cid:89)(cid:68)(cid:72)(cid:79)(cid:85)(cid:12)(cid:86)(cid:76)(cid:82)(cid:81) (cid:51)(cid:80)(cid:85)(cid:36)(cid:39)(cid:82)(cid:82)(cid:83)(cid:68)(cid:87)(cid:82)(cid:81)(cid:87)(cid:83)(cid:72)(cid:70)(cid:16)(cid:85)(cid:92)(cid:3)(cid:82)(cid:82)(cid:11)(cid:92)(cid:71)(cid:79)(cid:89)(cid:3)(cid:92)(cid:71)(cid:44)(cid:68)(cid:53)(cid:92)(cid:16)(cid:79)(cid:12)(cid:37) (cid:38)(cid:86)(cid:82)(cid:76)(cid:74)(cid:39)(cid:81)(cid:81)(cid:86)(cid:68)(cid:72)(cid:72)(cid:87)(cid:72)(cid:92)(cid:71)(cid:81)(cid:3)(cid:92)(cid:3)(cid:87)(cid:86)(cid:44)(cid:3)(cid:92)(cid:81)(cid:11)(cid:88)(cid:71)(cid:92)(cid:73)(cid:69)(cid:82)(cid:71)(cid:12)(cid:77)(cid:85)(cid:72)(cid:16)(cid:80)(cid:80)(cid:70)(cid:87)(cid:72)(cid:82)(cid:71)(cid:81)(cid:16) (cid:38)(cid:82)(cid:55)(cid:81)(cid:92)(cid:86)(cid:83)(cid:72)(cid:72)(cid:81)(cid:87) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:36)(cid:44)(cid:44)(cid:53)(cid:81)(cid:83)(cid:37)(cid:73)(cid:83)(cid:82)(cid:3)(cid:85)(cid:85)(cid:11)(cid:82)(cid:71)(cid:80)(cid:89)(cid:71)(cid:72)(cid:68)(cid:16)(cid:71)(cid:79)(cid:80)(cid:3)(cid:39)(cid:3)(cid:38)(cid:82)(cid:68)(cid:81)(cid:82)(cid:87)(cid:16)(cid:72)(cid:81)(cid:92)(cid:3)(cid:86)(cid:73)(cid:92)(cid:85)(cid:72)(cid:92)(cid:82)(cid:81)(cid:92)(cid:80)(cid:87)(cid:12)\n(cid:21) (cid:53)(cid:21)(cid:27)(cid:20)(cid:36)(cid:19)(cid:16)(cid:80)(cid:50)(cid:72)(cid:49)(cid:81)(cid:38)(cid:71)(cid:3)(cid:16)(cid:24)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22) (cid:21)(cid:20)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:11)(cid:43)(cid:48)(cid:41)(cid:36)(cid:76)(cid:76)(cid:68)(cid:69)(cid:72)(cid:86)(cid:81)(cid:79)(cid:71)(cid:87)(cid:81)(cid:76)(cid:71)(cid:82)(cid:87)(cid:76)(cid:82)(cid:92)(cid:76)(cid:70)(cid:85)(cid:81)(cid:85)(cid:12)(cid:92)(cid:68)(cid:80)(cid:74)(cid:3)(cid:79)(cid:18) (cid:54)(cid:87)(cid:80)(cid:68)(cid:85)(cid:82)(cid:87)(cid:3)(cid:81)(cid:39)(cid:16)(cid:68)(cid:92)(cid:87)(cid:92)(cid:72)(cid:92)(cid:3)(cid:11)(cid:92)(cid:71)(cid:12)(cid:71)(cid:16) (cid:88)(cid:81)(cid:38)(cid:78)(cid:81)(cid:75)(cid:71)(cid:82)(cid:72)(cid:68)(cid:70)(cid:90)(cid:87)(cid:78)(cid:81)(cid:72)(cid:3)(cid:73)(cid:3)(cid:86)(cid:82)(cid:87)(cid:85)(cid:68)(cid:85)(cid:87) (cid:50)(cid:68)(cid:72)(cid:87)(cid:81)(cid:3)(cid:81)(cid:86)(cid:74)(cid:87)(cid:87)(cid:82)(cid:85)(cid:88)(cid:92)(cid:76)(cid:71)(cid:81)(cid:34)(cid:92)(cid:74) (cid:50)(cid:54)(cid:38)(cid:42)(cid:81)(cid:83)(cid:55)(cid:85)(cid:74)(cid:72)(cid:38)(cid:44)(cid:68)(cid:82)(cid:73)(cid:70)(cid:71)(cid:36)(cid:76)(cid:76)(cid:81)(cid:72)(cid:73)(cid:40)(cid:92)(cid:74) (cid:11)(cid:11)(cid:40)(cid:85)(cid:71)(cid:72)(cid:81)(cid:92)(cid:71)(cid:86)(cid:39)(cid:71)(cid:92)(cid:16)(cid:82)(cid:68)(cid:80)(cid:3)(cid:92)(cid:79)(cid:71)(cid:87)(cid:89)(cid:92)(cid:72)(cid:82)(cid:68)(cid:72)(cid:12)(cid:81)(cid:87)(cid:71)(cid:72)(cid:16)(cid:12) (cid:88)(cid:81)(cid:38)(cid:78)(cid:75)(cid:81)(cid:71)(cid:72)(cid:82)(cid:70)(cid:68)(cid:90)(cid:78)(cid:87)(cid:72)(cid:81)(cid:3)(cid:73)(cid:3)(cid:82)(cid:72)(cid:85)(cid:81)(cid:71)\n(cid:20) (cid:36)(cid:49)(cid:40)(cid:48)(cid:44)(cid:36) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74) (cid:42)(cid:48)(cid:85)(cid:82)(cid:68)(cid:71)(cid:71)(cid:72)(cid:72)(cid:85)(cid:3)(cid:68)(cid:21)(cid:87)(cid:3)(cid:72)(cid:16) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39)\n(cid:21) (cid:43)(cid:55)(cid:60)(cid:53)(cid:51)(cid:40)(cid:50)(cid:48)(cid:49)(cid:44)(cid:36)(cid:36) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74) (cid:42)(cid:54)(cid:85)(cid:68)(cid:72)(cid:71)(cid:89)(cid:72)(cid:72)(cid:3)(cid:85)(cid:22)(cid:72)(cid:3)(cid:16) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:38)(cid:82)(cid:81)(cid:70)(cid:82)(cid:80)(cid:76)(cid:87)(cid:68)(cid:81)(cid:87)(cid:3)(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:47)(cid:39)(cid:80)(cid:76)(cid:86)(cid:85)(cid:83)(cid:72)(cid:87)(cid:88)(cid:3)(cid:71)(cid:72)(cid:82)(cid:74)(cid:85)(cid:76)(cid:81)(cid:3)(cid:70)(cid:3)(cid:49)(cid:79)(cid:79)(cid:68)(cid:76)(cid:92)(cid:81)(cid:68)(cid:87)(cid:3)(cid:76)(cid:72)(cid:80)(cid:82)(cid:82)(cid:81)(cid:81)(cid:72)(cid:72) (cid:44)(cid:81)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:51)(cid:48)(cid:48)(cid:44)(cid:79)(cid:72)(cid:73)(cid:72)(cid:72)(cid:68)(cid:3)(cid:68)(cid:44)(cid:71)(cid:71)(cid:83)(cid:81)(cid:86)(cid:76)(cid:85)(cid:76)(cid:83)(cid:71)(cid:70)(cid:70)(cid:72)(cid:72)(cid:68)(cid:85)(cid:76)(cid:68)(cid:3)(cid:70)(cid:70)(cid:82)(cid:86)(cid:79)(cid:79)(cid:82)(cid:3)(cid:68)(cid:3)(cid:72)(cid:83)(cid:43)(cid:43)(cid:85)(cid:87)(cid:79)(cid:85)(cid:76)(cid:71)(cid:72)(cid:76)(cid:76)(cid:76)(cid:82)(cid:86)(cid:86)(cid:68)(cid:70)(cid:17)(cid:81)(cid:87)(cid:87)(cid:87)(cid:87)(cid:82)(cid:82)(cid:72)(cid:3)(cid:3)(cid:76)(cid:87)(cid:85)(cid:85)(cid:86)(cid:75)(cid:92)(cid:92)(cid:72)(cid:15) (cid:40)(cid:44)(cid:73)(cid:89)(cid:3)(cid:68)(cid:44)(cid:72)(cid:81)(cid:83)(cid:81)(cid:71)(cid:83)(cid:87)(cid:40)(cid:76)(cid:85)(cid:15)(cid:70)(cid:82)(cid:3)(cid:89)(cid:51)(cid:68)(cid:83)(cid:72)(cid:79)(cid:87)(cid:85)(cid:72)(cid:81)(cid:76)(cid:76)(cid:82)(cid:68)(cid:87)(cid:68)(cid:3)(cid:81)(cid:86)(cid:87)(cid:85)(cid:72)(cid:3)(cid:72)(cid:72)(cid:76)(cid:3)(cid:86)(cid:70)(cid:3)(cid:36)(cid:86)(cid:3)(cid:82)(cid:36)(cid:72)(cid:71)(cid:85)(cid:79)(cid:89)(cid:71)(cid:71)(cid:72)(cid:72)(cid:89)(cid:17)(cid:70)(cid:85)(cid:72)(cid:87)(cid:86)(cid:3)(cid:85)(cid:87)(cid:72)(cid:86)(cid:75)(cid:72)(cid:72) (cid:39)(cid:82)(cid:86)(cid:72) (cid:39)(cid:56)(cid:82)(cid:81)(cid:86)(cid:76)(cid:87)(cid:72) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:41)(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:81)(cid:70)(cid:92) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:79)(cid:70)(cid:76)(cid:68)(cid:10)(cid:86)(cid:82)(cid:69)(cid:50)(cid:79)(cid:83)(cid:76)(cid:87)(cid:85)(cid:72)(cid:86)(cid:15)(cid:87)(cid:83)(cid:85)(cid:3)(cid:3)(cid:75)(cid:87)(cid:72)(cid:87)(cid:73)(cid:87)(cid:85)(cid:3)(cid:75)(cid:82)(cid:75)(cid:72)(cid:82)(cid:86)(cid:53)(cid:68)(cid:72)(cid:88)(cid:85)(cid:72)(cid:83)(cid:81)(cid:83)(cid:82)(cid:10)(cid:81)(cid:3)(cid:81)(cid:3)(cid:82)(cid:71)(cid:85)(cid:88)(cid:81)(cid:73)(cid:76)(cid:3)(cid:71)(cid:85)(cid:81)(cid:3)(cid:68)(cid:83)(cid:87)(cid:72)(cid:86)(cid:82)(cid:72)(cid:3)(cid:71)(cid:87)(cid:79)(cid:91)(cid:76)(cid:83)(cid:80)(cid:72)(cid:72)(cid:3)(cid:81)(cid:76)(cid:87)(cid:11)(cid:72)(cid:81)(cid:3)(cid:68)(cid:3)(cid:44)(cid:3)(cid:3)(cid:87)(cid:79)(cid:73)(cid:87)(cid:70)(cid:87)(cid:86)(cid:74)(cid:72)(cid:76)(cid:3)(cid:75)(cid:75)(cid:81)(cid:81)(cid:76)(cid:72)(cid:85)(cid:3)(cid:73)(cid:72)(cid:87)(cid:72)(cid:72)(cid:80)(cid:82)(cid:92)(cid:3)(cid:72)(cid:3)(cid:86)(cid:3)(cid:17)(cid:83)(cid:3)(cid:83)(cid:85)(cid:12)(cid:3)(cid:87)(cid:72)(cid:70)(cid:80)(cid:76)(cid:75)(cid:76)(cid:79)(cid:70)(cid:70)(cid:68)(cid:72)(cid:72)(cid:3)(cid:78)(cid:78)(cid:81)(cid:76)(cid:70)(cid:81)(cid:87) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:54)(cid:11)(cid:71)(cid:87)(cid:68)(cid:92)(cid:71)(cid:85)(cid:92)(cid:16)(cid:87)(cid:80)(cid:92)(cid:3)(cid:39)(cid:92)(cid:82)(cid:68)(cid:12)(cid:81)(cid:87)(cid:72)(cid:16) (cid:54)(cid:11)(cid:71)(cid:87)(cid:82)(cid:92)(cid:71)(cid:92)(cid:83)(cid:16)(cid:80)(cid:92)(cid:3)(cid:39)(cid:92)(cid:82)(cid:68)(cid:12)(cid:81)(cid:87)(cid:72)(cid:16) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74)\n(cid:20) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23) (cid:48)(cid:51)(cid:3)(cid:50)(cid:38)(cid:36)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:39)(cid:44)(cid:56)(cid:40) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:41)(cid:40)(cid:36)(cid:54)(cid:55)(cid:44)(cid:40)(cid:56)(cid:3)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26) (cid:40)(cid:48)(cid:40)(cid:49)(cid:39) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21)(cid:24) (cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:27) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:28) (cid:50)(cid:59)(cid:50)(cid:51)(cid:36)(cid:49)(cid:40) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24) (cid:80)(cid:74) (cid:51)(cid:53)(cid:49) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:20)(cid:19) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:20) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:21) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:22) (cid:51)(cid:38)(cid:50)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:44)(cid:39)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:23) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:51)(cid:40)(cid:43)(cid:54)(cid:36)(cid:44)(cid:55)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:24) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:25) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:26) (cid:47)(cid:36)(cid:49)(cid:54)(cid:50)(cid:53)(cid:3) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:22)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:20)(cid:27) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:28) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:19) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:20) (cid:51)(cid:38)(cid:50)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:44)(cid:39)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:21) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:41)(cid:40)(cid:36)(cid:54)(cid:55)(cid:44)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:22) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:23) (cid:40)(cid:48)(cid:40)(cid:49)(cid:39) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21)(cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:24) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:25) (cid:40)(cid:48)(cid:40)(cid:55)(cid:53)(cid:44)(cid:47) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85) (cid:51)(cid:53)(cid:36)(cid:50)(cid:59)(cid:51)(cid:44)(cid:43)(cid:54)(cid:60)(cid:47) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:21)(cid:26) (cid:40)(cid:48)(cid:40)(cid:39)(cid:56)(cid:53) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85) (cid:51)(cid:53)(cid:36)(cid:50)(cid:59)(cid:51)(cid:44)(cid:43)(cid:54)(cid:60)(cid:47) (cid:21)(cid:19)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:21)(cid:27) (cid:41)(cid:50)(cid:47)(cid:37)(cid:44)(cid:50)(cid:47) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85) (cid:51)(cid:53)(cid:36)(cid:50)(cid:59)(cid:51)(cid:44)(cid:43)(cid:54)(cid:60)(cid:47) (cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:21)(cid:28) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:19) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:20) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:21) (cid:51)(cid:38)(cid:50)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:44)(cid:39)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:22) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:51)(cid:40)(cid:43)(cid:54)(cid:36)(cid:44)(cid:55)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:23) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:24) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:25) (cid:40)(cid:48)(cid:40)(cid:49)(cid:39) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21)(cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:26) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:27) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:28) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:19) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:20) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:21) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:22) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:23) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:24) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:25) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:26) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:27) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:28) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:19) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:20) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:21) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:22) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:23) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:24) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:25) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:26) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:27) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:28) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:19) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:20) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:21) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:25)(cid:22) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:23) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:24) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:25) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:26) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:27) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:28) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:19) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:20) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:21) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:22) (cid:51)(cid:53)(cid:40)(cid:39)(cid:49)(cid:50)(cid:47) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:20)(cid:21)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:20)(cid:19)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:25)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:23) (cid:51)(cid:55)(cid:36)(cid:44)(cid:51)(cid:61)(cid:40)(cid:50)(cid:53)(cid:48)(cid:49)(cid:37)(cid:36)(cid:36)(cid:38)(cid:38)(cid:44)(cid:47)(cid:55)(cid:47)(cid:36)(cid:44) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:23)(cid:17)(cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:19)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:25)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:24) (cid:47)(cid:40)(cid:57)(cid:50)(cid:38)(cid:41)(cid:44)(cid:49)(cid:47)(cid:50)(cid:59)(cid:36) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:24)(cid:19)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:19)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:25)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:25) (cid:51)(cid:53)(cid:40)(cid:39)(cid:49)(cid:50)(cid:47) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:25)(cid:23) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:20)(cid:26)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:22)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:26) (cid:51)(cid:53)(cid:40)(cid:39)(cid:49)(cid:50)(cid:47) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:22)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:21)(cid:23)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:38)(cid:82)(cid:81)(cid:70)(cid:82)(cid:80)(cid:76)(cid:87)(cid:68)(cid:81)(cid:87)(cid:3)(cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:18)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:76)(cid:72)(cid:86)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:3)(cid:18)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92) (cid:53)(cid:72)(cid:68)(cid:86)(cid:51)(cid:82)(cid:85)(cid:81)(cid:82)(cid:3)(cid:73)(cid:70)(cid:82)(cid:72)(cid:85)(cid:71)(cid:3)(cid:54)(cid:88)(cid:88)(cid:85)(cid:72)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:18) (cid:44)(cid:73)(cid:3)(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:51)(cid:85)(cid:39)(cid:82)(cid:68)(cid:70)(cid:87)(cid:72)(cid:72)(cid:71)(cid:3)(cid:80)(cid:82)(cid:88)(cid:73)(cid:85)(cid:82)(cid:3)(cid:72)(cid:38)(cid:81)(cid:18)(cid:82)(cid:54)(cid:16)(cid:92)(cid:81)(cid:88)(cid:92)(cid:70)(cid:85)(cid:92)(cid:74)(cid:82)(cid:92)(cid:72)(cid:80)(cid:12)(cid:85)(cid:92)(cid:76)(cid:87)(cid:3)(cid:68)(cid:3)(cid:11)(cid:81)(cid:71)(cid:87)(cid:71)(cid:16)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)\n(cid:53)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:18)(cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72) (cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:3)(cid:47)(cid:82)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) (cid:44)(cid:73)(cid:3)(cid:54)(cid:88)(cid:50)(cid:85)(cid:87)(cid:74)(cid:75)(cid:72)(cid:72)(cid:85)(cid:85)(cid:92)(cid:15)(cid:3)(cid:3)(cid:47)(cid:86)(cid:83)(cid:82)(cid:72)(cid:70)(cid:70)(cid:68)(cid:76)(cid:87)(cid:73)(cid:76)(cid:92)(cid:82)(cid:81)(cid:3)(cid:76)(cid:86) (cid:39)(cid:11)(cid:71)(cid:68)(cid:71)(cid:87)(cid:72)(cid:16)(cid:80)(cid:3)(cid:82)(cid:82)(cid:73)(cid:3)(cid:81)(cid:54)(cid:16)(cid:88)(cid:92)(cid:85)(cid:92)(cid:74)(cid:92)(cid:72)(cid:92)(cid:85)(cid:12)(cid:92) (cid:38)(cid:75)(cid:72)(cid:70)(cid:78)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:56)(cid:81)(cid:78)(cid:81)(cid:82)(cid:90)(cid:81)(cid:3)(cid:39)(cid:68)(cid:87)(cid:72)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20)']
apiLogger::2021-10-14 15:26:47,135::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 15:26:47,135::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 15:26:47,571::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 15:26:47,572::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 15:26:47,572::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnimcw5hc 
apiLogger::2021-10-14 15:26:47,573::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 15:26:47,573::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 15:26:47,580::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 15:26:47,580::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnimcw5hc
apiLogger::2021-10-14 15:26:47,617::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 15:26:47,617::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 15:26:47,617::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 15:26:47,617::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 15:26:47,621::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:26:47,621::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 15:26:47,621::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 15:26:47,621::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Robin Fultz <robin.fultz@regeneron.com>\nReceived Date : 14-Oct-2021 15:25:06 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 04 - Robin Fultz\n \nScenario 04 14-Oct-2021 \n \n \nRobin Fultz, RN \nAssociate Mgr Case Management, GPS Case Evaluation and Reporting Management \nREGENERON\n  SCIENCE TO MEDICINE® \n(914) 255-8338 cell \nRobin.Fultz@regeneron.com\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \nUpcoming Out of office dates: N/A\n \n \n \n ']
apiLogger::2021-10-14 15:26:47,621::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 15:26:47,622::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 15:50:42,706::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 15:50:42,720::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 15:50:42,721::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmph0cm1swd 
apiLogger::2021-10-14 15:50:42,721::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 15:50:42,721::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 15:50:42,867::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 15:50:42,867::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmph0cm1swd
apiLogger::2021-10-14 15:50:43,360::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 15:50:43,360::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 15:50:43,360::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 15:50:43,360::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 15:50:43,365::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:50:43,365::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 15:50:43,365::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 15:50:43,365::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-14 15:50:43,365::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 15:50:43,365::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 15:50:43,670::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 15:50:43,685::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 15:50:43,685::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgmrrq1ko 
apiLogger::2021-10-14 15:50:43,686::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 15:50:43,686::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 15:50:45,001::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 15:50:45,001::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgmrrq1ko
apiLogger::2021-10-14 15:50:46,325::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 15:50:46,326::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 15:50:46,326::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 15:50:46,326::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 15:50:46,330::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:50:46,330::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 15:50:46,330::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 15:50:46,330::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 15:50:46,334::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:50:46,334::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 15:50:46,334::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 15:50:46,334::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-14 15:50:46,334::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 15:50:46,334::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 15:50:46,888::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 15:50:46,888::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 15:50:46,889::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpelv6mu50 
apiLogger::2021-10-14 15:50:46,889::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 15:50:46,889::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 15:50:46,895::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 15:50:46,895::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpelv6mu50
apiLogger::2021-10-14 15:50:46,915::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 15:50:46,915::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 15:50:46,915::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 15:50:46,915::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 15:50:46,919::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 15:50:46,919::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 15:50:46,919::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 15:50:46,919::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 14-Oct-2021 15:49:28 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario #1 - MWL\nScenario #1 – One More Time 14-Oct-2021 \n \nMarc Lamberti \n617.515.6030 \nUpcoming PTO: 22-Oct \n ']
apiLogger::2021-10-14 15:50:46,919::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 15:50:46,919::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 18:20:42,915::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 18:20:42,999::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 18:20:42,999::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5wvajc14 
apiLogger::2021-10-14 18:20:43,003::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 18:20:43,003::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 18:20:43,757::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 18:20:43,757::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5wvajc14
apiLogger::2021-10-14 18:20:47,833::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 18:20:47,833::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 18:20:47,833::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 18:20:47,833::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 18:20:47,837::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 18:20:47,837::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 18:20:47,837::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 18:20:47,838::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 18:20:47,838::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 18:20:47,838::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 18:20:47,838::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 18:20:47,838::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 18:20:47,838::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 18:20:47,838::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 18:21:21,061::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 18:21:21,061::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 19:14:42,847::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 19:14:42,936::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 19:14:42,936::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu68ebhak 
apiLogger::2021-10-14 19:14:42,940::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 19:14:42,940::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 19:14:43,692::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 19:14:43,692::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu68ebhak
apiLogger::2021-10-14 19:14:47,763::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 19:14:47,763::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 19:14:47,763::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 19:14:47,763::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 19:14:47,767::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 19:14:47,767::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 19:14:47,767::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 19:14:47,767::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 19:14:47,767::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 19:14:47,768::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 19:14:47,768::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 19:14:47,768::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 19:14:47,768::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 19:14:47,768::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 19:15:21,083::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 19:15:21,083::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 19:32:43,155::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 19:32:43,240::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 19:32:43,240::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmyu6mek5 
apiLogger::2021-10-14 19:32:43,244::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 19:32:43,244::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 19:32:43,997::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 19:32:43,997::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmyu6mek5
apiLogger::2021-10-14 19:32:48,065::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 19:32:48,065::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 19:32:48,066::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 19:32:48,066::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 19:32:48,070::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-14 19:32:48,070::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 19:32:48,070::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 19:32:48,070::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-14 19:32:48,070::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-14 19:32:48,070::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 19:32:48,070::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-14 19:32:48,070::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 19:32:48,070::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 19:32:48,071::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 19:33:21,428::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 19:33:21,428::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 20:48:42,719::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 20:48:42,725::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 20:48:42,726::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpt8z5ewi_ 
apiLogger::2021-10-14 20:48:42,726::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 20:48:42,726::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 20:48:42,876::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 20:48:42,876::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpt8z5ewi_
apiLogger::2021-10-14 20:48:44,496::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 20:48:44,496::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 20:48:44,496::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 20:48:44,496::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 20:48:44,500::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 20:48:44,500::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 20:48:44,500::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 20:48:44,500::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 20:48:44,504::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 20:48:44,504::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 20:48:44,504::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 20:48:44,504::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-14 20:48:44,507::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-14 20:48:44,507::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-14 20:48:44,507::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-14 20:48:44,507::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-14 20:48:44,507::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-14 20:48:44,508::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-14 20:48:44,508::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-14 20:48:44,508::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-14 20:48:44,508::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-14 20:48:44,508::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-14 20:48:59,079::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-14 20:48:59,079::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 21:00:42,714::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 21:00:42,718::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 21:00:42,718::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2cjnlofc 
apiLogger::2021-10-14 21:00:42,719::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 21:00:42,719::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 21:00:42,887::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 21:00:42,887::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2cjnlofc
apiLogger::2021-10-14 21:00:43,620::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 21:00:43,620::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 21:00:43,620::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 21:00:43,620::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 21:00:43,625::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:43,625::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 21:00:43,625::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 21:00:43,625::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 21:00:43,629::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:43,629::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 21:00:43,629::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 21:00:43,629::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-14 21:00:43,632::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:43,632::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-14 21:00:43,632::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-14 21:00:43,632::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-14 21:00:43,633::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 21:00:43,633::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 21:00:43,832::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 21:00:43,846::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 21:00:43,846::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqdwsqe6e 
apiLogger::2021-10-14 21:00:43,847::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 21:00:43,847::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 21:00:43,993::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 21:00:43,993::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqdwsqe6e
apiLogger::2021-10-14 21:00:44,486::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 21:00:44,486::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 21:00:44,486::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 21:00:44,486::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 21:00:44,491::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:44,491::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 21:00:44,491::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 21:00:44,491::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-14 21:00:44,491::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 21:00:44,491::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 21:00:44,749::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 21:00:44,766::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 21:00:44,767::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnb4k6b6v 
apiLogger::2021-10-14 21:00:44,768::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 21:00:44,768::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 21:00:45,014::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 21:00:45,014::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnb4k6b6v
apiLogger::2021-10-14 21:00:45,767::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 21:00:45,767::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 21:00:45,767::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 21:00:45,767::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 21:00:45,772::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:45,772::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 21:00:45,772::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 21:00:45,772::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-14 21:00:45,776::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:45,776::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-14 21:00:45,776::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-14 21:00:45,776::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-14 21:00:45,778::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:45,778::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-14 21:00:45,778::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-14 21:00:45,778::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-14 21:00:45,781::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:45,781::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-14 21:00:45,781::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-14 21:00:45,781::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-14 21:00:45,783::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:45,783::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-14 21:00:45,783::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-14 21:00:45,783::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-14 21:00:45,783::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-14 21:00:45,783::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-14 21:00:46,337::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-14 21:00:46,338::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-14 21:00:46,339::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxs1a0dmq 
apiLogger::2021-10-14 21:00:46,339::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-14 21:00:46,339::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-14 21:00:46,345::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-14 21:00:46,345::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxs1a0dmq
apiLogger::2021-10-14 21:00:46,364::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-14 21:00:46,365::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-14 21:00:46,365::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-14 21:00:46,365::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-14 21:00:46,369::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-14 21:00:46,369::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-14 21:00:46,369::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-14 21:00:46,369::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 14-Oct-2021 21:00:25 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario #1 - MWL Follow Up\nScenario #1 Follow Up – 14-Oct-2021 \n \n \nMarc Lamberti \n617.515.6030 \nUpcoming PTO: 22-Oct ']
apiLogger::2021-10-14 21:00:46,369::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-14 21:00:46,369::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 00:22:42,760::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 00:22:42,766::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 00:22:42,767::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpztzcwjnx 
apiLogger::2021-10-15 00:22:42,767::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 00:22:42,767::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 00:22:42,917::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 00:22:42,917::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpztzcwjnx
apiLogger::2021-10-15 00:22:44,541::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 00:22:44,541::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 00:22:44,541::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 00:22:44,541::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 00:22:44,545::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 00:22:44,546::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 00:22:44,546::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 00:22:44,546::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 00:22:44,549::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 00:22:44,549::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 00:22:44,549::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 00:22:44,549::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 00:22:44,553::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 00:22:44,553::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 00:22:44,553::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 00:22:44,553::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-15 00:22:44,553::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-15 00:22:44,553::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 00:22:44,553::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 00:22:44,553::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 00:22:44,553::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 00:22:44,553::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 00:22:59,123::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 00:22:59,123::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 02:36:42,618::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 02:36:42,628::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 02:36:42,629::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpiuhj_4k4 
apiLogger::2021-10-15 02:36:42,629::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 02:36:42,630::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 02:36:42,936::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 02:36:42,936::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpiuhj_4k4
apiLogger::2021-10-15 02:36:46,792::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 02:36:46,793::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 02:36:46,793::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 02:36:46,793::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 02:36:46,798::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,798::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 02:36:46,798::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 02:36:46,798::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 02:36:46,803::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,803::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 02:36:46,803::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 02:36:46,803::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 02:36:46,808::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,808::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 02:36:46,808::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-15 02:36:46,808::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-15 02:36:46,813::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,813::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-15 02:36:46,813::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-15 02:36:46,813::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-15 02:36:46,818::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,818::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-15 02:36:46,818::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-15 02:36:46,818::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-15 02:36:46,822::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,822::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-15 02:36:46,822::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-15 02:36:46,822::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-15 02:36:46,835::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,835::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-15 02:36:46,835::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-15 02:36:46,836::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-15 02:36:46,841::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,842::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-15 02:36:46,842::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-15 02:36:46,842::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-15 02:36:46,846::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,846::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-15 02:36:46,846::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-15 02:36:46,846::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-15 02:36:46,850::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:46,850::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-15 02:36:46,850::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-15 02:36:46,850::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '(cid:45)(cid:82)(cid:86)(cid:72)(cid:83)(cid:75)(cid:15)(cid:3)(cid:54)(cid:75)(cid:72)(cid:69)(cid:68)(cid:3)(cid:53)(cid:82)(cid:86)(cid:75)(cid:68)(cid:81)\n(cid:41)(cid:85)(cid:82)(cid:80)(cid:29) (cid:81)(cid:82)(cid:85)(cid:72)(cid:83)(cid:79)(cid:92)(cid:35)(cid:80)(cid:71)(cid:86)(cid:82)(cid:79)(cid:17)(cid:70)(cid:82)(cid:80)\n(cid:54)(cid:72)(cid:81)(cid:87)(cid:29) (cid:21)(cid:27)(cid:3)(cid:45)(cid:88)(cid:79)(cid:92)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:19)(cid:21)(cid:29)(cid:21)(cid:26)\n(cid:55)(cid:82)(cid:29) (cid:54)(cid:36)(cid:40)(cid:36)(cid:47)(cid:40)(cid:53)(cid:55)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:51)(cid:53)(cid:50)(cid:39)(cid:21)(cid:30)(cid:3)(cid:54)(cid:36)(cid:40)(cid:36)(cid:47)(cid:40)(cid:53)(cid:55)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:51)(cid:53)(cid:50)(cid:39)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:29) (cid:62)(cid:40)(cid:59)(cid:55)(cid:40)(cid:53)(cid:49)(cid:36)(cid:47)(cid:64)(cid:3)(cid:36)(cid:55)(cid:55)(cid:40)(cid:49)(cid:55)(cid:44)(cid:50)(cid:49)(cid:4)(cid:3)(cid:36)(cid:81)(cid:3)(cid:36)(cid:40)(cid:54)(cid:44)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:72)(cid:81)(cid:87)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:17)(cid:3)\n(cid:51)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:85)(cid:72)(cid:89)(cid:76)(cid:72)(cid:90)(cid:3)(cid:36)(cid:54)(cid:36)(cid:51)(cid:3)(cid:68)(cid:87)(cid:3)(cid:75)(cid:87)(cid:87)(cid:83)(cid:86)(cid:29)(cid:18)(cid:18)(cid:83)(cid:85)(cid:82)(cid:87)(cid:72)(cid:70)(cid:87)(cid:16)\n(cid:72)(cid:88)(cid:17)(cid:80)(cid:76)(cid:80)(cid:72)(cid:70)(cid:68)(cid:86)(cid:87)(cid:17)(cid:70)(cid:82)(cid:80)(cid:18)(cid:86)(cid:18)(cid:84)(cid:85)(cid:69)(cid:41)(cid:38)(cid:23)(cid:53)(cid:80)(cid:50)(cid:76)(cid:37)(cid:57)(cid:19)(cid:22)(cid:37)(cid:58)(cid:43)(cid:50)(cid:74)(cid:71)(cid:50)(cid:58)(cid:34)(cid:71)(cid:82)(cid:80)(cid:68)(cid:76)(cid:81)(cid:32)(cid:79)(cid:82)(cid:74)(cid:76)(cid:81)(cid:17)(cid:76)(cid:80)(cid:72)(cid:71)(cid:76)(cid:71)(cid:68)(cid:87)(cid:68)(cid:17)(cid:70)(cid:82)(cid:80)\n(cid:41)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:3)(cid:56)(cid:83)(cid:3)(cid:41)(cid:79)(cid:68)(cid:74)(cid:29) (cid:41)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:3)(cid:88)(cid:83)\n(cid:41)(cid:79)(cid:68)(cid:74)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:88)(cid:86)(cid:29) (cid:41)(cid:79)(cid:68)(cid:74)(cid:74)(cid:72)(cid:71)\n(cid:4)(cid:374)(cid:3)(cid:4)(cid:28)(cid:94)(cid:47)(cid:3)(cid:381)(cid:296)(cid:3)(cid:100)(cid:90)(cid:75)(cid:68)(cid:17)(cid:75)(cid:47)(cid:100)(cid:75)(cid:87)(cid:28)(cid:69)(cid:47)(cid:4)(cid:3)(cid:346)(cid:258)(cid:400)(cid:3)(cid:271)(cid:286)(cid:286)(cid:374)(cid:3)(cid:396)(cid:286)(cid:393)(cid:381)(cid:396)(cid:410)(cid:286)(cid:282)(cid:3)(cid:296)(cid:381)(cid:396)(cid:3)(cid:94)(cid:437)(cid:271)(cid:361)(cid:286)(cid:272)(cid:410)(cid:3)(cid:69)(cid:437)(cid:373)(cid:271)(cid:286)(cid:396)(cid:3)(cid:1011)(cid:1013)(cid:1006)(cid:1004)(cid:1005)(cid:1006)(cid:1004)(cid:1004)(cid:1009)(cid:3)(cid:449)(cid:349)(cid:410)(cid:346)(cid:3)(cid:94)(cid:410)(cid:258)(cid:396)(cid:410)(cid:3)(cid:24)(cid:258)(cid:410)(cid:286)(cid:3)(cid:894)(cid:282)(cid:282)(cid:882)(cid:373)(cid:381)(cid:374)(cid:882)(cid:455)(cid:455)(cid:455)(cid:455)(cid:895)(cid:3)(cid:855)(cid:3)(cid:1006)(cid:1011)(cid:3)(cid:58)(cid:104)(cid:62)(cid:3)\n(cid:1006)(cid:1004)(cid:1006)(cid:1005)(cid:3)(cid:3)(cid:449)(cid:349)(cid:410)(cid:346)(cid:3)(cid:4)(cid:28)(cid:3)(cid:400)(cid:437)(cid:400)(cid:393)(cid:286)(cid:272)(cid:410)(cid:286)(cid:282)(cid:3)(cid:410)(cid:381)(cid:3)(cid:271)(cid:286)(cid:3)(cid:272)(cid:258)(cid:437)(cid:400)(cid:286)(cid:282)(cid:3)(cid:271)(cid:455)(cid:3)(cid:271)(cid:367)(cid:349)(cid:374)(cid:282)(cid:286)(cid:282)(cid:3)(cid:400)(cid:410)(cid:437)(cid:282)(cid:455)(cid:3)(cid:282)(cid:396)(cid:437)(cid:336)(cid:845)(cid:3)(cid:855)(cid:3)(cid:69)(cid:75)(cid:3)\n(cid:3)\n(cid:116)(cid:116)(cid:90)(cid:24)(cid:3)(cid:894)(cid:39)(cid:68)(cid:100)(cid:895)(cid:855)(cid:3)(cid:1006)(cid:1011)(cid:3)(cid:58)(cid:437)(cid:367)(cid:3)(cid:1006)(cid:1004)(cid:1006)(cid:1005)(cid:3)(cid:1006)(cid:1004)(cid:855)(cid:1009)(cid:1010)(cid:855)(cid:1005)(cid:1011)(cid:3)\n(cid:3)\n(cid:20) (cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:16)(cid:37)(cid:68)(cid:86)(cid:78)(cid:72)(cid:81)(cid:87)(cid:3)(cid:56)(cid:81)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:55)(cid:76)(cid:83)(cid:3)(cid:41)(cid:68)(cid:78)(cid:88)(cid:79)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:36)(cid:71)(cid:68)(cid:81)(cid:68)(cid:3)(cid:43)(cid:68)(cid:86)(cid:87)(cid:68)(cid:81)(cid:72)(cid:86)(cid:76)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:19)(cid:19)(cid:24)\n(cid:41)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:29)(cid:3)(cid:54)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)\n(cid:41)(cid:82)(cid:85)(cid:80)(cid:29)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)\n(cid:39)(cid:68)(cid:87)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:29)(cid:3)(cid:11)(cid:36)(cid:86)(cid:72)(cid:93)(cid:72)(cid:85)(cid:20)(cid:12)(cid:3)(cid:19)(cid:27)(cid:3)(cid:41)(cid:72)(cid:69)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:19)(cid:28)(cid:29)(cid:21)(cid:26)(cid:29)(cid:23)(cid:28)\n(cid:42)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:50)(cid:81)(cid:29)(cid:3)(cid:21)(cid:27)(cid:3)(cid:45)(cid:88)(cid:79)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:20)(cid:20)(cid:29)(cid:24)(cid:26)(cid:29)(cid:22)(cid:19)\n(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:29)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:29)(cid:3)(cid:3)(cid:48)(cid:68)(cid:76)(cid:81)(cid:3)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:37)(cid:76)(cid:82)(cid:83)(cid:86)(cid:92)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:54)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:41)(cid:76)(cid:85)(cid:86)(cid:87)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81) (cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:22)\n(cid:44)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:51)(cid:68)(cid:85)(cid:87)(cid:20)(cid:3)(cid:82)(cid:85)(cid:3)(cid:51)(cid:68)(cid:85)(cid:87)(cid:3)(cid:21)(cid:3)(cid:82)(cid:73) (cid:51)(cid:68)(cid:85)(cid:87)(cid:3)(cid:21)\n(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:34)\n(cid:42)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)\n(cid:43)(cid:68)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:74)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69) (cid:60)(cid:72)(cid:86)\n(cid:86)(cid:87)(cid:88)(cid:71)(cid:92)(cid:34)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:42)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:50)(cid:81)(cid:79)(cid:92)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:72)(cid:84)(cid:88)(cid:72)(cid:81)(cid:70)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:88)(cid:80)(cid:82)(cid:85) (cid:60)(cid:72)(cid:86)\n(cid:87)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:76)(cid:85)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:88)(cid:80)(cid:82)(cid:85)(cid:3)(cid:39)(cid:49)(cid:36)(cid:3)(cid:86)(cid:68)(cid:80)(cid:83)(cid:79)(cid:72)(cid:86)(cid:34)\n(cid:38)(cid:51)(cid:51)(cid:38)(cid:20)(cid:21)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:3)(cid:19)(cid:19)(cid:21)(cid:26) (cid:20)(cid:3)(cid:82)(cid:73)(cid:3)(cid:23)\n(cid:11)(cid:28)(cid:19)(cid:26)(cid:23)(cid:12) (cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:16)(cid:37)(cid:68)(cid:86)(cid:78)(cid:72)(cid:81)(cid:87)(cid:3)(cid:56)(cid:81)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:55)(cid:76)(cid:83)(cid:3)(cid:41)(cid:68)(cid:78)(cid:88)(cid:79)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:36)(cid:71)(cid:68)(cid:81)(cid:68)(cid:3)(cid:43)(cid:68)(cid:86)(cid:87)(cid:68)(cid:81)(cid:72)(cid:86)(cid:76)(cid:29)(cid:3)(cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:19)(cid:19)(cid:24)\n(cid:41)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:29)(cid:3)(cid:54)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:33)(cid:33)(cid:3)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:55)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:76)(cid:72)(cid:86)(cid:3)(cid:11)(cid:20)(cid:12)\n(cid:41)(cid:82)(cid:85)(cid:80)(cid:29)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:55)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:76)(cid:72)(cid:86)(cid:3)(cid:60)(cid:72)(cid:86)(cid:18)(cid:49)(cid:82)\n(cid:39)(cid:68)(cid:87)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:29)(cid:3)(cid:11)(cid:36)(cid:86)(cid:72)(cid:93)(cid:72)(cid:85)(cid:20)(cid:12)(cid:3)(cid:19)(cid:27)(cid:3)(cid:41)(cid:72)(cid:69)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:19)(cid:28)(cid:29)(cid:21)(cid:26)(cid:29)(cid:24)(cid:21)\n(cid:42)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:50)(cid:81)(cid:29)(cid:3)(cid:21)(cid:27)(cid:3)(cid:45)(cid:88)(cid:79)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:3)(cid:20)(cid:20)(cid:29)(cid:24)(cid:25)(cid:29)(cid:19)(cid:25)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:54)(cid:92)(cid:86)(cid:87)(cid:72)(cid:80)(cid:76)(cid:70)(cid:3)(cid:55)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:92)(cid:34) (cid:49)(cid:82)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:68)(cid:71)(cid:76)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:68)(cid:83)(cid:92)(cid:34) (cid:60)(cid:72)(cid:86)\n(cid:39)(cid:76)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:34) (cid:49)(cid:82)\n(cid:38)(cid:51)(cid:51)(cid:38)(cid:20)(cid:21)(cid:3)(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:3)(cid:19)(cid:19)(cid:21)(cid:26) (cid:20)(cid:3)(cid:82)(cid:73)(cid:3)(cid:22)\n(cid:11)(cid:28)(cid:19)(cid:26)(cid:23)(cid:12) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:51)(cid:85)(cid:82)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:83)(cid:85)(cid:82)(cid:77)(cid:72)(cid:70)(cid:87) (cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)\n(cid:44)(cid:38)(cid:50)(cid:49)(cid:3)(cid:54)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)(cid:70)(cid:82)(cid:71)(cid:72) (cid:19)(cid:23)(cid:24)(cid:25)(cid:18)(cid:19)(cid:20)(cid:23)(cid:25)\n(cid:72)(cid:81)(cid:89)(cid:76)(cid:85)(cid:82)(cid:81)(cid:80)(cid:72)(cid:81)(cid:87)(cid:49)(cid:68)(cid:80)(cid:72) (cid:51)(cid:85)(cid:82)(cid:71)\n(cid:54)(cid:76)(cid:87)(cid:72) (cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:16)(cid:37)(cid:68)(cid:86)(cid:78)(cid:72)(cid:81)(cid:87)(cid:3)(cid:56)(cid:81)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:55)(cid:76)(cid:83)(cid:3)(cid:41)(cid:68)(cid:78)(cid:88)(cid:79)(cid:87)(cid:72)(cid:86)(cid:76)(cid:3)(cid:36)(cid:71)(cid:68)(cid:81)(cid:68)(cid:3)(cid:43)(cid:68)(cid:86)(cid:87)(cid:68)(cid:81)(cid:72)(cid:86)(cid:76)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85) (cid:24)\n(cid:54)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:44)(cid:39) (cid:26)(cid:28)(cid:21)(cid:19)(cid:20)(cid:21)(cid:19)(cid:19)(cid:24)(cid:20)(cid:20)\n(cid:43)(cid:68)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:85)(cid:72)(cid:86)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:72)(cid:71)(cid:34) (cid:49)(cid:82)\n(cid:44)(cid:73)(cid:3)(cid:60)(cid:72)(cid:86)(cid:15)(cid:3)(cid:83)(cid:85)(cid:72)(cid:89)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:86)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:44)(cid:39)(cid:29)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:79)(cid:76)(cid:74)(cid:76)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:44)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:72)(cid:79)(cid:76)(cid:74)(cid:76)(cid:69)(cid:86)(cid:79)(cid:72)(cid:87)(cid:88)(cid:3)(cid:87)(cid:71)(cid:82)(cid:92)(cid:3)(cid:83)(cid:34)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86) (cid:60)(cid:72)(cid:86)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:54)(cid:88)(cid:38)(cid:69)(cid:77)(cid:82)(cid:72)(cid:81)(cid:70)(cid:86)(cid:87)(cid:3)(cid:72)(cid:54)(cid:81)(cid:76)(cid:74)(cid:87)(cid:3)(cid:81)(cid:11)(cid:71)(cid:72)(cid:71)(cid:71)(cid:16)(cid:3)(cid:80)(cid:87)(cid:75)(cid:82)(cid:72)(cid:81)(cid:3)(cid:41)(cid:16)(cid:92)(cid:76)(cid:85)(cid:92)(cid:86)(cid:92)(cid:87)(cid:3)(cid:92)(cid:44)(cid:81)(cid:12)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:43)(cid:76)(cid:83)(cid:68)(cid:86)(cid:68)(cid:3)(cid:87)(cid:87)(cid:72)(cid:75)(cid:3)(cid:76)(cid:72)(cid:81)(cid:3)(cid:86)(cid:3)(cid:87)(cid:88)(cid:75)(cid:69)(cid:72)(cid:77)(cid:3)(cid:72)(cid:74)(cid:70)(cid:72)(cid:87)(cid:81)(cid:3)(cid:70)(cid:82)(cid:82)(cid:80)(cid:81)(cid:76)(cid:86)(cid:70)(cid:72)(cid:86)(cid:81)(cid:3)(cid:86)(cid:87)(cid:88)(cid:72)(cid:71)(cid:69)(cid:3)(cid:3)(cid:87)(cid:86)(cid:82)(cid:87)(cid:88)(cid:71)(cid:92)(cid:34) (cid:60)(cid:72)(cid:86)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:42)(cid:72)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:92)(cid:86)(cid:92)(cid:3)(cid:92)(cid:38)(cid:92)(cid:82)(cid:12)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81) (cid:57)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:22)\n(cid:39)(cid:72)(cid:80)(cid:82)(cid:74)(cid:85)(cid:68)(cid:83)(cid:75)(cid:76)(cid:70)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:39)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:37)(cid:76)(cid:85)(cid:87)(cid:75)(cid:3)(cid:11)(cid:71)(cid:71)(cid:16)(cid:80)(cid:82)(cid:81)(cid:16)(cid:92)(cid:92)(cid:92)(cid:92)(cid:12) (cid:20)(cid:28)(cid:25)(cid:19)\n(cid:36)(cid:74)(cid:72)(cid:3)(cid:11)(cid:39)(cid:72)(cid:85)(cid:76)(cid:89)(cid:72)(cid:71)(cid:12)(cid:3)(cid:11)(cid:54)(cid:36)(cid:76)(cid:79)(cid:87)(cid:79)(cid:72)(cid:3)(cid:40)(cid:86)(cid:59)(cid:12)(cid:38)(cid:40)(cid:51)(cid:55)(cid:3)(cid:42)(cid:72)(cid:85)(cid:80)(cid:68)(cid:81) (cid:25)(cid:19)\n(cid:54)(cid:72)(cid:91) (cid:48)(cid:68)(cid:79)(cid:72)\n(cid:53)(cid:68)(cid:70)(cid:72)(cid:3)(cid:11)(cid:70)(cid:75)(cid:82)(cid:82)(cid:86)(cid:72)(cid:3)(cid:82)(cid:81)(cid:79)(cid:92)(cid:3)(cid:82)(cid:81)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:80)(cid:68)(cid:85)(cid:92)(cid:3)(cid:85)(cid:68)(cid:70)(cid:72)(cid:12) (cid:58)(cid:75)(cid:76)(cid:87)(cid:72)\n(cid:44)(cid:73)(cid:3)(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92)\n(cid:40)(cid:87)(cid:75)(cid:81)(cid:76)(cid:70)(cid:76)(cid:87)(cid:92) (cid:49)(cid:82)(cid:87)(cid:3)(cid:43)(cid:76)(cid:86)(cid:83)(cid:68)(cid:81)(cid:76)(cid:70)(cid:3)(cid:82)(cid:85)(cid:3)(cid:47)(cid:68)(cid:87)(cid:76)(cid:81)(cid:82)\n(cid:54)(cid:80)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:54)(cid:80)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:88)(cid:86) (cid:51)(cid:68)(cid:86)(cid:87)(cid:3)(cid:54)(cid:80)(cid:82)(cid:78)(cid:72)(cid:85)\n(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:60)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)(cid:54)(cid:80)(cid:82)(cid:78)(cid:72)(cid:71) (cid:22)(cid:24)\n(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:76)(cid:74)(cid:68)(cid:85)(cid:72)(cid:87)(cid:87)(cid:72)(cid:86)(cid:3)(cid:51)(cid:72)(cid:85)(cid:3)(cid:39)(cid:68)(cid:92) (cid:20)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:70)(cid:82)(cid:79)(cid:3)(cid:36)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:55)(cid:85)(cid:68)(cid:70)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:16)(cid:3)(cid:54)(cid:70)(cid:85)(cid:72)(cid:72)(cid:81)(cid:76)(cid:81)(cid:74)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:51)(cid:85)(cid:82)(cid:87)(cid:82)(cid:11)(cid:42)(cid:70)(cid:79)(cid:82)(cid:82)(cid:79)(cid:69)(cid:3)(cid:89)(cid:68)(cid:72)(cid:79)(cid:85)(cid:12)(cid:86)(cid:76)(cid:82)(cid:81) (cid:51)(cid:80)(cid:85)(cid:36)(cid:39)(cid:82)(cid:82)(cid:83)(cid:68)(cid:87)(cid:82)(cid:81)(cid:87)(cid:83)(cid:72)(cid:70)(cid:16)(cid:85)(cid:92)(cid:3)(cid:82)(cid:82)(cid:11)(cid:92)(cid:71)(cid:79)(cid:89)(cid:3)(cid:92)(cid:71)(cid:44)(cid:68)(cid:53)(cid:92)(cid:16)(cid:79)(cid:12)(cid:37) (cid:38)(cid:86)(cid:82)(cid:76)(cid:74)(cid:39)(cid:81)(cid:81)(cid:86)(cid:68)(cid:72)(cid:72)(cid:87)(cid:72)(cid:92)(cid:71)(cid:81)(cid:3)(cid:92)(cid:3)(cid:87)(cid:86)(cid:44)(cid:3)(cid:92)(cid:81)(cid:11)(cid:88)(cid:71)(cid:92)(cid:73)(cid:69)(cid:82)(cid:71)(cid:12)(cid:77)(cid:85)(cid:72)(cid:16)(cid:80)(cid:80)(cid:70)(cid:87)(cid:72)(cid:82)(cid:71)(cid:81)(cid:16) (cid:38)(cid:82)(cid:55)(cid:81)(cid:92)(cid:86)(cid:83)(cid:72)(cid:72)(cid:81)(cid:87) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:36)(cid:44)(cid:44)(cid:53)(cid:81)(cid:83)(cid:37)(cid:73)(cid:83)(cid:82)(cid:3)(cid:85)(cid:85)(cid:11)(cid:82)(cid:71)(cid:80)(cid:89)(cid:71)(cid:72)(cid:68)(cid:16)(cid:71)(cid:79)(cid:80)(cid:3)(cid:39)(cid:3)(cid:38)(cid:82)(cid:68)(cid:81)(cid:82)(cid:87)(cid:16)(cid:72)(cid:81)(cid:92)(cid:3)(cid:86)(cid:73)(cid:92)(cid:85)(cid:72)(cid:92)(cid:82)(cid:81)(cid:92)(cid:80)(cid:87)(cid:12)\n(cid:21) (cid:53)(cid:21)(cid:27)(cid:20)(cid:36)(cid:19)(cid:16)(cid:80)(cid:50)(cid:72)(cid:49)(cid:81)(cid:38)(cid:71)(cid:3)(cid:16)(cid:24)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22) (cid:21)(cid:20)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:43)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:11)(cid:43)(cid:48)(cid:41)(cid:36)(cid:76)(cid:76)(cid:68)(cid:69)(cid:72)(cid:86)(cid:81)(cid:79)(cid:71)(cid:87)(cid:81)(cid:76)(cid:71)(cid:82)(cid:87)(cid:76)(cid:82)(cid:92)(cid:76)(cid:70)(cid:85)(cid:81)(cid:85)(cid:12)(cid:92)(cid:68)(cid:80)(cid:74)(cid:3)(cid:79)(cid:18) (cid:54)(cid:87)(cid:80)(cid:68)(cid:85)(cid:82)(cid:87)(cid:3)(cid:81)(cid:39)(cid:16)(cid:68)(cid:92)(cid:87)(cid:92)(cid:72)(cid:92)(cid:3)(cid:11)(cid:92)(cid:71)(cid:12)(cid:71)(cid:16) (cid:88)(cid:81)(cid:38)(cid:78)(cid:81)(cid:75)(cid:71)(cid:82)(cid:72)(cid:68)(cid:70)(cid:90)(cid:87)(cid:78)(cid:81)(cid:72)(cid:3)(cid:73)(cid:3)(cid:86)(cid:82)(cid:87)(cid:85)(cid:68)(cid:85)(cid:87) (cid:50)(cid:68)(cid:72)(cid:87)(cid:81)(cid:3)(cid:81)(cid:86)(cid:74)(cid:87)(cid:87)(cid:82)(cid:85)(cid:88)(cid:92)(cid:76)(cid:71)(cid:81)(cid:34)(cid:92)(cid:74) (cid:50)(cid:54)(cid:38)(cid:42)(cid:81)(cid:83)(cid:55)(cid:85)(cid:74)(cid:72)(cid:38)(cid:44)(cid:68)(cid:82)(cid:73)(cid:70)(cid:71)(cid:36)(cid:76)(cid:76)(cid:81)(cid:72)(cid:73)(cid:40)(cid:92)(cid:74) (cid:11)(cid:11)(cid:40)(cid:85)(cid:71)(cid:72)(cid:81)(cid:92)(cid:71)(cid:86)(cid:39)(cid:71)(cid:92)(cid:16)(cid:82)(cid:68)(cid:80)(cid:3)(cid:92)(cid:79)(cid:71)(cid:87)(cid:89)(cid:92)(cid:72)(cid:82)(cid:68)(cid:72)(cid:12)(cid:81)(cid:87)(cid:71)(cid:72)(cid:16)(cid:12) (cid:88)(cid:81)(cid:38)(cid:78)(cid:75)(cid:81)(cid:71)(cid:72)(cid:82)(cid:70)(cid:68)(cid:90)(cid:78)(cid:87)(cid:72)(cid:81)(cid:3)(cid:73)(cid:3)(cid:82)(cid:72)(cid:85)(cid:81)(cid:71)\n(cid:20) (cid:36)(cid:49)(cid:40)(cid:48)(cid:44)(cid:36) (cid:21)(cid:21)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74) (cid:42)(cid:48)(cid:85)(cid:82)(cid:68)(cid:71)(cid:71)(cid:72)(cid:72)(cid:85)(cid:3)(cid:68)(cid:21)(cid:87)(cid:3)(cid:72)(cid:16) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39)\n(cid:21) (cid:43)(cid:55)(cid:60)(cid:53)(cid:51)(cid:40)(cid:50)(cid:48)(cid:49)(cid:44)(cid:36)(cid:36) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74) (cid:42)(cid:54)(cid:85)(cid:68)(cid:72)(cid:71)(cid:89)(cid:72)(cid:72)(cid:3)(cid:85)(cid:22)(cid:72)(cid:3)(cid:16) (cid:56)(cid:49)(cid:38)(cid:43)(cid:40)(cid:38)(cid:46)(cid:40)(cid:39)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:38)(cid:82)(cid:81)(cid:70)(cid:82)(cid:80)(cid:76)(cid:87)(cid:68)(cid:81)(cid:87)(cid:3)(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:47)(cid:39)(cid:80)(cid:76)(cid:86)(cid:85)(cid:83)(cid:72)(cid:87)(cid:88)(cid:3)(cid:71)(cid:72)(cid:82)(cid:74)(cid:85)(cid:76)(cid:81)(cid:3)(cid:70)(cid:3)(cid:49)(cid:79)(cid:79)(cid:68)(cid:76)(cid:92)(cid:81)(cid:68)(cid:87)(cid:3)(cid:76)(cid:72)(cid:80)(cid:82)(cid:82)(cid:81)(cid:81)(cid:72)(cid:72) (cid:44)(cid:81)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:51)(cid:48)(cid:48)(cid:44)(cid:79)(cid:72)(cid:73)(cid:72)(cid:72)(cid:68)(cid:3)(cid:68)(cid:44)(cid:71)(cid:71)(cid:83)(cid:81)(cid:86)(cid:76)(cid:85)(cid:76)(cid:83)(cid:71)(cid:70)(cid:70)(cid:72)(cid:72)(cid:68)(cid:85)(cid:76)(cid:68)(cid:3)(cid:70)(cid:70)(cid:82)(cid:86)(cid:79)(cid:79)(cid:82)(cid:3)(cid:68)(cid:3)(cid:72)(cid:83)(cid:43)(cid:43)(cid:85)(cid:87)(cid:79)(cid:85)(cid:76)(cid:71)(cid:72)(cid:76)(cid:76)(cid:76)(cid:82)(cid:86)(cid:86)(cid:68)(cid:70)(cid:17)(cid:81)(cid:87)(cid:87)(cid:87)(cid:87)(cid:82)(cid:82)(cid:72)(cid:3)(cid:3)(cid:76)(cid:87)(cid:85)(cid:85)(cid:86)(cid:75)(cid:92)(cid:92)(cid:72)(cid:15) (cid:40)(cid:44)(cid:73)(cid:89)(cid:3)(cid:68)(cid:44)(cid:72)(cid:81)(cid:83)(cid:81)(cid:71)(cid:83)(cid:87)(cid:40)(cid:76)(cid:85)(cid:15)(cid:70)(cid:82)(cid:3)(cid:89)(cid:51)(cid:68)(cid:83)(cid:72)(cid:79)(cid:87)(cid:85)(cid:72)(cid:81)(cid:76)(cid:76)(cid:82)(cid:68)(cid:87)(cid:68)(cid:3)(cid:81)(cid:86)(cid:87)(cid:85)(cid:72)(cid:3)(cid:72)(cid:72)(cid:76)(cid:3)(cid:86)(cid:70)(cid:3)(cid:36)(cid:86)(cid:3)(cid:82)(cid:36)(cid:72)(cid:71)(cid:85)(cid:79)(cid:89)(cid:71)(cid:71)(cid:72)(cid:72)(cid:89)(cid:17)(cid:70)(cid:85)(cid:72)(cid:87)(cid:86)(cid:3)(cid:85)(cid:87)(cid:72)(cid:86)(cid:75)(cid:72)(cid:72) (cid:39)(cid:82)(cid:86)(cid:72) (cid:39)(cid:56)(cid:82)(cid:81)(cid:86)(cid:76)(cid:87)(cid:72) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:41)(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:81)(cid:70)(cid:92) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:79)(cid:70)(cid:76)(cid:68)(cid:10)(cid:86)(cid:82)(cid:69)(cid:50)(cid:79)(cid:83)(cid:76)(cid:87)(cid:85)(cid:72)(cid:86)(cid:15)(cid:87)(cid:83)(cid:85)(cid:3)(cid:3)(cid:75)(cid:87)(cid:72)(cid:87)(cid:73)(cid:87)(cid:85)(cid:3)(cid:75)(cid:82)(cid:75)(cid:72)(cid:82)(cid:86)(cid:53)(cid:68)(cid:72)(cid:88)(cid:85)(cid:72)(cid:83)(cid:81)(cid:83)(cid:82)(cid:10)(cid:81)(cid:3)(cid:81)(cid:3)(cid:82)(cid:71)(cid:85)(cid:88)(cid:81)(cid:73)(cid:76)(cid:3)(cid:71)(cid:85)(cid:81)(cid:3)(cid:68)(cid:83)(cid:87)(cid:72)(cid:86)(cid:82)(cid:72)(cid:3)(cid:71)(cid:87)(cid:79)(cid:91)(cid:76)(cid:83)(cid:80)(cid:72)(cid:72)(cid:3)(cid:81)(cid:76)(cid:87)(cid:11)(cid:72)(cid:81)(cid:3)(cid:68)(cid:3)(cid:44)(cid:3)(cid:3)(cid:87)(cid:79)(cid:73)(cid:87)(cid:70)(cid:87)(cid:86)(cid:74)(cid:72)(cid:76)(cid:3)(cid:75)(cid:75)(cid:81)(cid:81)(cid:76)(cid:72)(cid:85)(cid:3)(cid:73)(cid:72)(cid:87)(cid:72)(cid:72)(cid:80)(cid:82)(cid:92)(cid:3)(cid:72)(cid:3)(cid:86)(cid:3)(cid:17)(cid:83)(cid:3)(cid:83)(cid:85)(cid:12)(cid:3)(cid:87)(cid:72)(cid:70)(cid:80)(cid:76)(cid:75)(cid:76)(cid:79)(cid:70)(cid:70)(cid:68)(cid:72)(cid:72)(cid:3)(cid:78)(cid:78)(cid:81)(cid:76)(cid:70)(cid:81)(cid:87) (cid:44)(cid:86)(cid:73)(cid:3)(cid:83)(cid:50)(cid:72)(cid:87)(cid:70)(cid:75)(cid:76)(cid:72)(cid:73)(cid:92)(cid:85)(cid:15) (cid:54)(cid:11)(cid:71)(cid:87)(cid:68)(cid:92)(cid:71)(cid:85)(cid:92)(cid:16)(cid:87)(cid:80)(cid:92)(cid:3)(cid:39)(cid:92)(cid:82)(cid:68)(cid:12)(cid:81)(cid:87)(cid:72)(cid:16) (cid:54)(cid:11)(cid:71)(cid:87)(cid:82)(cid:92)(cid:71)(cid:92)(cid:83)(cid:16)(cid:80)(cid:92)(cid:3)(cid:39)(cid:92)(cid:82)(cid:68)(cid:12)(cid:81)(cid:87)(cid:72)(cid:16) (cid:50)(cid:81)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74)\n(cid:20) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23) (cid:48)(cid:51)(cid:3)(cid:50)(cid:38)(cid:36)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:39)(cid:44)(cid:56)(cid:40) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:41)(cid:40)(cid:36)(cid:54)(cid:55)(cid:44)(cid:40)(cid:56)(cid:3)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26) (cid:40)(cid:48)(cid:40)(cid:49)(cid:39) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21)(cid:24) (cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:27) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:26)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:28) (cid:50)(cid:59)(cid:50)(cid:51)(cid:36)(cid:49)(cid:40) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24) (cid:80)(cid:74) (cid:51)(cid:53)(cid:49) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:22)(cid:3)(cid:45)(cid:56)(cid:47)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:20)(cid:19) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:20) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:21) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:22) (cid:51)(cid:38)(cid:50)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:44)(cid:39)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:23) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:51)(cid:40)(cid:43)(cid:54)(cid:36)(cid:44)(cid:55)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:24) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:25) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:26) (cid:47)(cid:36)(cid:49)(cid:54)(cid:50)(cid:53)(cid:3) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:22)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:20)(cid:26)(cid:3)(cid:36)(cid:56)(cid:42)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:20)(cid:27) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:20)(cid:28) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:19) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:20) (cid:51)(cid:38)(cid:50)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:44)(cid:39)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:21) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:41)(cid:40)(cid:36)(cid:54)(cid:55)(cid:44)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:22) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:23) (cid:40)(cid:48)(cid:40)(cid:49)(cid:39) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21)(cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:24) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:21)(cid:25) (cid:40)(cid:48)(cid:40)(cid:55)(cid:53)(cid:44)(cid:47) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85) (cid:51)(cid:53)(cid:36)(cid:50)(cid:59)(cid:51)(cid:44)(cid:43)(cid:54)(cid:60)(cid:47) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:21)(cid:26) (cid:40)(cid:48)(cid:40)(cid:39)(cid:56)(cid:53) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85) (cid:51)(cid:53)(cid:36)(cid:50)(cid:59)(cid:51)(cid:44)(cid:43)(cid:54)(cid:60)(cid:47) (cid:21)(cid:19)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:21)(cid:27) (cid:41)(cid:50)(cid:47)(cid:37)(cid:44)(cid:50)(cid:47) (cid:50)(cid:87)(cid:75)(cid:72)(cid:85) (cid:51)(cid:53)(cid:36)(cid:50)(cid:59)(cid:51)(cid:44)(cid:43)(cid:54)(cid:60)(cid:47) (cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:19)(cid:26)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:21)(cid:28) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:19) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:20) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:21) (cid:51)(cid:38)(cid:50)(cid:43)(cid:55)(cid:47)(cid:36)(cid:50)(cid:54)(cid:53)(cid:54)(cid:44)(cid:44)(cid:39)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:19)(cid:17)(cid:19)(cid:21) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:22) (cid:48)(cid:54)(cid:36)(cid:56)(cid:42)(cid:47)(cid:49)(cid:51)(cid:40)(cid:43)(cid:54)(cid:36)(cid:44)(cid:55)(cid:56)(cid:40)(cid:48) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:24) (cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:23) (cid:48)(cid:36)(cid:49)(cid:49)(cid:44)(cid:55)(cid:50)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19) (cid:80)(cid:47) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:24) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:25) (cid:40)(cid:48)(cid:40)(cid:49)(cid:39) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21)(cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:22)(cid:19)(cid:3)(cid:54)(cid:40)(cid:51)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:26) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:27) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:22)(cid:28) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:19) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:20)(cid:3)(cid:50)(cid:38)(cid:55)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:20) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:21) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:22) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:23) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:20)(cid:20)(cid:3)(cid:49)(cid:50)(cid:57)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:24) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:25) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:26) (cid:56)(cid:47)(cid:38)(cid:56)(cid:53)(cid:36)(cid:49) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:24)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:27) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:19)(cid:21)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:23)(cid:28) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:19) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:20) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:21)(cid:22)(cid:3)(cid:39)(cid:40)(cid:38)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:21) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:22) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:23) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:22)(cid:3)(cid:45)(cid:36)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:24) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:25) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:26) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:24)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:27) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:24)(cid:28) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:19) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:25)(cid:3)(cid:41)(cid:40)(cid:37)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:20) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:21) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:25)(cid:22) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:27)(cid:3)(cid:48)(cid:36)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:23) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:24) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:25) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:19)(cid:26)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:26) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:27) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:25)(cid:28) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:17)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:28)(cid:3)(cid:36)(cid:51)(cid:53)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:19) (cid:46)(cid:60)(cid:55)(cid:53)(cid:44)(cid:47) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:20) (cid:39)(cid:40)(cid:46)(cid:50)(cid:53)(cid:55) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:21) (cid:39)(cid:50)(cid:39)(cid:40)(cid:59) (cid:51)(cid:85)(cid:72)(cid:3)(cid:48)(cid:72)(cid:71) (cid:20)(cid:19)(cid:19)(cid:19) (cid:80)(cid:70)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:80)(cid:88)(cid:86)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:19)(cid:3)(cid:48)(cid:36)(cid:60)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:22) (cid:51)(cid:53)(cid:40)(cid:39)(cid:49)(cid:50)(cid:47) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:20)(cid:21)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:20)(cid:19)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:25)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:23) (cid:51)(cid:55)(cid:36)(cid:44)(cid:51)(cid:61)(cid:40)(cid:50)(cid:53)(cid:48)(cid:49)(cid:37)(cid:36)(cid:36)(cid:38)(cid:38)(cid:44)(cid:47)(cid:55)(cid:47)(cid:36)(cid:44) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:23)(cid:17)(cid:24) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:19)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:25)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:24) (cid:47)(cid:40)(cid:57)(cid:50)(cid:38)(cid:41)(cid:44)(cid:49)(cid:47)(cid:50)(cid:59)(cid:36) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:24)(cid:19)(cid:19) (cid:80)(cid:74) (cid:52)(cid:39) (cid:44)(cid:81)(cid:87)(cid:85)(cid:68)(cid:89)(cid:72)(cid:81)(cid:82)(cid:88)(cid:86) (cid:20)(cid:19)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:20)(cid:25)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:25) (cid:51)(cid:53)(cid:40)(cid:39)(cid:49)(cid:50)(cid:47) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:25)(cid:23) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:20)(cid:26)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:21)(cid:22)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:56)(cid:49)(cid:46)(cid:38)(cid:40)(cid:43)(cid:39)(cid:40)(cid:38)\n(cid:26)(cid:26) (cid:51)(cid:53)(cid:40)(cid:39)(cid:49)(cid:50)(cid:47) (cid:36)(cid:40)(cid:71)(cid:89)(cid:89)(cid:72)(cid:72)(cid:81)(cid:85)(cid:86)(cid:87)(cid:72) (cid:26)(cid:66)(cid:44)(cid:48)(cid:48)(cid:56)(cid:49)(cid:40)(cid:3)(cid:51)(cid:49)(cid:50)(cid:48)(cid:50)(cid:49)(cid:44)(cid:36) (cid:22)(cid:21) (cid:80)(cid:74) (cid:52)(cid:39) (cid:50)(cid:85)(cid:68)(cid:79) (cid:21)(cid:23)(cid:3)(cid:45)(cid:56)(cid:49)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20) (cid:38)(cid:43)(cid:40)(cid:39)(cid:38)(cid:46)(cid:40)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:38)(cid:82)(cid:81)(cid:70)(cid:82)(cid:80)(cid:76)(cid:87)(cid:68)(cid:81)(cid:87)(cid:3)(cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:18)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:76)(cid:72)(cid:86)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:3)(cid:18)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92) (cid:53)(cid:72)(cid:68)(cid:86)(cid:51)(cid:82)(cid:85)(cid:81)(cid:82)(cid:3)(cid:73)(cid:70)(cid:82)(cid:72)(cid:85)(cid:71)(cid:3)(cid:54)(cid:88)(cid:88)(cid:85)(cid:72)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:18) (cid:44)(cid:73)(cid:3)(cid:50)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:92) (cid:51)(cid:85)(cid:39)(cid:82)(cid:68)(cid:70)(cid:87)(cid:72)(cid:72)(cid:71)(cid:3)(cid:80)(cid:82)(cid:88)(cid:73)(cid:85)(cid:82)(cid:3)(cid:72)(cid:38)(cid:81)(cid:18)(cid:82)(cid:54)(cid:16)(cid:92)(cid:81)(cid:88)(cid:92)(cid:70)(cid:85)(cid:92)(cid:74)(cid:82)(cid:92)(cid:72)(cid:80)(cid:12)(cid:85)(cid:92)(cid:76)(cid:87)(cid:3)(cid:68)(cid:3)(cid:11)(cid:81)(cid:71)(cid:87)(cid:71)(cid:16)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20) (cid:53)(cid:72)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:82)(cid:81)(cid:3)(cid:51)(cid:75)(cid:68)(cid:85)(cid:80)(cid:68)(cid:70)(cid:72)(cid:88)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)\n(cid:54)(cid:72)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:36)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:40)(cid:89)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:11)(cid:54)(cid:36)(cid:40)(cid:12)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)\n(cid:51)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:38)(cid:68)(cid:81)(cid:70)(cid:72)(cid:85)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)\n(cid:53)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:18)(cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)\n(cid:51)(cid:53)(cid:82)(cid:72)(cid:86)(cid:70)(cid:76)(cid:82)(cid:87)(cid:76)(cid:85)(cid:82)(cid:71)(cid:81) (cid:51)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72) (cid:54)(cid:88)(cid:85)(cid:74)(cid:72)(cid:85)(cid:92)(cid:3)(cid:47)(cid:82)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81) (cid:44)(cid:73)(cid:3)(cid:54)(cid:88)(cid:50)(cid:85)(cid:87)(cid:74)(cid:75)(cid:72)(cid:72)(cid:85)(cid:85)(cid:92)(cid:15)(cid:3)(cid:3)(cid:47)(cid:86)(cid:83)(cid:82)(cid:72)(cid:70)(cid:70)(cid:68)(cid:76)(cid:87)(cid:73)(cid:76)(cid:92)(cid:82)(cid:81)(cid:3)(cid:76)(cid:86) (cid:39)(cid:11)(cid:71)(cid:68)(cid:71)(cid:87)(cid:72)(cid:16)(cid:80)(cid:3)(cid:82)(cid:82)(cid:73)(cid:3)(cid:81)(cid:54)(cid:16)(cid:88)(cid:92)(cid:85)(cid:92)(cid:74)(cid:92)(cid:72)(cid:92)(cid:85)(cid:12)(cid:92) (cid:38)(cid:75)(cid:72)(cid:70)(cid:78)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:56)(cid:81)(cid:78)(cid:81)(cid:82)(cid:90)(cid:81)(cid:3)(cid:39)(cid:68)(cid:87)(cid:72)\n(cid:53)(cid:21)(cid:27)(cid:20)(cid:19)(cid:16)(cid:50)(cid:49)(cid:38)(cid:16)(cid:20)(cid:25)(cid:20)(cid:20)(cid:22)(cid:66)(cid:54)(cid:36)(cid:40)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:66)(cid:21)(cid:27)(cid:16)(cid:45)(cid:56)(cid:47)(cid:16)(cid:21)(cid:19)(cid:21)(cid:20)']
apiLogger::2021-10-15 02:36:46,851::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 02:36:46,851::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 02:36:47,279::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 02:36:47,280::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 02:36:47,280::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpr2eh353i 
apiLogger::2021-10-15 02:36:47,281::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 02:36:47,281::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 02:36:47,288::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 02:36:47,288::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpr2eh353i
apiLogger::2021-10-15 02:36:47,322::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 02:36:47,322::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 02:36:47,322::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 02:36:47,322::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 02:36:47,326::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 02:36:47,326::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 02:36:47,326::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 02:36:47,326::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Robin Fultz <robin.fultz@regeneron.com>\nReceived Date : 15-Oct-2021 02:35:34 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 04 - Robin Fultz\nScenario 04 14-Oct-2021 \n \n \n \nRobin Fultz, RN \nAssociate Mgr Case Management, GPS Case Evaluation and Reporting Management \nREGENERON\n  SCIENCE TO MEDICINE® \n(914) 255-8338 cell \nRobin.Fultz@regeneron.com\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \nUpcoming Out of office dates: N/A\n \n \n \n ']
apiLogger::2021-10-15 02:36:47,326::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 02:36:47,326::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 03:18:42,725::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 03:18:42,746::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 03:18:42,746::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqgkg_veg 
apiLogger::2021-10-15 03:18:42,748::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 03:18:42,748::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 03:18:43,132::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 03:18:43,132::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqgkg_veg
apiLogger::2021-10-15 03:18:47,155::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 03:18:47,155::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 03:18:47,155::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 03:18:47,155::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 03:18:47,160::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-15 03:18:47,160::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 03:18:47,160::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 03:18:47,160::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-15 03:18:47,160::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-15 03:18:47,160::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 03:18:47,160::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-15 03:18:47,161::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 03:18:47,161::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 03:18:47,161::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 03:19:19,086::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 03:19:19,086::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 03:34:42,655::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 03:34:42,660::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 03:34:42,660::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmponynnvnm 
apiLogger::2021-10-15 03:34:42,661::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 03:34:42,661::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 03:34:42,793::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 03:34:42,794::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmponynnvnm
apiLogger::2021-10-15 03:34:44,656::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 03:34:44,656::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 03:34:44,656::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 03:34:44,656::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 03:34:44,660::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 03:34:44,660::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 03:34:44,661::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 03:34:44,661::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 03:34:44,664::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 03:34:44,664::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 03:34:44,664::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 03:34:44,664::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 03:34:44,664::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 03:34:44,664::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 03:34:44,664::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 03:34:44,664::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 03:34:44,665::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 03:34:44,665::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 03:34:59,133::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 03:34:59,133::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 04:22:42,714::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 04:22:42,720::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 04:22:42,720::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5wkuvwnl 
apiLogger::2021-10-15 04:22:42,721::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 04:22:42,721::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 04:22:42,871::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 04:22:42,871::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5wkuvwnl
apiLogger::2021-10-15 04:22:44,489::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 04:22:44,489::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 04:22:44,489::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 04:22:44,489::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 04:22:44,493::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 04:22:44,493::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 04:22:44,493::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 04:22:44,493::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 04:22:44,497::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 04:22:44,497::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 04:22:44,497::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 04:22:44,497::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 04:22:44,501::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 04:22:44,501::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 04:22:44,501::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 04:22:44,501::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-15 04:22:44,501::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-15 04:22:44,501::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 04:22:44,502::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 04:22:44,502::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 04:22:44,502::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 04:22:44,502::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 04:22:59,054::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 04:22:59,054::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 05:34:42,636::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 05:34:42,644::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 05:34:42,644::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_5jiqanl 
apiLogger::2021-10-15 05:34:42,645::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 05:34:42,645::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 05:34:42,852::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 05:34:42,853::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_5jiqanl
apiLogger::2021-10-15 05:34:44,591::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 05:34:44,591::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 05:34:44,591::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 05:34:44,591::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 05:34:44,595::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 05:34:44,595::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 05:34:44,595::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 05:34:44,595::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 05:34:44,599::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 05:34:44,599::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 05:34:44,599::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 05:34:44,599::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 05:34:44,602::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 05:34:44,602::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 05:34:44,602::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 05:34:44,602::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-15 05:34:44,602::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,030\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-15 05:34:44,602::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 05:34:44,602::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 05:34:44,603::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 05:34:44,603::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 05:34:44,603::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 05:34:59,845::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 05:34:59,845::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 05:36:42,642::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 05:36:42,648::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 05:36:42,649::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpw_jfm7ik 
apiLogger::2021-10-15 05:36:42,649::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 05:36:42,649::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 05:36:42,800::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 05:36:42,800::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpw_jfm7ik
apiLogger::2021-10-15 05:36:44,425::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 05:36:44,425::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 05:36:44,425::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 05:36:44,425::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 05:36:44,429::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 05:36:44,429::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 05:36:44,429::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 05:36:44,429::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 05:36:44,433::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 05:36:44,433::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 05:36:44,433::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 05:36:44,433::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 05:36:44,437::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 05:36:44,437::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 05:36:44,437::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 05:36:44,437::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-15 05:36:44,437::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-15 05:36:44,437::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 05:36:44,437::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 05:36:44,437::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 05:36:44,437::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 05:36:44,437::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 05:36:59,140::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 05:36:59,140::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 06:40:42,699::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 06:40:42,726::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 06:40:42,727::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3y3ux5ca 
apiLogger::2021-10-15 06:40:42,727::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 06:40:42,727::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 06:40:42,859::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 06:40:42,860::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3y3ux5ca
apiLogger::2021-10-15 06:40:44,716::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 06:40:44,716::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 06:40:44,716::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 06:40:44,716::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 06:40:44,720::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 06:40:44,721::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 06:40:44,721::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 06:40:44,721::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 06:40:44,724::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 06:40:44,724::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 06:40:44,724::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 06:40:44,724::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 06:40:44,724::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 06:40:44,725::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 06:40:44,725::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 06:40:44,725::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 06:40:44,725::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 06:40:44,725::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 06:40:59,313::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 06:40:59,313::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:12:42,607::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:12:42,612::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:12:42,612::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzgfiysaa 
apiLogger::2021-10-15 07:12:42,613::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:12:42,613::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:12:42,746::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:12:42,746::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzgfiysaa
apiLogger::2021-10-15 07:12:44,610::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:12:44,610::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:12:44,610::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:12:44,610::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:12:44,614::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:12:44,615::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:12:44,615::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:12:44,615::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 07:12:44,618::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 07:12:44,618::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 07:12:44,618::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 07:12:44,618::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 07:12:44,618::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 07:12:44,619::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 07:12:44,619::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 07:12:44,619::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 07:12:44,619::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 07:12:44,619::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 07:12:59,194::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 07:12:59,194::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:16:42,669::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:16:42,669::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:16:42,670::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgd_4k3_j 
apiLogger::2021-10-15 07:16:42,670::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:16:42,670::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:16:42,676::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:16:42,676::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgd_4k3_j
apiLogger::2021-10-15 07:16:42,715::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:16:42,716::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:16:42,716::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:16:42,716::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:16:42,720::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:16:42,720::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:16:42,720::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:16:42,720::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:14:57 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Unable to save the outgoing e-mail to mailbox\nSystem is unable to save outgoing e-mails to "Sent Items" folder of mailbox\nMedsaf.dev3@regeneron.com E-mail Type: Case Intake Acknowledgement Date/Time: 15-Oct-\n2021 12:44:56 +0530 Error: Remote host closed connection during handshake \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:16:42,720::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:16:42,720::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:18:42,698::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:18:42,698::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:18:42,699::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphq03ty6d 
apiLogger::2021-10-15 07:18:42,699::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:18:42,699::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:18:42,705::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:18:42,705::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphq03ty6d
apiLogger::2021-10-15 07:18:42,739::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:18:42,739::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:18:42,739::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:18:42,739::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:18:42,743::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:18:42,743::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:18:42,743::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:18:42,743::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:17:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000456 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000456. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:18:42,743::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:18:42,743::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:20:42,702::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:20:42,703::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:20:42,703::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1yle5af2 
apiLogger::2021-10-15 07:20:42,704::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:20:42,704::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:20:42,710::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:20:42,710::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1yle5af2
apiLogger::2021-10-15 07:20:42,743::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:20:42,743::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:20:42,743::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:20:42,743::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:20:42,747::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:20:42,747::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:20:42,747::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:20:42,747::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:19:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000457 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000457. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:20:42,747::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:20:42,747::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:22:42,707::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:22:42,708::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:22:42,708::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjj26c480 
apiLogger::2021-10-15 07:22:42,708::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:22:42,708::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:22:42,714::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:22:42,714::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjj26c480
apiLogger::2021-10-15 07:22:42,747::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:22:42,747::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:22:42,747::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:22:42,747::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:22:42,751::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:22:42,752::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:22:42,752::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:22:42,752::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:21:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000458 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000458. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:22:42,752::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:22:42,752::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:24:42,689::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:24:42,690::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:24:42,690::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfuetfl0v 
apiLogger::2021-10-15 07:24:42,690::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:24:42,690::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:24:42,696::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:24:42,696::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfuetfl0v
apiLogger::2021-10-15 07:24:42,729::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:24:42,729::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:24:42,729::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:24:42,729::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:24:42,734::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:24:42,734::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:24:42,734::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:24:42,734::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:23:43 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000459 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000459. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:24:42,734::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:24:42,734::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:26:42,686::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:26:42,687::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:26:42,687::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpd9u4zzlm 
apiLogger::2021-10-15 07:26:42,688::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:26:42,688::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:26:42,694::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:26:42,694::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpd9u4zzlm
apiLogger::2021-10-15 07:26:42,727::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:26:42,727::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:26:42,727::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:26:42,727::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:26:42,731::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:26:42,731::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:26:42,731::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:26:42,731::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:25:47 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000460 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000460. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:26:42,731::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:26:42,731::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:28:42,665::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:28:42,666::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:28:42,666::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphqzrc4fg 
apiLogger::2021-10-15 07:28:42,666::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:28:42,666::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:28:42,672::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:28:42,672::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphqzrc4fg
apiLogger::2021-10-15 07:28:42,705::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:28:42,705::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:28:42,706::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:28:42,706::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:28:42,710::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:28:42,710::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:28:42,710::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:28:42,710::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:27:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000461 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000461. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:28:42,710::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:28:42,710::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:30:42,583::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:30:42,583::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:30:42,584::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp95a216q4 
apiLogger::2021-10-15 07:30:42,584::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:30:42,584::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:30:42,590::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:30:42,590::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp95a216q4
apiLogger::2021-10-15 07:30:42,623::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:30:42,623::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:30:42,623::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:30:42,623::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:30:42,627::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:30:42,627::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:30:42,627::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:30:42,627::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:29:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000462 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000462. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:30:42,627::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:30:42,627::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:32:42,636::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:32:42,637::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:32:42,638::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_ogn282y 
apiLogger::2021-10-15 07:32:42,638::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:32:42,639::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:32:42,645::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:32:42,645::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_ogn282y
apiLogger::2021-10-15 07:32:42,678::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:32:42,678::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:32:42,678::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:32:42,678::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:32:42,682::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:32:42,682::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:32:42,682::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:32:42,683::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:31:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000463 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000463. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:32:42,683::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:32:42,683::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:34:42,660::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:34:42,661::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:34:42,661::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpoi8ut27v 
apiLogger::2021-10-15 07:34:42,661::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:34:42,661::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:34:42,667::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:34:42,667::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpoi8ut27v
apiLogger::2021-10-15 07:34:42,700::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:34:42,701::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:34:42,701::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:34:42,701::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:34:42,705::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:34:42,705::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:34:42,705::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:34:42,705::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:33:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000464 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000464. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:34:42,705::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:34:42,705::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:36:42,907::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:36:42,914::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:36:42,914::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpilphcqcy 
apiLogger::2021-10-15 07:36:42,915::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:36:42,915::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:36:42,995::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:36:42,996::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpilphcqcy
apiLogger::2021-10-15 07:36:45,323::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:36:45,323::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:36:45,323::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:36:45,323::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:36:45,327::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-15 07:36:45,328::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:36:45,328::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 07:36:45,328::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-15 07:36:45,328::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-15 07:36:45,328::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 07:36:45,328::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-15 07:36:45,328::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 07:36:45,328::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 07:36:45,328::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 07:36:56,580::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 07:36:56,580::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:36:56,654::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:36:56,655::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:36:56,655::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpol76j7kl 
apiLogger::2021-10-15 07:36:56,655::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:36:56,655::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:36:56,661::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:36:56,661::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpol76j7kl
apiLogger::2021-10-15 07:36:56,694::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:36:56,694::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:36:56,694::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:36:56,694::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:36:56,699::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:36:56,699::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:36:56,699::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:36:56,699::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:35:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000465 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000465. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:36:56,699::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:36:56,699::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:38:42,925::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:38:42,946::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:38:42,947::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpk_r9knac 
apiLogger::2021-10-15 07:38:42,948::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:38:42,948::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:38:43,221::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:38:43,221::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpk_r9knac
apiLogger::2021-10-15 07:38:46,061::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:38:46,061::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:38:46,061::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:38:46,061::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:38:46,065::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-15 07:38:46,065::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:38:46,065::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 07:38:46,065::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-15 07:38:46,065::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-15 07:38:46,066::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 07:38:46,066::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-15 07:38:46,066::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 07:38:46,066::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 07:38:46,066::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 07:39:05,664::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 07:39:05,664::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:39:05,738::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:39:05,739::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:39:05,739::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprsowz1u6 
apiLogger::2021-10-15 07:39:05,739::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:39:05,739::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:39:05,745::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:39:05,745::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprsowz1u6
apiLogger::2021-10-15 07:39:05,778::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:39:05,778::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:39:05,778::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:39:05,778::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:39:05,782::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:39:05,783::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:39:05,783::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:39:05,783::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Medsaf.dev3@regeneron.com\nReceived Date : 15-Oct-2021 07:37:42 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Adverse Event Receipt Acknowledgment 20211000466 Initial\nDear Sender, Thank you for the safety information provided. The report information provided by\nyou was received by Regeneron and has been logged as intake case # 20211000466. \nRegards, \nRegeneron Case Evaluation and Reporting Management (CERM)\n \nREGENERON SCIENCE TO MEDICINE® Regeneron Pharmaceuticals Inc. 777 Old\nSaw Mill River Rd, Tarrytown, NY 10591\n \n \nPlease do NOT reply to this auto-generated e-mail. Please address any questions to\nVCM.Distribution@regeneron.com ']
apiLogger::2021-10-15 07:39:05,783::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 07:39:05,783::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 07:48:42,631::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 07:48:42,636::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 07:48:42,636::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpphz192j7 
apiLogger::2021-10-15 07:48:42,637::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 07:48:42,637::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 07:48:42,769::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 07:48:42,770::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpphz192j7
apiLogger::2021-10-15 07:48:44,629::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 07:48:44,629::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 07:48:44,629::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 07:48:44,629::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 07:48:44,633::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 07:48:44,633::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 07:48:44,633::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 07:48:44,633::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 07:48:44,637::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 07:48:44,637::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 07:48:44,637::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 07:48:44,637::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 07:48:44,637::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 07:48:44,637::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 07:48:44,637::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 07:48:44,637::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 07:48:44,637::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 07:48:44,637::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 07:48:59,211::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 07:48:59,211::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 08:01:59,824::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 08:01:59,830::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 08:01:59,831::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpywo02xpa 
apiLogger::2021-10-15 08:01:59,831::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 08:01:59,831::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 08:01:59,964::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 08:01:59,964::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpywo02xpa
apiLogger::2021-10-15 08:02:01,826::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 08:02:01,827::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 08:02:01,827::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 08:02:01,827::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 08:02:01,831::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 08:02:01,831::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 08:02:01,831::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 08:02:01,831::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 08:02:01,835::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 08:02:01,835::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 08:02:01,835::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 08:02:01,835::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 08:02:01,835::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 08:02:01,835::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 08:02:01,835::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 08:02:01,835::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 08:02:01,835::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 08:02:01,835::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 08:02:16,403::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 08:02:16,403::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 08:16:42,635::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 08:16:42,641::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 08:16:42,642::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpufvjodd0 
apiLogger::2021-10-15 08:16:42,642::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 08:16:42,642::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 08:16:42,792::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 08:16:42,792::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpufvjodd0
apiLogger::2021-10-15 08:16:44,412::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 08:16:44,412::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 08:16:44,412::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 08:16:44,412::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 08:16:44,416::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 08:16:44,416::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 08:16:44,416::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 08:16:44,416::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 08:16:44,420::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 08:16:44,420::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 08:16:44,420::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 08:16:44,420::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 08:16:44,424::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 08:16:44,424::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 08:16:44,424::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 08:16:44,424::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-15 08:16:44,424::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-15 08:16:44,424::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 08:16:44,424::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 08:16:44,424::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 08:16:44,424::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 08:16:44,425::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 08:16:58,985::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 08:16:58,985::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 08:20:42,717::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 08:20:42,723::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 08:20:42,723::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6xp6pfzt 
apiLogger::2021-10-15 08:20:42,723::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 08:20:42,724::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 08:20:42,873::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 08:20:42,873::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6xp6pfzt
apiLogger::2021-10-15 08:20:44,489::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 08:20:44,490::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 08:20:44,490::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 08:20:44,490::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 08:20:44,494::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 08:20:44,494::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 08:20:44,494::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 08:20:44,494::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 08:20:44,498::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 08:20:44,498::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 08:20:44,498::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 08:20:44,498::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 08:20:44,502::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 08:20:44,502::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 08:20:44,502::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 08:20:44,502::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-15 08:20:44,502::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-15 08:20:44,502::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 08:20:44,502::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 08:20:44,502::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 08:20:44,502::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 08:20:44,502::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 08:20:58,939::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 08:20:58,939::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 09:04:42,597::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 09:04:42,603::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 09:04:42,603::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0l3vxizv 
apiLogger::2021-10-15 09:04:42,603::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 09:04:42,603::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 09:04:42,736::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 09:04:42,736::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0l3vxizv
apiLogger::2021-10-15 09:04:44,600::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 09:04:44,600::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 09:04:44,600::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 09:04:44,600::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 09:04:44,604::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 09:04:44,604::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 09:04:44,604::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 09:04:44,604::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 09:04:44,608::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 09:04:44,608::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 09:04:44,608::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 09:04:44,608::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 09:04:44,608::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 09:04:44,608::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 09:04:44,608::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 09:04:44,608::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 09:04:44,608::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 09:04:44,609::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 09:04:59,071::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 09:04:59,071::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 10:32:42,852::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 10:32:42,937::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 10:32:42,937::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpixftxz9h 
apiLogger::2021-10-15 10:32:42,941::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 10:32:42,941::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 10:32:43,680::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 10:32:43,680::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpixftxz9h
apiLogger::2021-10-15 10:32:47,742::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 10:32:47,742::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 10:32:47,742::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 10:32:47,742::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 10:32:47,747::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-15 10:32:47,747::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 10:32:47,747::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 10:32:47,747::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-15 10:32:47,747::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-15 10:32:47,747::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 10:32:47,747::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-15 10:32:47,747::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 10:32:47,747::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 10:32:47,747::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 10:33:21,059::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 10:33:21,060::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 12:14:42,634::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 12:14:42,639::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 12:14:42,639::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuxdkx60y 
apiLogger::2021-10-15 12:14:42,640::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 12:14:42,640::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 12:14:42,772::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 12:14:42,773::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuxdkx60y
apiLogger::2021-10-15 12:14:44,635::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 12:14:44,635::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 12:14:44,636::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 12:14:44,636::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 12:14:44,640::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 12:14:44,640::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 12:14:44,640::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 12:14:44,640::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 12:14:44,644::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 12:14:44,644::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 12:14:44,644::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 12:14:44,644::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 12:14:44,644::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 12:14:44,644::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 12:14:44,644::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 12:14:44,644::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 12:14:44,644::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 12:14:44,644::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 12:14:59,120::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 12:14:59,121::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 12:38:42,672::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 12:38:42,677::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 12:38:42,677::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsl5jdbou 
apiLogger::2021-10-15 12:38:42,678::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 12:38:42,678::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 12:38:42,810::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 12:38:42,811::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsl5jdbou
apiLogger::2021-10-15 12:38:44,674::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 12:38:44,674::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 12:38:44,674::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 12:38:44,674::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 12:38:44,678::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 12:38:44,679::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 12:38:44,679::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 12:38:44,679::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 12:38:44,683::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 12:38:44,683::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 12:38:44,683::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 12:38:44,683::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 12:38:44,683::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 12:38:44,683::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 12:38:44,683::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 12:38:44,683::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 12:38:44,683::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 12:38:44,683::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 12:38:59,145::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 12:38:59,145::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:00:42,677::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:00:42,683::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:00:42,683::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgbcdvv75 
apiLogger::2021-10-15 13:00:42,683::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:00:42,683::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:00:42,816::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:00:42,816::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgbcdvv75
apiLogger::2021-10-15 13:00:44,675::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:00:44,675::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:00:44,675::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:00:44,675::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:00:44,679::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:00:44,679::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:00:44,679::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:00:44,679::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 13:00:44,683::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 13:00:44,683::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 13:00:44,683::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 13:00:44,684::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 13:00:44,684::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 13:00:44,684::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 13:00:44,684::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 13:00:44,684::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 13:00:44,684::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 13:00:44,684::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 13:00:59,353::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 13:00:59,353::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:08:42,563::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:08:42,569::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:08:42,569::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphyaubekb 
apiLogger::2021-10-15 13:08:42,570::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:08:42,570::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:08:42,703::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:08:42,703::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphyaubekb
apiLogger::2021-10-15 13:08:44,568::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:08:44,568::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:08:44,568::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:08:44,568::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:08:44,573::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:08:44,573::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:08:44,573::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:08:44,573::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 13:08:44,577::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 13:08:44,577::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 13:08:44,577::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 13:08:44,577::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 13:08:44,577::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 13:08:44,577::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 13:08:44,578::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 13:08:44,578::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 13:08:44,578::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 13:08:44,578::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 13:08:59,154::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 13:08:59,154::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:32:42,687::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:32:42,688::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:32:42,688::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppeaptukq 
apiLogger::2021-10-15 13:32:42,688::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:32:42,688::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:32:42,693::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:32:42,693::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppeaptukq
apiLogger::2021-10-15 13:32:42,705::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:32:42,705::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:32:42,705::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:32:42,705::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:32:42,709::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:32:42,709::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:32:42,709::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:32:42,710::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 15-Oct-2021 13:30:42 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : test\n ']
apiLogger::2021-10-15 13:32:42,710::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 13:32:42,710::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:34:42,683::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:34:42,684::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:34:42,684::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnkmp7kyr 
apiLogger::2021-10-15 13:34:42,684::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:34:42,684::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:34:42,690::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:34:42,690::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnkmp7kyr
apiLogger::2021-10-15 13:34:42,702::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:34:42,702::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:34:42,702::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:34:42,702::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:34:42,706::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:34:42,706::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:34:42,706::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:34:42,706::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 15-Oct-2021 13:33:43 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Test\nTest ']
apiLogger::2021-10-15 13:34:42,706::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 13:34:42,706::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:38:42,758::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:38:42,758::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:38:42,759::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmph2e8tm02 
apiLogger::2021-10-15 13:38:42,759::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:38:42,759::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:38:42,764::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:38:42,764::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmph2e8tm02
apiLogger::2021-10-15 13:38:42,780::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:38:42,780::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:38:42,780::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:38:42,780::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:38:42,784::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:38:42,785::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:38:42,785::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:38:42,785::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh <reshabh.reshabh@rxlogix.com>\nReceived Date : 15-Oct-2021 13:37:49 +0000\nTo : "Medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> Test\nEXTERNAL MESSAGE \n \nTest ']
apiLogger::2021-10-15 13:38:42,785::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 13:38:42,785::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:40:42,741::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:40:42,742::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:40:42,742::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpun9numpd 
apiLogger::2021-10-15 13:40:42,742::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:40:42,742::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:40:42,748::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:40:42,748::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpun9numpd
apiLogger::2021-10-15 13:40:42,763::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:40:42,763::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:40:42,763::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:40:42,763::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:40:42,768::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:40:42,768::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:40:42,768::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:40:42,768::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh <reshabh.reshabh@rxlogix.com>\nReceived Date : 15-Oct-2021 13:39:56 +0000\nTo : "Medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> Test\nEXTERNAL MESSAGE \n \nTest ']
apiLogger::2021-10-15 13:40:42,768::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 13:40:42,768::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:42:42,658::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:42:42,663::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:42:42,663::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpya2obpd4 
apiLogger::2021-10-15 13:42:42,664::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:42:42,664::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:42:42,797::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:42:42,797::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpya2obpd4
apiLogger::2021-10-15 13:42:44,661::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:42:44,661::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:42:44,661::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:42:44,661::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:42:44,666::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:42:44,666::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:42:44,666::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:42:44,666::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 13:42:44,670::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 13:42:44,670::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 13:42:44,670::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 13:42:44,670::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 13:42:44,670::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 13:42:44,670::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 13:42:44,670::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 13:42:44,670::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 13:42:44,670::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 13:42:44,670::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 13:42:59,256::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 13:42:59,256::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:50:42,757::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:50:42,758::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:50:42,759::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplkml9kq_ 
apiLogger::2021-10-15 13:50:42,759::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:50:42,759::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:50:42,764::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:50:42,765::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplkml9kq_
apiLogger::2021-10-15 13:50:42,784::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:50:42,784::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:50:42,785::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:50:42,785::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:50:42,789::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:50:42,789::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:50:42,789::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:50:42,789::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 15-Oct-2021 13:50:23 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : FW: test\n \n \nFrom: Ritu Sharma-External Sent: Friday, October 15, 2021 7:01 PM To: Medsaf.dev3\n<Medsaf.dev3@regeneron.com> Subject: test \n \n ']
apiLogger::2021-10-15 13:50:42,789::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 13:50:42,789::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 13:54:42,676::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 13:54:42,682::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 13:54:42,682::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmptl96_lnb 
apiLogger::2021-10-15 13:54:42,682::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 13:54:42,682::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 13:54:42,869::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 13:54:42,869::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmptl96_lnb
apiLogger::2021-10-15 13:54:44,857::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 13:54:44,858::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 13:54:44,858::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 13:54:44,858::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 13:54:44,862::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 13:54:44,862::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 13:54:44,862::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 13:54:44,862::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 13:54:44,866::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 13:54:44,866::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 13:54:44,866::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 13:54:44,867::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-15 13:54:44,867::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,030\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-15 13:54:44,867::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 13:54:44,867::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 13:54:44,867::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 13:54:44,867::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 13:54:44,867::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 13:54:59,763::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 13:54:59,763::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 14:00:42,687::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 14:00:42,701::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 14:00:42,701::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphj9ibfxx 
apiLogger::2021-10-15 14:00:42,702::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 14:00:42,702::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 14:00:42,848::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 14:00:42,848::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphj9ibfxx
apiLogger::2021-10-15 14:00:43,340::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 14:00:43,341::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 14:00:43,341::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 14:00:43,341::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 14:00:43,346::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 14:00:43,346::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 14:00:43,346::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 14:00:43,346::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-15 14:00:43,346::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 14:00:43,346::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 14:00:43,620::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 14:00:43,634::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 14:00:43,634::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmj234itr 
apiLogger::2021-10-15 14:00:43,635::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 14:00:43,635::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 14:00:44,943::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 14:00:44,943::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmj234itr
apiLogger::2021-10-15 14:00:46,264::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 14:00:46,264::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 14:00:46,264::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 14:00:46,264::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 14:00:46,269::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 14:00:46,269::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 14:00:46,269::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 14:00:46,269::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 14:00:46,273::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 14:00:46,273::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 14:00:46,273::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 14:00:46,274::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-15 14:00:46,274::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 14:00:46,274::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 14:00:46,765::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 14:00:46,765::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 14:00:46,766::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqmpeej1i 
apiLogger::2021-10-15 14:00:46,766::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 14:00:46,766::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 14:00:46,771::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 14:00:46,771::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqmpeej1i
apiLogger::2021-10-15 14:00:46,784::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 14:00:46,784::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 14:00:46,784::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 14:00:46,784::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 14:00:46,788::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 14:00:46,788::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 14:00:46,788::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 14:00:46,788::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 15-Oct-2021 14:00:32 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 initial\nScenario 1: 15/10/2021 ']
apiLogger::2021-10-15 14:00:46,789::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 14:00:46,789::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 15:14:42,785::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 15:14:42,807::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 15:14:42,808::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplxzqip20 
apiLogger::2021-10-15 15:14:42,809::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 15:14:42,809::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 15:14:43,195::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 15:14:43,195::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplxzqip20
apiLogger::2021-10-15 15:14:47,230::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 15:14:47,230::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 15:14:47,230::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 15:14:47,230::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 15:14:47,235::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-15 15:14:47,235::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 15:14:47,235::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 15:14:47,235::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-15 15:14:47,235::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-15 15:14:47,235::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 15:14:47,235::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-15 15:14:47,235::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 15:14:47,235::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 15:14:47,236::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 15:15:19,280::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 15:15:19,280::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 15:22:42,780::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 15:22:42,801::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 15:22:42,801::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpimo3pmjo 
apiLogger::2021-10-15 15:22:42,803::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 15:22:42,803::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 15:22:43,076::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 15:22:43,077::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpimo3pmjo
apiLogger::2021-10-15 15:22:45,925::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 15:22:45,925::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 15:22:45,925::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 15:22:45,925::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 15:22:45,930::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-15 15:22:45,930::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 15:22:45,930::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 15:22:45,930::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-15 15:22:45,930::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-15 15:22:45,930::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 15:22:45,930::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-15 15:22:45,930::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 15:22:45,930::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 15:22:45,931::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 15:23:05,556::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 15:23:05,556::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 15:40:42,698::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 15:40:42,698::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 15:40:42,699::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx6ko0xyg 
apiLogger::2021-10-15 15:40:42,699::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 15:40:42,699::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 15:40:42,704::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 15:40:42,704::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx6ko0xyg
apiLogger::2021-10-15 15:40:42,714::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 15:40:42,715::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 15:40:42,715::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 15:40:42,715::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 15:40:42,719::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 15:40:42,719::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 15:40:42,719::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 15:40:42,719::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 15-Oct-2021 15:39:55 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\ntest ']
apiLogger::2021-10-15 15:40:42,719::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 15:40:42,719::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 17:38:42,684::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 17:38:42,698::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 17:38:42,698::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp490hqsfm 
apiLogger::2021-10-15 17:38:42,699::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 17:38:42,699::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 17:38:42,845::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 17:38:42,845::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp490hqsfm
apiLogger::2021-10-15 17:38:43,338::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 17:38:43,339::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 17:38:43,339::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 17:38:43,339::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 17:38:43,344::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:43,344::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 17:38:43,344::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 17:38:43,344::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-15 17:38:43,344::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 17:38:43,344::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 17:38:43,610::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 17:38:43,628::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 17:38:43,628::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdgz_39lt 
apiLogger::2021-10-15 17:38:43,629::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 17:38:43,629::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 17:38:43,873::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 17:38:43,873::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdgz_39lt
apiLogger::2021-10-15 17:38:44,625::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 17:38:44,625::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 17:38:44,625::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 17:38:44,625::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 17:38:44,630::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:44,630::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 17:38:44,630::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 17:38:44,630::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 17:38:44,634::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:44,634::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 17:38:44,634::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 17:38:44,634::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 17:38:44,637::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:44,637::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 17:38:44,637::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-15 17:38:44,637::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-15 17:38:44,640::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:44,640::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-15 17:38:44,640::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-15 17:38:44,640::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-15 17:38:44,643::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:44,643::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-15 17:38:44,643::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-15 17:38:44,643::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-15 17:38:44,643::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-15 17:38:44,643::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 17:38:44,884::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 17:38:44,889::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 17:38:44,889::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5ab36cpw 
apiLogger::2021-10-15 17:38:44,889::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 17:38:44,889::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 17:38:45,057::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 17:38:45,058::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5ab36cpw
apiLogger::2021-10-15 17:38:45,788::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 17:38:45,789::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 17:38:45,789::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 17:38:45,789::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 17:38:45,794::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:45,794::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 17:38:45,794::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 17:38:45,794::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 17:38:45,798::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:45,798::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 17:38:45,798::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 17:38:45,798::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 17:38:45,802::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:45,802::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 17:38:45,802::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-15 17:38:45,802::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88291 (v.2)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88291 (v.2)\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88291 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-15 17:38:45,802::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 17:38:45,802::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 17:38:46,205::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 17:38:46,206::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 17:38:46,206::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2jm50zn_ 
apiLogger::2021-10-15 17:38:46,207::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 17:38:46,207::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 17:38:46,212::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 17:38:46,212::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2jm50zn_
apiLogger::2021-10-15 17:38:46,223::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 17:38:46,223::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 17:38:46,223::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 17:38:46,224::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 17:38:46,228::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 17:38:46,228::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 17:38:46,228::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 17:38:46,228::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 15-Oct-2021 17:37:13 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : sv 2\n ']
apiLogger::2021-10-15 17:38:46,228::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 17:38:46,228::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 17:52:42,709::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 17:52:42,730::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 17:52:42,730::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpubwurq13 
apiLogger::2021-10-15 17:52:42,731::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 17:52:42,731::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 17:52:43,004::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 17:52:43,004::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpubwurq13
apiLogger::2021-10-15 17:52:45,849::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 17:52:45,849::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 17:52:45,849::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 17:52:45,849::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 17:52:45,853::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-15 17:52:45,854::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 17:52:45,854::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 17:52:45,854::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-15 17:52:45,854::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-15 17:52:45,854::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 17:52:45,854::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-15 17:52:45,854::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 17:52:45,854::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 17:52:45,854::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 17:53:05,358::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 17:53:05,358::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 18:54:42,758::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 18:54:42,764::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 18:54:42,765::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp66l9mw3n 
apiLogger::2021-10-15 18:54:42,765::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 18:54:42,765::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 18:54:42,915::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 18:54:42,915::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp66l9mw3n
apiLogger::2021-10-15 18:54:44,539::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 18:54:44,539::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 18:54:44,539::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 18:54:44,539::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 18:54:44,544::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 18:54:44,544::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 18:54:44,544::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 18:54:44,544::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-15 18:54:44,548::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 18:54:44,548::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-15 18:54:44,548::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-15 18:54:44,548::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-15 18:54:44,553::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-15 18:54:44,553::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-15 18:54:44,553::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-15 18:54:44,553::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-15 18:54:44,553::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-15 18:54:44,553::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-15 18:54:44,553::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-15 18:54:44,553::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-15 18:54:44,553::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-15 18:54:44,553::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-15 18:54:59,307::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-15 18:54:59,307::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-15 19:19:13,786::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-15 19:19:13,786::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-15 19:19:13,787::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpe17gn9zl 
apiLogger::2021-10-15 19:19:13,787::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-15 19:19:13,787::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-15 19:19:13,792::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-15 19:19:13,792::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpe17gn9zl
apiLogger::2021-10-15 19:19:13,805::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-15 19:19:13,805::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-15 19:19:13,805::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-15 19:19:13,805::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-15 19:19:13,809::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-15 19:19:13,809::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-15 19:19:13,809::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-15 19:19:13,810::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Spam Daily Digest <digest@regeneron.com>\nReceived Date : 15-Oct-2021 15:17:34 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Spam Daily Digest: 0 New Messages  (2 Valid Emails)\nProofpoint']
apiLogger::2021-10-15 19:19:13,810::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-15 19:19:13,810::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
